<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Oxygenation &amp; Gas Exchange â€” Comprehensive Learning Guide (Ch 17-20)</title>
<style>
:root {
  --blue: #2563eb; --blue-light: #dbeafe; --blue-bg: #eff6ff;
  --red: #dc2626; --red-light: #fee2e2; --red-bg: #fef2f2;
  --amber: #d97706; --amber-light: #fef3c7; --amber-bg: #fffbeb;
  --green: #059669; --green-light: #d1fae5; --green-bg: #ecfdf5;
  --purple: #7c3aed; --purple-light: #ede9fe; --purple-bg: #f5f3ff;
  --teal: #0d9488; --teal-light: #ccfbf1; --teal-bg: #f0fdfa;
  --slate: #1e293b; --slate-mid: #64748b; --slate-light: #f8fafc;
  --border: #e2e8f0;
}
*{box-sizing:border-box;margin:0;padding:0;}
body{font-family:'Segoe UI',system-ui,-apple-system,sans-serif;line-height:1.75;color:var(--slate);background:var(--slate-light);}
.page-wrap{display:flex;min-height:100vh;}

/* NAV */
nav.toc{position:sticky;top:0;left:0;width:280px;min-width:280px;height:100vh;overflow-y:auto;background:#fff;border-right:1px solid var(--border);padding:1.5rem 1rem;font-size:.8rem;z-index:100;}
nav.toc h2{font-size:.95rem;color:var(--blue);margin-bottom:.75rem;border:none;background:none;padding:0;}
nav.toc a{display:block;padding:.3rem .5rem;color:var(--slate-mid);text-decoration:none;border-radius:4px;transition:all .15s;}
nav.toc a:hover{background:var(--blue-bg);color:var(--blue);}
nav.toc a.sub{padding-left:1.25rem;font-size:.75rem;}
nav.toc .nav-group{margin-bottom:.4rem;}
nav.toc .nav-label{font-weight:700;color:var(--slate);font-size:.7rem;text-transform:uppercase;letter-spacing:.5px;padding:.5rem .5rem .15rem;margin-top:.5rem;}

/* MAIN */
main{flex:1;max-width:940px;margin:0 auto;padding:2.5rem 3rem 4rem;}

/* TYPOGRAPHY */
h1{font-size:2rem;color:var(--blue);border-bottom:4px solid var(--blue);padding-bottom:.5rem;margin-bottom:.25rem;}
.subtitle{color:var(--slate-mid);margin-bottom:2.5rem;font-size:.88rem;}
h2.section-title{font-size:1.3rem;color:#fff;padding:.75rem 1.2rem;border-radius:6px;margin:3rem 0 1.25rem;scroll-margin-top:1rem;}
h2.blue{background:linear-gradient(135deg,var(--blue),#3b82f6);}
h2.teal{background:linear-gradient(135deg,var(--teal),#14b8a6);}
h2.red{background:linear-gradient(135deg,var(--red),#ef4444);}
h2.purple{background:linear-gradient(135deg,var(--purple),#8b5cf6);}
h2.amber{background:linear-gradient(135deg,var(--amber),#f59e0b);}
h2.green{background:linear-gradient(135deg,var(--green),#10b981);}
h3{color:var(--blue);border-left:4px solid var(--blue);padding-left:.75rem;margin:2rem 0 .75rem;font-size:1.08rem;scroll-margin-top:1rem;}
h3.teal{color:var(--teal);border-color:var(--teal);}
h3.red{color:var(--red);border-color:var(--red);}
h3.purple{color:var(--purple);border-color:var(--purple);}
h4{color:var(--slate);margin:1.25rem 0 .5rem;font-size:.95rem;}
p{margin-bottom:.85rem;}
strong{color:var(--slate);}

/* SOURCE TAGS */
.tag{display:inline-block;padding:.1rem .45rem;border-radius:10px;font-size:.65rem;font-weight:700;vertical-align:middle;margin-left:.25rem;}
.tag-slides{background:#dbeafe;color:#1d4ed8;}
.tag-heavy{background:#fee2e2;color:#991b1b;}
.tag-textbook{background:#fef3c7;color:#92400e;}

/* CALLOUTS */
.callout{padding:1rem 1.2rem;margin:1.25rem 0;border-radius:0 8px 8px 0;border-left:5px solid;}
.callout-title{font-weight:700;font-size:.82rem;margin-bottom:.3rem;}
.callout p:last-child,.callout ul:last-child{margin-bottom:0;}
.pearl{background:var(--blue-bg);border-color:var(--blue);}.pearl .callout-title{color:var(--blue);}
.warning{background:var(--red-bg);border-color:var(--red);}.warning .callout-title{color:var(--red);}
.memory{background:var(--purple-bg);border-color:var(--purple);}.memory .callout-title{color:var(--purple);}
.clinical{background:var(--teal-bg);border-color:var(--teal);font-style:italic;}.clinical .callout-title{color:var(--teal);font-style:normal;}

/* TABLES */
table{width:100%;border-collapse:collapse;margin:1rem 0;box-shadow:0 1px 4px rgba(0,0,0,.07);border-radius:6px;overflow:hidden;}
th{background:var(--blue);color:#fff;padding:.6rem .7rem;text-align:left;font-size:.8rem;font-weight:600;}
td{padding:.55rem .7rem;border-bottom:1px solid var(--border);font-size:.84rem;vertical-align:top;}
tr:nth-child(even){background:#f8fafc;}
tr:hover{background:#e0f2fe;}
table.teal th{background:var(--teal);}
table.red th{background:var(--red);}
table.purple th{background:var(--purple);}
table.amber th{background:var(--amber);}
table.green th{background:var(--green);}

/* COMPARE CARDS */
.compare-row{display:grid;grid-template-columns:1fr 1fr;gap:1.25rem;margin:1.25rem 0;}
.compare-card{border-radius:8px;padding:1.2rem;border:2px solid;}
.compare-card h4{margin-top:0;}
.compare-card.left{border-color:var(--blue);background:var(--blue-bg);}
.compare-card.right{border-color:var(--teal);background:var(--teal-bg);}

/* FLOW CHAINS */
.flow-chain{display:flex;align-items:center;flex-wrap:wrap;gap:.25rem;margin:1rem 0;font-size:.84rem;}
.flow-step{background:var(--blue-bg);border:1px solid var(--blue);color:var(--blue);padding:.35rem .7rem;border-radius:18px;font-weight:600;white-space:nowrap;}
.flow-step.danger{background:var(--red-bg);border-color:var(--red);color:var(--red);}
.flow-step.warn{background:var(--amber-bg);border-color:var(--amber);color:var(--amber);}
.flow-step.good{background:var(--green-bg);border-color:var(--green);color:var(--green);}
.flow-arrow{color:var(--slate-mid);font-weight:700;font-size:1.1rem;}

/* PATHO CHAIN */
.patho-chain{background:var(--slate);color:#67e8f9;padding:1.25rem 1.5rem;border-radius:8px;font-family:'Cascadia Code','Consolas',monospace;font-size:.8rem;line-height:2;margin:1.25rem 0;overflow-x:auto;white-space:pre-wrap;}

/* DIAGRAM GRID */
.diagram{background:#fff;border:1px solid var(--border);border-radius:8px;padding:1.25rem;margin:1.25rem 0;box-shadow:0 2px 6px rgba(0,0,0,.05);}
.diagram-title{font-weight:700;color:var(--slate);font-size:.88rem;text-align:center;margin-bottom:1rem;}

/* LISTS */
ul,ol{margin-left:1.5rem;margin-bottom:.9rem;}
li{margin-bottom:.3rem;font-size:.9rem;}

/* COLLAPSIBLE */
details.pause{margin:1.5rem 0;border:2px dashed var(--purple);border-radius:8px;background:var(--purple-bg);}
details.pause summary{cursor:pointer;padding:.7rem 1rem;font-weight:600;color:var(--purple);font-size:.88rem;list-style:none;}
details.pause summary::before{content:'+ ';font-weight:800;}
details.pause[open] summary::before{content:'- ';}
details.pause .pause-content{padding:0 1rem 1rem;color:var(--slate);font-size:.88rem;}

/* RESPONSIVE */
@media(max-width:900px){
  nav.toc{display:none;}
  main{padding:1.5rem 1rem;}
  .compare-row{grid-template-columns:1fr;}
}
</style>
</head>
<body>
<div class="page-wrap">

<!-- NAVIGATION -->
<nav class="toc">
<h2>Oxygenation Guide</h2>

<div class="nav-label">I. Foundations</div>
<div class="nav-group">
<a href="#s1">Gas Exchange &amp; Transport</a>
<a href="#s1-vq" class="sub">V/Q Ratios</a>
<a href="#s1-compliance" class="sub">Compliance &amp; Resistance</a>
<a href="#s1-volumes" class="sub">Lung Volumes &amp; Capacities</a>
<a href="#s1-neuro" class="sub">Neurologic Control</a>
</div>

<div class="nav-label">II. Assessment</div>
<div class="nav-group">
<a href="#s2">Respiratory Assessment</a>
<a href="#s2-symptoms" class="sub">Key Symptoms</a>
<a href="#s2-physical" class="sub">Physical Findings</a>
<a href="#s2-patterns" class="sub">Breathing Patterns</a>
<a href="#s2-sounds" class="sub">Breath &amp; Percussion Sounds</a>
</div>

<div class="nav-label">III. Diagnostics</div>
<div class="nav-group">
<a href="#s3">Diagnostics &amp; ABGs</a>
<a href="#s3-abg" class="sub">ABG Interpretation</a>
<a href="#s3-etco2" class="sub">ETCO2 / Capnography</a>
<a href="#s3-imaging" class="sub">Imaging &amp; Procedures</a>
</div>

<div class="nav-label">IV. O2 Therapy</div>
<div class="nav-group">
<a href="#s4">Oxygen Therapy</a>
<a href="#s4-devices" class="sub">Delivery Devices</a>
</div>

<div class="nav-label">V. Upper Resp</div>
<div class="nav-group">
<a href="#s5">Upper Respiratory Disorders</a>
<a href="#s5-osa" class="sub">Obstructive Sleep Apnea</a>
<a href="#s5-laryngeal" class="sub">Laryngeal Cancer</a>
</div>

<div class="nav-label">VI. Lower Resp</div>
<div class="nav-group">
<a href="#s6">Pneumonia &amp; Infections</a>
</div>

<div class="nav-label">VII. Obstructive Disease</div>
<div class="nav-group">
<a href="#s7">COPD, Asthma, CF</a>
<a href="#s7-atelectasis" class="sub">Atelectasis</a>
<a href="#s7-copd" class="sub">COPD</a>
<a href="#s7-asthma" class="sub">Asthma</a>
<a href="#s7-cf" class="sub">Cystic Fibrosis</a>
</div>

<div class="nav-label">VIII. Cancer &amp; Surgery</div>
<div class="nav-group">
<a href="#s8">Lung Cancer &amp; Thoracic Surgery</a>
</div>

<div class="nav-label">IX. Pleural &amp; Trauma</div>
<div class="nav-group">
<a href="#s9">Chest Trauma &amp; Pleural</a>
<a href="#s9-chest-tubes" class="sub">Chest Tubes</a>
</div>

<div class="nav-label">X. Critical Care</div>
<div class="nav-group">
<a href="#s10">ARF &amp; ARDS</a>
<a href="#s11">Mech Ventilation</a>
<a href="#s11-vap" class="sub">VAP &amp; ABCDEF</a>
<a href="#s11-weaning" class="sub">Weaning &amp; Extubation</a>
</div>

<div class="nav-label">XI. Vascular</div>
<div class="nav-group">
<a href="#s12">PE &amp; Pulm HTN</a>
</div>

<div class="nav-label">XII. COVID-19</div>
<div class="nav-group">
<a href="#s13">COVID-19</a>
</div>

<div class="nav-label">XIII. Special Pops</div>
<div class="nav-group">
<a href="#s14">Gerontologic</a>
</div>

<div class="nav-label">XIV. Pharm</div>
<div class="nav-group">
<a href="#s15">Pharmacology Summary</a>
</div>

<div class="nav-label">XV. Review</div>
<div class="nav-group">
<a href="#s16">NCLEX High-Yield</a>
</div>
</nav>

<!-- MAIN CONTENT -->
<main>

<h1>Oxygenation &amp; Gas Exchange</h1>
<p class="subtitle">Brunner &amp; Suddarth Chapters 17-20 &mdash; Comprehensive Learning Guide</p>

<!-- ============================================================ -->
<!-- SECTION 1: FOUNDATIONS -->
<!-- ============================================================ -->

<h2 class="section-title blue" id="s1">I. Foundations of Respiratory Function</h2>

<h3>Gas Exchange &amp; Oxygen Transport</h3>

<p>The entire purpose of the respiratory system can be stated in one sentence: deliver oxygen to every cell in the body and remove the carbon dioxide those cells produce. <span class="tag tag-slides">SLIDES</span> Oxygen diffuses from capillary blood, across the capillary wall, and into the interstitial fluid surrounding cells. Carbon dioxide travels the opposite direction&mdash;from the cell into the blood&mdash;and is transported back to the lungs for exhalation.</p>

<p>Two terms anchor everything that follows. <strong>Respiration</strong> is the entire process of gas exchange between atmospheric air and blood, and between blood and cells. <strong>Ventilation</strong> is the mechanical component&mdash;the movement of the thoracic walls and diaphragm that physically moves air in and out of the lungs. You can have ventilation without adequate respiration (think dead-space ventilation), and that distinction matters clinically.</p>

<h4>The Respiratory Center</h4>
<p>Breathing is controlled by the brainstem. The <strong>medulla oblongata</strong> houses the inspiratory and expiratory centers that set the baseline rate and depth of ventilation. The <strong>pons</strong> fine-tunes this: the lower pons (apneustic center) promotes deep, prolonged inspiration, while the upper pons (pneumotaxic center) controls the overall pattern of respirations. <span class="tag tag-slides">SLIDES</span></p>

<p>Two types of chemoreceptors keep this system responsive to metabolic demands:</p>
<ul>
<li><strong>Central chemoreceptors</strong> (medulla): respond to pH changes in the cerebrospinal fluid, which reflect blood CO2 levels. When pH drops (more acidic = more CO2), these receptors signal the lungs to increase depth, then rate, of ventilation.</li>
<li><strong>Peripheral chemoreceptors</strong> (aortic arch and carotid bodies): respond <em>first</em> to changes in PaO2, then to PaCO2 and pH. These are your backup system&mdash;they kick in when oxygen levels drop.</li>
</ul>

<div class="callout pearl">
<div class="callout-title">Pearl: Why This Matters for COPD</div>
<p>In healthy people, the primary drive to breathe is rising CO2 detected by central chemoreceptors. In chronic CO2 retainers (severe COPD), the central chemoreceptors become desensitized to chronically elevated CO2. Their remaining drive to breathe is <strong>hypoxic drive</strong>&mdash;low O2 detected by peripheral chemoreceptors. This is why high-flow O2 can suppress respiratory drive in COPD patients.</p>
</div>

<p>Additional control mechanisms from the textbook: <span class="tag tag-textbook">TEXTBOOK</span></p>
<ul>
<li><strong>Hering-Breuer reflex</strong>: stretch receptors in the alveoli inhibit inspiration when the lungs become overdistended&mdash;a built-in safety valve against overinflation.</li>
<li><strong>Proprioceptors</strong>: respond to body movements and increase ventilation. This is the physiologic rationale for range-of-motion exercises and early mobilization in immobile patients.</li>
</ul>

<h4>Pressure, Airflow, and Resistance</h4>
<p>Air moves from areas of high pressure to low pressure&mdash;that is the entire mechanical basis of breathing. <span class="tag tag-slides">SLIDES</span> During <strong>inspiration</strong>, the diaphragm contracts and the thoracic cavity expands, creating lower pressure inside the lungs than outside&mdash;air flows in. During <strong>expiration</strong>, the elastic recoil of lung tissue raises alveolar pressure above atmospheric pressure&mdash;air flows out.</p>

<p><strong>Airflow resistance</strong> is determined by airway diameter and lung volumes. If bronchial diameter changes for any reason, resistance changes with it. Increased resistance means the patient must work harder to move air. <span class="tag tag-slides">SLIDES</span></p>

<h3 id="s1-compliance">Compliance &amp; Resistance</h3>

<p><strong>Compliance</strong> is the ease with which the lungs can expand under pressure&mdash;the elasticity and expandability of the lungs and thoracic structures. Think of it as how stretchy the lung is. <span class="tag tag-heavy">HEAVY IN SLIDES</span></p>

<div class="compare-row">
<div class="compare-card left">
<h4>Increased Compliance</h4>
<p>The lungs have <em>lost</em> their elastic recoil and are overdistended. Air goes in easily but won't come back out. The classic example is <strong>emphysema</strong>&mdash;the destroyed alveolar walls can no longer spring back during exhalation.</p>
</div>
<div class="compare-card right">
<h4>Decreased Compliance</h4>
<p>The lungs are <em>stiff</em> and require greater energy to inflate. Conditions that decrease compliance:</p>
<ul>
<li>Pneumothorax, hemothorax</li>
<li>Morbid obesity</li>
<li>Pleural effusion</li>
<li>Pulmonary edema</li>
<li>Atelectasis</li>
<li>Pulmonary fibrosis</li>
<li><strong>ARDS</strong></li>
</ul>
</div>
</div>

<h4>Causes of Increased Airway Resistance <span class="tag tag-slides">SLIDES</span></h4>
<table>
<tr><th>Mechanism</th><th>Pathology</th></tr>
<tr><td>Bronchial smooth muscle contraction</td><td><strong>Asthma</strong></td></tr>
<tr><td>Bronchial mucosa thickening</td><td><strong>Chronic bronchitis</strong></td></tr>
<tr><td>Airway obstruction</td><td>Tumor, mucus plug, foreign body</td></tr>
<tr><td>Loss of elasticity</td><td><strong>Emphysema</strong> (connective tissue normally keeps airways open during both inspiration and expiration)</td></tr>
</table>

<h3 id="s1-volumes">Lung Volumes &amp; Capacities</h3>

<p>Understanding lung volumes is foundational because they change predictably with disease&mdash;obstructive diseases trap air (volumes increase), while restrictive diseases limit expansion (volumes decrease). <span class="tag tag-heavy">HEAVY IN SLIDES</span></p>

<h4>Lung Volumes (Directly Measured)</h4>
<table>
<tr><th>Volume</th><th>Definition</th><th>Normal</th><th>Clinical Significance</th></tr>
<tr><td><strong>Tidal Volume (TV)</strong></td><td>Air inhaled and exhaled with each normal breath</td><td>500 mL (5-10 mL/kg)</td><td>May not vary even with severe disease</td></tr>
<tr><td><strong>Inspiratory Reserve (IRV)</strong></td><td>Maximum additional air inhaled after normal inhalation</td><td>3,000 mL</td><td>Decreased in restrictive disease</td></tr>
<tr><td><strong>Expiratory Reserve (ERV)</strong></td><td>Maximum air forcibly exhaled after normal exhalation</td><td>1,100 mL</td><td>Decreased with obesity, ascites, pregnancy</td></tr>
<tr><td><strong>Residual Volume (RV)</strong></td><td>Air remaining in lungs after maximum exhalation</td><td>1,200 mL</td><td>May increase with obstructive disease (air trapping)</td></tr>
</table>

<h4>Lung Capacities (Calculated)</h4>
<table class="teal">
<tr><th>Capacity</th><th>Formula</th><th>Clinical Significance</th></tr>
<tr><td><strong>Vital Capacity (VC)</strong></td><td>TV + IRV + ERV</td><td>Decreased in neuromuscular disease, fatigue, atelectasis, pulmonary edema, COPD, obesity. <strong>VC &lt;10 mL/kg = unable to sustain spontaneous ventilation</strong></td></tr>
<tr><td><strong>Inspiratory Capacity (IC)</strong></td><td>TV + IRV</td><td>Decreased in restrictive disease, obesity</td></tr>
<tr><td><strong>Functional Residual Capacity (FRC)</strong></td><td>ERV + RV</td><td>Increased in COPD; decreased in ARDS and obesity</td></tr>
<tr><td><strong>Total Lung Capacity (TLC)</strong></td><td>TV + IRV + ERV + RV</td><td>Decreased in restrictive disease (atelectasis, PNA); increased in COPD</td></tr>
</table>

<div class="callout memory">
<div class="callout-title">Memory: Obstructive vs. Restrictive Pattern</div>
<p><strong>Obstructive</strong> = air gets <em>trapped</em> (can't get out) &rarr; RV, FRC, TLC all <em>increase</em>. Think emphysema: lungs full of trapped air.<br>
<strong>Restrictive</strong> = lungs can't <em>expand</em> (can't get in) &rarr; VC, IC, TLC all <em>decrease</em>. Think fibrosis: stiff, shrunken lungs.</p>
</div>

<svg viewBox="0 0 740 540" style="max-width: 740px;" role="img" aria-label="Lung volumes stacked bar chart comparing three columns: Normal lung volumes showing residual volume 1200 mL, expiratory reserve 1100 mL, tidal volume 500 mL, and inspiratory reserve 3000 mL totaling 5800 mL TLC; COPD obstructive pattern with increased residual volume from air trapping and increased total lung capacity; and Restrictive disease with all volumes decreased and reduced total lung capacity. Capacity brackets show FRC, VC, IC, and TLC.">
    <defs>
        <linearGradient id="lv-rv" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#c4b5fd"/>
            <stop offset="100%" stop-color="#a78bfa"/>
        </linearGradient>
        <linearGradient id="lv-erv" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#93c5fd"/>
            <stop offset="100%" stop-color="#60a5fa"/>
        </linearGradient>
        <linearGradient id="lv-tv" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#86efac"/>
            <stop offset="100%" stop-color="#4ade80"/>
        </linearGradient>
        <linearGradient id="lv-irv" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#fde68a"/>
            <stop offset="100%" stop-color="#fbbf24"/>
        </linearGradient>
    </defs>

    <!-- Title -->
    <text x="370" y="26" text-anchor="middle" font-size="16" font-weight="bold" fill="#1a365d">Lung Volumes &amp; Capacities &mdash; Normal vs. Disease</text>

    <!-- Y-axis label -->
    <text x="16" y="260" text-anchor="middle" font-size="11" fill="#4a5568" font-weight="bold" transform="rotate(-90 16 260)">Volume (mL)</text>

    <!-- Y-axis scale (0 to 7000, baseline at y=470, top at y=50, range 420px) -->
    <!-- Scale: 1 mL = 420/7000 = 0.06px -->
    <line x1="55" y1="50" x2="55" y2="470" stroke="#4a5568" stroke-width="1"/>
    <line x1="55" y1="470" x2="700" y2="470" stroke="#4a5568" stroke-width="1"/>

    <!-- Y gridlines -->
    <text x="48" y="474" text-anchor="end" font-size="9" fill="#64748b">0</text>
    <text x="48" y="414" text-anchor="end" font-size="9" fill="#64748b">1000</text>
    <line x1="55" y1="410" x2="700" y2="410" stroke="#e2e8f0" stroke-width="0.5" stroke-dasharray="4,4"/>
    <text x="48" y="354" text-anchor="end" font-size="9" fill="#64748b">2000</text>
    <line x1="55" y1="350" x2="700" y2="350" stroke="#e2e8f0" stroke-width="0.5" stroke-dasharray="4,4"/>
    <text x="48" y="294" text-anchor="end" font-size="9" fill="#64748b">3000</text>
    <line x1="55" y1="290" x2="700" y2="290" stroke="#e2e8f0" stroke-width="0.5" stroke-dasharray="4,4"/>
    <text x="48" y="234" text-anchor="end" font-size="9" fill="#64748b">4000</text>
    <line x1="55" y1="230" x2="700" y2="230" stroke="#e2e8f0" stroke-width="0.5" stroke-dasharray="4,4"/>
    <text x="48" y="174" text-anchor="end" font-size="9" fill="#64748b">5000</text>
    <line x1="55" y1="170" x2="700" y2="170" stroke="#e2e8f0" stroke-width="0.5" stroke-dasharray="4,4"/>
    <text x="48" y="114" text-anchor="end" font-size="9" fill="#64748b">6000</text>
    <line x1="55" y1="110" x2="700" y2="110" stroke="#e2e8f0" stroke-width="0.5" stroke-dasharray="4,4"/>
    <text x="48" y="54" text-anchor="end" font-size="9" fill="#64748b">7000</text>

    <!-- ===== COLUMN 1: NORMAL (x=100, w=140) ===== -->
    <!-- RV: 1200 mL = 72px, bottom at 470, top at 398 -->
    <rect x="100" y="398" width="140" height="72" fill="url(#lv-rv)" stroke="#7c3aed" stroke-width="1"/>
    <text x="170" y="440" text-anchor="middle" font-size="10" fill="#5b21b6" font-weight="bold">RV</text>
    <text x="170" y="454" text-anchor="middle" font-size="9" fill="#5b21b6">1200 mL</text>

    <!-- ERV: 1100 mL = 66px, top at 332 -->
    <rect x="100" y="332" width="140" height="66" fill="url(#lv-erv)" stroke="#2563eb" stroke-width="1"/>
    <text x="170" y="370" text-anchor="middle" font-size="10" fill="#1d4ed8" font-weight="bold">ERV</text>
    <text x="170" y="384" text-anchor="middle" font-size="9" fill="#1d4ed8">1100 mL</text>

    <!-- TV: 500 mL = 30px, top at 302 -->
    <rect x="100" y="302" width="140" height="30" fill="url(#lv-tv)" stroke="#059669" stroke-width="1"/>
    <text x="170" y="321" text-anchor="middle" font-size="10" fill="#047857" font-weight="bold">TV 500 mL</text>

    <!-- IRV: 3000 mL = 180px, top at 122 -->
    <rect x="100" y="122" width="140" height="180" fill="url(#lv-irv)" stroke="#d97706" stroke-width="1"/>
    <text x="170" y="210" text-anchor="middle" font-size="10" fill="#92400e" font-weight="bold">IRV</text>
    <text x="170" y="226" text-anchor="middle" font-size="9" fill="#92400e">3000 mL</text>

    <!-- TLC label -->
    <text x="170" y="115" text-anchor="middle" font-size="11" font-weight="bold" fill="#1a365d">TLC: 5800 mL</text>

    <!-- Column label -->
    <text x="170" y="498" text-anchor="middle" font-size="13" font-weight="bold" fill="#1a365d">Normal</text>

    <!-- Capacity brackets (right of normal column) -->
    <!-- FRC = ERV + RV = 2300 mL (y398 to y332) -->
    <line x1="245" y1="470" x2="255" y2="470" stroke="#4a5568" stroke-width="1"/>
    <line x1="255" y1="470" x2="255" y2="332" stroke="#4a5568" stroke-width="1"/>
    <line x1="245" y1="332" x2="255" y2="332" stroke="#4a5568" stroke-width="1"/>
    <text x="260" y="405" font-size="9" fill="#4a5568" font-weight="bold">FRC</text>
    <text x="260" y="417" font-size="8" fill="#64748b">2300</text>

    <!-- VC = ERV + TV + IRV = 4600 mL (y398 to y122) BUT VC starts at bottom of ERV -->
    <!-- Actually VC = TV + IRV + ERV, so from top of IRV to bottom of ERV: y122 to y398 -->
    <line x1="245" y1="398" x2="260" y2="398" stroke="#4a5568" stroke-width="1"/>
    <line x1="260" y1="398" x2="260" y2="122" stroke="#4a5568" stroke-width="1"/>
    <line x1="245" y1="122" x2="260" y2="122" stroke="#4a5568" stroke-width="1"/>
    <text x="265" y="264" font-size="9" fill="#4a5568" font-weight="bold">VC</text>
    <text x="265" y="276" font-size="8" fill="#64748b">4600</text>

    <!-- IC = TV + IRV = 3500 mL (y302 to y122) -->
    <line x1="85" y1="302" x2="95" y2="302" stroke="#4a5568" stroke-width="1"/>
    <line x1="85" y1="302" x2="85" y2="122" stroke="#4a5568" stroke-width="1"/>
    <line x1="85" y1="122" x2="95" y2="122" stroke="#4a5568" stroke-width="1"/>
    <text x="80" y="216" text-anchor="end" font-size="9" fill="#4a5568" font-weight="bold">IC</text>
    <text x="80" y="228" text-anchor="end" font-size="8" fill="#64748b">3500</text>

    <!-- ===== COLUMN 2: COPD (x=320, w=140) ===== -->
    <!-- RV: 3000 mL = 180px, top at 290 -->
    <rect x="320" y="290" width="140" height="180" fill="url(#lv-rv)" stroke="#7c3aed" stroke-width="1"/>
    <text x="390" y="385" text-anchor="middle" font-size="10" fill="#5b21b6" font-weight="bold">RV &uarr;&uarr;</text>
    <text x="390" y="399" text-anchor="middle" font-size="9" fill="#5b21b6">3000 mL</text>
    <text x="390" y="413" text-anchor="middle" font-size="9" fill="#dc2626" font-style="italic">Air trapping</text>

    <!-- ERV: 800 mL = 48px, top at 242 -->
    <rect x="320" y="242" width="140" height="48" fill="url(#lv-erv)" stroke="#2563eb" stroke-width="1"/>
    <text x="390" y="271" text-anchor="middle" font-size="10" fill="#1d4ed8" font-weight="bold">ERV &darr;</text>

    <!-- TV: 500 mL = 30px, top at 212 -->
    <rect x="320" y="212" width="140" height="30" fill="url(#lv-tv)" stroke="#059669" stroke-width="1"/>
    <text x="390" y="231" text-anchor="middle" font-size="10" fill="#047857" font-weight="bold">TV 500</text>

    <!-- IRV: 2200 mL = 132px, top at 80 -->
    <rect x="320" y="80" width="140" height="132" fill="url(#lv-irv)" stroke="#d97706" stroke-width="1"/>
    <text x="390" y="150" text-anchor="middle" font-size="10" fill="#92400e" font-weight="bold">IRV &darr;</text>

    <!-- TLC label -->
    <text x="390" y="72" text-anchor="middle" font-size="11" font-weight="bold" fill="#dc2626">TLC: 6500 &uarr;</text>

    <!-- Column label -->
    <text x="390" y="498" text-anchor="middle" font-size="13" font-weight="bold" fill="#d97706">COPD</text>
    <text x="390" y="512" text-anchor="middle" font-size="10" fill="#d97706">(Obstructive)</text>

    <!-- ===== COLUMN 3: RESTRICTIVE (x=540, w=140) ===== -->
    <!-- RV: 600 mL = 36px, top at 434 -->
    <rect x="540" y="434" width="140" height="36" fill="url(#lv-rv)" stroke="#7c3aed" stroke-width="1"/>
    <text x="610" y="458" text-anchor="middle" font-size="10" fill="#5b21b6" font-weight="bold">RV &darr;</text>

    <!-- ERV: 500 mL = 30px, top at 404 -->
    <rect x="540" y="404" width="140" height="30" fill="url(#lv-erv)" stroke="#2563eb" stroke-width="1"/>
    <text x="610" y="423" text-anchor="middle" font-size="10" fill="#1d4ed8" font-weight="bold">ERV &darr;</text>

    <!-- TV: 400 mL = 24px, top at 380 -->
    <rect x="540" y="380" width="140" height="24" fill="url(#lv-tv)" stroke="#059669" stroke-width="1"/>
    <text x="610" y="396" text-anchor="middle" font-size="9" fill="#047857" font-weight="bold">TV &darr;</text>

    <!-- IRV: 1500 mL = 90px, top at 290 -->
    <rect x="540" y="290" width="140" height="90" fill="url(#lv-irv)" stroke="#d97706" stroke-width="1"/>
    <text x="610" y="340" text-anchor="middle" font-size="10" fill="#92400e" font-weight="bold">IRV &darr;&darr;</text>

    <!-- TLC label -->
    <text x="610" y="282" text-anchor="middle" font-size="11" font-weight="bold" fill="#dc2626">TLC: 3000 &darr;&darr;</text>

    <!-- Column label -->
    <text x="610" y="498" text-anchor="middle" font-size="13" font-weight="bold" fill="#dc2626">Restrictive</text>
    <text x="610" y="512" text-anchor="middle" font-size="10" fill="#dc2626">(e.g., Fibrosis)</text>

    <!-- Legend -->
    <rect x="130" y="525" width="14" height="12" rx="2" fill="#a78bfa"/>
    <text x="150" y="535" font-size="10" fill="#4a5568">RV (Residual)</text>
    <rect x="255" y="525" width="14" height="12" rx="2" fill="#60a5fa"/>
    <text x="275" y="535" font-size="10" fill="#4a5568">ERV (Exp. Reserve)</text>
    <rect x="405" y="525" width="14" height="12" rx="2" fill="#4ade80"/>
    <text x="425" y="535" font-size="10" fill="#4a5568">TV (Tidal)</text>
    <rect x="510" y="525" width="14" height="12" rx="2" fill="#fbbf24"/>
    <text x="530" y="535" font-size="10" fill="#4a5568">IRV (Insp. Reserve)</text>
</svg>

<h3>Gas Exchange &amp; Partial Pressure</h3>

<p>Atmospheric air at sea level exerts <strong>760 mmHg</strong> of total pressure. That pressure is shared among the gases present: nitrogen (78%), oxygen (21%), and CO2 (0.04%). The <strong>partial pressure</strong> of each gas is the fraction of total pressure it contributes. <span class="tag tag-slides">SLIDES</span></p>

<p>Key abbreviations you must know:</p>
<table>
<tr><th>Abbreviation</th><th>Meaning</th><th>Normal</th></tr>
<tr><td>PaO2</td><td>Partial pressure of arterial oxygen</td><td><strong>80-100 mmHg</strong></td></tr>
<tr><td>PaCO2</td><td>Partial pressure of arterial CO2</td><td>35-45 mmHg</td></tr>
<tr><td>PAO2</td><td>Partial pressure of alveolar oxygen</td><td>~100 mmHg (at sea level, no supplemental O2)</td></tr>
<tr><td>SaO2</td><td>Arterial oxygen saturation</td><td><strong>95-98%</strong></td></tr>
<tr><td>P50</td><td>PaO2 when hemoglobin is 50% saturated</td><td>~27 mmHg</td></tr>
</table>

<h4>The Oxyhemoglobin Dissociation Curve <span class="tag tag-textbook">TEXTBOOK</span></h4>

<p>This sigmoid-shaped curve describes the relationship between PaO2 and how much oxygen hemoglobin actually carries (SaO2). The shape matters enormously at the bedside:</p>

<p>At the <strong>top of the curve</strong> (PaO2 &gt;70 mmHg), the curve is flat. A patient's PaO2 could drop from 100 to 80 mmHg and their saturation barely changes (97% &rarr; ~94%). This is the "safe zone"&mdash;there is a cushion.</p>

<p>At the <strong>steep part of the curve</strong> (PaO2 &lt;60 mmHg), small drops in PaO2 cause dramatic drops in saturation. A PaO2 of 60 gives you ~90% saturation. Drop to 40 and you are at roughly 75%. This is why <strong>SpO2 of 90% is the critical threshold</strong>&mdash;below it, you are on the steep slope and deterioration accelerates.</p>

<!-- SVG: Oxyhemoglobin Dissociation Curve -->
<div style="text-align:center; margin:2rem 0;">
<svg viewBox="0 0 620 440" xmlns="http://www.w3.org/2000/svg" style="max-width:620px; width:100%; font-family:'Segoe UI',system-ui,sans-serif;">
  <defs>
    <!-- Danger zone fill -->
    <linearGradient id="dangerGrad" x1="0" y1="0" x2="0" y2="1">
      <stop offset="0%" stop-color="#fee2e2"/>
      <stop offset="100%" stop-color="#fecaca"/>
    </linearGradient>
    <!-- Caution zone fill -->
    <linearGradient id="cautionGrad" x1="0" y1="0" x2="0" y2="1">
      <stop offset="0%" stop-color="#fef9c3"/>
      <stop offset="100%" stop-color="#fef08a"/>
    </linearGradient>
    <!-- Safe zone fill -->
    <linearGradient id="safeGrad" x1="0" y1="0" x2="0" y2="1">
      <stop offset="0%" stop-color="#dcfce7"/>
      <stop offset="100%" stop-color="#bbf7d0"/>
    </linearGradient>
  </defs>

  <!-- Title -->
  <text x="310" y="28" text-anchor="middle" font-size="16" font-weight="700" fill="#1e293b">Oxyhemoglobin Dissociation Curve</text>

  <!-- Chart area: left=80, top=45, right=530, bottom=370 -->
  <!-- Background zones -->
  <!-- Danger: SaO2 0-75% => y 370 down to y ~138  BUT we want bottom portion. SaO2 0-75 maps y: 370 to 126 -->
  <!-- Safe zone: PaO2 >70 region, SaO2 >93% => top-right area -->
  <!-- Steep zone: PaO2 <60, SaO2 <90% => bottom-left area -->

  <!-- Zone shading by PaO2 regions on x-axis -->
  <!-- Danger zone: PaO2 0-40 (x: 80 to 260) -->
  <rect x="80" y="45" width="180" height="325" fill="url(#dangerGrad)" opacity="0.5" rx="0"/>
  <!-- Caution zone: PaO2 40-60 (x: 260 to 350) -->
  <rect x="260" y="45" width="90" height="325" fill="url(#cautionGrad)" opacity="0.5" rx="0"/>
  <!-- Safe zone: PaO2 60-100 (x: 350 to 530) -->
  <rect x="350" y="45" width="180" height="325" fill="url(#safeGrad)" opacity="0.4" rx="0"/>

  <!-- Zone labels -->
  <text x="170" y="65" text-anchor="middle" font-size="11" font-weight="600" fill="#dc2626">STEEP / DANGER</text>
  <text x="305" y="65" text-anchor="middle" font-size="10" font-weight="600" fill="#a16207">CAUTION</text>
  <text x="440" y="65" text-anchor="middle" font-size="11" font-weight="600" fill="#16a34a">FLAT / SAFE</text>

  <!-- Grid lines - horizontal (SaO2) -->
  <line x1="80" y1="370" x2="530" y2="370" stroke="#cbd5e1" stroke-width="0.5"/>
  <line x1="80" y1="337.5" x2="530" y2="337.5" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="305" x2="530" y2="305" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="272.5" x2="530" y2="272.5" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="240" x2="530" y2="240" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="207.5" x2="530" y2="207.5" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="175" x2="530" y2="175" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="142.5" x2="530" y2="142.5" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="110" x2="530" y2="110" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="77.5" x2="530" y2="77.5" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="80" y1="45" x2="530" y2="45" stroke="#cbd5e1" stroke-width="0.5"/>

  <!-- Grid lines - vertical (PaO2) -->
  <line x1="80" y1="45" x2="80" y2="370" stroke="#cbd5e1" stroke-width="0.5"/>
  <line x1="125" y1="45" x2="125" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="170" y1="45" x2="170" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="215" y1="45" x2="215" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="260" y1="45" x2="260" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="305" y1="45" x2="305" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="350" y1="45" x2="350" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="395" y1="45" x2="395" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="440" y1="45" x2="440" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="485" y1="45" x2="485" y2="370" stroke="#cbd5e1" stroke-width="0.5" stroke-dasharray="4,4"/>
  <line x1="530" y1="45" x2="530" y2="370" stroke="#cbd5e1" stroke-width="0.5"/>

  <!-- Axes -->
  <line x1="80" y1="370" x2="530" y2="370" stroke="#334155" stroke-width="2"/>
  <line x1="80" y1="45" x2="80" y2="370" stroke="#334155" stroke-width="2"/>

  <!-- X-axis labels (PaO2: 0 to 100 mmHg) -->
  <text x="80" y="388" text-anchor="middle" font-size="11" fill="#475569">0</text>
  <text x="125" y="388" text-anchor="middle" font-size="11" fill="#475569">10</text>
  <text x="170" y="388" text-anchor="middle" font-size="11" fill="#475569">20</text>
  <text x="215" y="388" text-anchor="middle" font-size="11" fill="#475569">30</text>
  <text x="260" y="388" text-anchor="middle" font-size="11" fill="#475569">40</text>
  <text x="305" y="388" text-anchor="middle" font-size="11" fill="#475569">50</text>
  <text x="350" y="388" text-anchor="middle" font-size="11" fill="#475569">60</text>
  <text x="395" y="388" text-anchor="middle" font-size="11" fill="#475569">70</text>
  <text x="440" y="388" text-anchor="middle" font-size="11" fill="#475569">80</text>
  <text x="485" y="388" text-anchor="middle" font-size="11" fill="#475569">90</text>
  <text x="530" y="388" text-anchor="middle" font-size="11" fill="#475569">100</text>
  <text x="305" y="410" text-anchor="middle" font-size="13" font-weight="600" fill="#1e293b">PaO2 (mmHg)</text>

  <!-- Y-axis labels (SaO2: 0 to 100%) -->
  <text x="72" y="374" text-anchor="end" font-size="11" fill="#475569">0</text>
  <text x="72" y="309" text-anchor="end" font-size="11" fill="#475569">25</text>
  <text x="72" y="244" text-anchor="end" font-size="11" fill="#475569">50</text>
  <text x="72" y="179" text-anchor="end" font-size="11" fill="#475569">75</text>
  <text x="72" y="114" text-anchor="end" font-size="11" fill="#475569">90</text>
  <text x="72" y="49" text-anchor="end" font-size="11" fill="#475569">100</text>
  <text x="25" y="210" text-anchor="middle" font-size="13" font-weight="600" fill="#1e293b" transform="rotate(-90,25,210)">SaO2 (%)</text>

  <!-- The sigmoid curve (Normal) - key data points:
       PaO2 10 -> SaO2 13%    x=125, y=327.7
       PaO2 20 -> SaO2 35%    x=170, y=256.2
       PaO2 27 -> SaO2 50%    x=201, y=207.5 (P50)
       PaO2 30 -> SaO2 57%    x=215, y=184.7
       PaO2 40 -> SaO2 75%    x=260, y=126.2
       PaO2 50 -> SaO2 85%    x=305, y=93.8
       PaO2 60 -> SaO2 90%    x=350, y=77.5
       PaO2 70 -> SaO2 93%    x=395, y=67.7
       PaO2 80 -> SaO2 95%    x=440, y=61.2
       PaO2 90 -> SaO2 97%    x=485, y=54.6
       PaO2 100-> SaO2 98%    x=530, y=51.4
  -->
  <path d="M 80,370 C 100,365 115,340 125,328 C 140,300 155,270 170,256 C 185,235 195,218 201,208 C 210,192 215,185 220,175 C 235,150 250,132 260,126 C 275,110 290,100 305,94 C 320,87 335,82 350,78 C 365,73 380,70 395,68 C 415,64 430,62 440,61 C 460,58 475,56 485,55 C 505,53 520,52 530,51"
        fill="none" stroke="#2563eb" stroke-width="3.5" stroke-linecap="round"/>

  <!-- Right-shifted curve (dashed red) -->
  <path d="M 80,370 C 105,365 130,345 145,330 C 160,305 175,278 190,260 C 205,240 220,220 235,205 C 250,185 265,165 280,145 C 295,125 310,112 330,100 C 350,90 370,83 390,78 C 410,73 430,69 450,66 C 470,63 490,60 510,58 C 520,57 525,56 530,55"
        fill="none" stroke="#dc2626" stroke-width="2.5" stroke-dasharray="8,5" stroke-linecap="round" opacity="0.8"/>

  <!-- Left-shifted curve (dashed green) -->
  <path d="M 80,370 C 95,362 105,340 110,325 C 120,298 130,270 140,252 C 150,235 160,215 170,200 C 182,178 195,155 210,135 C 225,115 240,100 260,88 C 275,80 290,74 310,69 C 330,64 350,60 370,57 C 390,54 410,52 440,50 C 470,48 500,47 530,46"
        fill="none" stroke="#16a34a" stroke-width="2.5" stroke-dasharray="8,5" stroke-linecap="round" opacity="0.8"/>

  <!-- Critical threshold line: PaO2=60, SaO2=90% -->
  <line x1="350" y1="77.5" x2="350" y2="370" stroke="#dc2626" stroke-width="1.5" stroke-dasharray="6,3" opacity="0.6"/>
  <line x1="80" y1="77.5" x2="350" y2="77.5" stroke="#dc2626" stroke-width="1.5" stroke-dasharray="6,3" opacity="0.6"/>
  <!-- Critical point dot -->
  <circle cx="350" cy="78" r="6" fill="#dc2626" stroke="#fff" stroke-width="2"/>
  <text x="345" y="95" text-anchor="end" font-size="11" font-weight="700" fill="#dc2626">Critical: PaO2 60 / SaO2 90%</text>

  <!-- P50 marker -->
  <circle cx="201" cy="208" r="5" fill="#7c3aed" stroke="#fff" stroke-width="2"/>
  <text x="210" y="225" font-size="10" font-weight="600" fill="#7c3aed">P50 = 27 mmHg</text>

  <!-- Curve labels -->
  <text x="540" y="48" font-size="11" font-weight="600" fill="#16a34a">&larr; Left shift</text>
  <text x="540" y="53" font-size="9" fill="#16a34a">(holds O2 tighter)</text>
  <text x="540" y="56" font-size="0" fill="none">.</text>
  <text x="535" y="79" font-size="11" font-weight="600" fill="#2563eb">Normal</text>
  <text x="540" y="110" font-size="11" font-weight="600" fill="#dc2626">&larr; Right shift</text>
  <text x="540" y="122" font-size="9" fill="#dc2626">(releases O2)</text>

  <!-- Right shift causes (bottom-right annotation) -->
  <rect x="365" y="290" width="160" height="75" rx="6" fill="#fff" stroke="#dc2626" stroke-width="1.5" opacity="0.95"/>
  <text x="375" y="307" font-size="11" font-weight="700" fill="#dc2626">Right Shift Causes:</text>
  <text x="375" y="322" font-size="10" fill="#475569">&uarr; CO2, &uarr; Temp, &uarr; 2,3-DPG</text>
  <text x="375" y="336" font-size="10" fill="#475569">Acidosis (pH &darr;)</text>
  <text x="375" y="350" font-size="10" fill="#475569">Exercise, Fever, Sepsis</text>
  <text x="375" y="362" font-size="9" font-style="italic" fill="#7c3aed">Mnemonic: "CADET face Right"</text>

  <!-- Left shift causes (top-left annotation) -->
  <rect x="100" y="80" width="150" height="65" rx="6" fill="#fff" stroke="#16a34a" stroke-width="1.5" opacity="0.95"/>
  <text x="110" y="97" font-size="11" font-weight="700" fill="#16a34a">Left Shift Causes:</text>
  <text x="110" y="112" font-size="10" fill="#475569">&darr; CO2, &darr; Temp, &darr; 2,3-DPG</text>
  <text x="110" y="127" font-size="10" fill="#475569">Alkalosis (pH &uarr;)</text>
  <text x="110" y="140" font-size="10" fill="#475569">Hypothermia, CO poisoning</text>

  <!-- Steep slope annotation arrow -->
  <path d="M 165,290 L 195,265" fill="none" stroke="#94a3b8" stroke-width="1.5" marker-end="url(#arrowGray)"/>
  <text x="100" y="300" font-size="10" font-weight="600" fill="#64748b">Steep slope:</text>
  <text x="100" y="313" font-size="10" fill="#64748b">small PaO2 change</text>
  <text x="100" y="326" font-size="10" fill="#64748b">= big SaO2 drop</text>

  <!-- Arrow marker definition -->
  <defs>
    <marker id="arrowGray" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="6" markerHeight="6" orient="auto-start-reverse">
      <path d="M 0 0 L 10 5 L 0 10 z" fill="#94a3b8"/>
    </marker>
  </defs>
</svg>
</div>

<div class="callout pearl">
<div class="callout-title">Pearl: Shift Right = Release</div>
<p><strong>Right shift</strong> (decreased Hgb affinity &rarr; MORE O2 released to tissues): increased CO2, acidosis, increased temperature, increased 2,3-DPG. These are all states where tissues are metabolically active and need more O2.</p>
<p><strong>Left shift</strong> (increased Hgb affinity &rarr; LESS O2 released): decreased CO2, alkalosis, decreased temperature, decreased 2,3-DPG. Hemoglobin holds on tighter&mdash;tissues may become hypoxic even with adequate SaO2.</p>
</div>

<h4>Alveolar Anatomy &amp; Surfactant <span class="tag tag-textbook">TEXTBOOK</span></h4>
<p>The lungs contain approximately 300 million alveoli with a total surface area of 50-100 m2. Two cell types line them:</p>
<ul>
<li><strong>Type I alveolar cells</strong>: 95% of the alveolar surface area. They form the barrier between air and the alveolar surface&mdash;the membrane gas must diffuse across.</li>
<li><strong>Type II alveolar cells</strong>: only 5% of surface area but critically important. They produce <strong>surfactant</strong> (reduces surface tension, prevents alveolar collapse) and can regenerate Type I cells after injury.</li>
</ul>
<p><strong>Alveolar macrophages</strong> are the resident phagocytes&mdash;they ingest foreign matter and bacteria as a key defense mechanism. The conducting airways contain ~150 mL of air that never reaches alveoli, known as <strong>anatomic dead space</strong>.</p>

<h3 id="s1-vq">Ventilation-Perfusion (V/Q) Ratios</h3>

<p>Adequate gas exchange requires that ventilation (airflow to alveoli) matches perfusion (blood flow to those alveoli). The V/Q ratio describes this balance, and imbalances are the underlying mechanism of hypoxemia in most respiratory diseases. <span class="tag tag-heavy">HEAVY IN SLIDES</span></p>

<!-- SVG: V/Q Ratio Diagram (4 panels) -->
<div style="text-align:center; margin:2rem 0;">
<svg viewBox="0 0 680 520" xmlns="http://www.w3.org/2000/svg" style="max-width:680px; width:100%; font-family:'Segoe UI',system-ui,sans-serif;">
  <defs>
    <marker id="airArrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
      <path d="M 0 0 L 10 5 L 0 10 z" fill="#3b82f6"/>
    </marker>
    <marker id="bloodArrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
      <path d="M 0 0 L 10 5 L 0 10 z" fill="#dc2626"/>
    </marker>
    <marker id="noArrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
      <path d="M 0 0 L 10 5 L 0 10 z" fill="#94a3b8"/>
    </marker>
  </defs>

  <!-- Title -->
  <text x="340" y="28" text-anchor="middle" font-size="16" font-weight="700" fill="#1e293b">Ventilation-Perfusion (V/Q) Ratios</text>

  <!-- ======= PANEL 1: Normal V/Q (top-left) ======= -->
  <rect x="15" y="45" width="315" height="215" rx="10" fill="#f0fdf4" stroke="#86efac" stroke-width="2"/>
  <text x="172" y="70" text-anchor="middle" font-size="14" font-weight="700" fill="#16a34a">Normal V/Q (ratio ~ 0.8)</text>

  <!-- Alveolus -->
  <ellipse cx="172" cy="140" rx="55" ry="40" fill="#dbeafe" stroke="#3b82f6" stroke-width="2" opacity="0.8"/>
  <text x="172" y="135" text-anchor="middle" font-size="11" font-weight="600" fill="#1d4ed8">O2</text>
  <text x="172" y="150" text-anchor="middle" font-size="10" fill="#1d4ed8">Alveolus</text>

  <!-- Airway (ventilation arrow) -->
  <line x1="172" y1="85" x2="172" y2="98" stroke="#3b82f6" stroke-width="3" marker-end="url(#airArrow)"/>
  <text x="195" y="93" font-size="10" font-weight="600" fill="#3b82f6">V (air in)</text>

  <!-- Capillary (blood flow) -->
  <path d="M 100,190 Q 140,175 172,180 Q 205,185 245,190" fill="none" stroke="#dc2626" stroke-width="3" marker-end="url(#bloodArrow)"/>
  <text x="172" y="210" text-anchor="middle" font-size="10" font-weight="600" fill="#dc2626">Q (blood flow)</text>

  <!-- Gas exchange arrows -->
  <line x1="145" y1="165" x2="135" y2="178" stroke="#7c3aed" stroke-width="1.5" stroke-dasharray="3,2"/>
  <line x1="200" y1="165" x2="210" y2="178" stroke="#7c3aed" stroke-width="1.5" stroke-dasharray="3,2"/>
  <text x="172" y="175" text-anchor="middle" font-size="8" fill="#7c3aed">exchange</text>

  <!-- Result label -->
  <rect x="55" y="225" width="235" height="28" rx="5" fill="#16a34a" opacity="0.15"/>
  <text x="172" y="244" text-anchor="middle" font-size="11" fill="#16a34a" font-weight="600">Efficient gas exchange &mdash; Normal PaO2</text>

  <!-- ======= PANEL 2: Low V/Q - Shunt (top-right) ======= -->
  <rect x="350" y="45" width="315" height="215" rx="10" fill="#fef2f2" stroke="#fca5a5" stroke-width="2"/>
  <text x="507" y="70" text-anchor="middle" font-size="14" font-weight="700" fill="#dc2626">Low V/Q &mdash; Shunt</text>

  <!-- Collapsed/blocked alveolus -->
  <ellipse cx="507" cy="140" rx="35" ry="22" fill="#e2e8f0" stroke="#94a3b8" stroke-width="2" opacity="0.6"/>
  <text x="507" y="137" text-anchor="middle" font-size="9" fill="#64748b">Blocked</text>
  <text x="507" y="148" text-anchor="middle" font-size="9" fill="#64748b">Alveolus</text>

  <!-- Blocked airway (X mark) -->
  <line x1="507" y1="85" x2="507" y2="100" stroke="#94a3b8" stroke-width="3" stroke-dasharray="4,3"/>
  <text x="522" y="88" font-size="18" font-weight="700" fill="#dc2626">&times;</text>
  <text x="530" y="100" font-size="10" font-weight="600" fill="#94a3b8">V &darr;&darr;</text>

  <!-- Capillary (thick = lots of blood) -->
  <path d="M 435,190 Q 470,175 507,180 Q 540,185 580,190" fill="none" stroke="#dc2626" stroke-width="5" marker-end="url(#bloodArrow)"/>
  <text x="507" y="210" text-anchor="middle" font-size="10" font-weight="600" fill="#dc2626">Q normal (blood bypasses)</text>

  <!-- Result label -->
  <rect x="385" y="225" width="245" height="28" rx="5" fill="#dc2626" opacity="0.12"/>
  <text x="507" y="244" text-anchor="middle" font-size="11" fill="#dc2626" font-weight="600">Blood NOT oxygenated &mdash; Hypoxemia</text>

  <!-- Examples -->
  <text x="507" y="257" text-anchor="middle" font-size="9" fill="#64748b" font-style="italic">Pneumonia, atelectasis, mucus plug</text>

  <!-- ======= PANEL 3: High V/Q - Dead Space (bottom-left) ======= -->
  <rect x="15" y="280" width="315" height="225" rx="10" fill="#fefce8" stroke="#fde68a" stroke-width="2"/>
  <text x="172" y="305" text-anchor="middle" font-size="14" font-weight="700" fill="#a16207">High V/Q &mdash; Dead Space</text>

  <!-- Normal alveolus (well ventilated) -->
  <ellipse cx="172" cy="375" rx="55" ry="40" fill="#dbeafe" stroke="#3b82f6" stroke-width="2" opacity="0.9"/>
  <text x="172" y="370" text-anchor="middle" font-size="11" font-weight="600" fill="#1d4ed8">O2</text>
  <text x="172" y="385" text-anchor="middle" font-size="10" fill="#1d4ed8">Ventilated</text>

  <!-- Airway (good ventilation) -->
  <line x1="172" y1="320" x2="172" y2="333" stroke="#3b82f6" stroke-width="3" marker-end="url(#airArrow)"/>
  <text x="195" y="328" font-size="10" font-weight="600" fill="#3b82f6">V normal</text>

  <!-- Blocked capillary -->
  <path d="M 100,425 Q 130,418 148,420" fill="none" stroke="#94a3b8" stroke-width="3" stroke-dasharray="5,4"/>
  <text x="165" y="435" font-size="18" font-weight="700" fill="#dc2626">&times;</text>
  <text x="200" y="438" font-size="10" font-weight="600" fill="#94a3b8">Q &darr;&darr; (blocked)</text>

  <!-- Result label -->
  <rect x="45" y="460" width="255" height="28" rx="5" fill="#a16207" opacity="0.12"/>
  <text x="172" y="479" text-anchor="middle" font-size="11" fill="#a16207" font-weight="600">Wasted ventilation &mdash; CO2 retention</text>

  <!-- Examples -->
  <text x="172" y="497" text-anchor="middle" font-size="9" fill="#64748b" font-style="italic">PE, pulmonary infarction, cardiogenic shock</text>

  <!-- ======= PANEL 4: Silent Unit (bottom-right) ======= -->
  <rect x="350" y="280" width="315" height="225" rx="10" fill="#f1f5f9" stroke="#cbd5e1" stroke-width="2"/>
  <text x="507" y="305" text-anchor="middle" font-size="14" font-weight="700" fill="#475569">Silent Unit</text>

  <!-- Collapsed alveolus -->
  <ellipse cx="507" cy="375" rx="35" ry="22" fill="#e2e8f0" stroke="#94a3b8" stroke-width="2" opacity="0.5"/>
  <text x="507" y="370" text-anchor="middle" font-size="9" fill="#94a3b8">No air</text>
  <text x="507" y="382" text-anchor="middle" font-size="9" fill="#94a3b8">No blood</text>

  <!-- Blocked airway -->
  <line x1="507" y1="320" x2="507" y2="340" stroke="#94a3b8" stroke-width="3" stroke-dasharray="4,3"/>
  <text x="522" y="325" font-size="18" font-weight="700" fill="#94a3b8">&times;</text>
  <text x="540" y="337" font-size="10" font-weight="600" fill="#94a3b8">V = 0</text>

  <!-- Blocked capillary -->
  <path d="M 435,425 Q 460,418 475,420" fill="none" stroke="#94a3b8" stroke-width="3" stroke-dasharray="5,4"/>
  <text x="490" y="435" font-size="18" font-weight="700" fill="#94a3b8">&times;</text>
  <text x="530" y="438" font-size="10" font-weight="600" fill="#94a3b8">Q = 0</text>

  <!-- Result label -->
  <rect x="385" y="460" width="245" height="28" rx="5" fill="#64748b" opacity="0.12"/>
  <text x="507" y="479" text-anchor="middle" font-size="11" fill="#475569" font-weight="600">No ventilation, no perfusion &mdash; Dead tissue</text>

  <!-- Examples -->
  <text x="507" y="497" text-anchor="middle" font-size="9" fill="#64748b" font-style="italic">Pneumothorax, severe ARDS</text>

  <!-- Legend -->
  <rect x="200" y="510" width="280" height="4" rx="2" fill="none"/>
  <line x1="210" y1="515" x2="230" y2="515" stroke="#3b82f6" stroke-width="3"/>
  <text x="235" y="518" font-size="10" fill="#3b82f6">= Ventilation (air)</text>
  <line x1="340" y1="515" x2="360" y2="515" stroke="#dc2626" stroke-width="3"/>
  <text x="365" y="518" font-size="10" fill="#dc2626">= Perfusion (blood)</text>
</svg>
</div>

<table class="teal">
<tr><th>V/Q State</th><th>What Happens</th><th>Clinical Examples</th></tr>
<tr><td><strong>Normal V/Q</strong></td><td>Ventilation matches perfusion. Gas exchange occurs efficiently.</td><td>Healthy lung</td></tr>
<tr><td><strong>Low V/Q (Shunt)</strong></td><td>Perfusion exceeds ventilation. Blood passes through the pulmonary capillaries without encountering well-ventilated alveoli&mdash;it bypasses gas exchange.</td><td>Pneumonia, atelectasis, tumor, mucus plug</td></tr>
<tr><td><strong>High V/Q (Dead Space)</strong></td><td>Ventilation exceeds perfusion. Alveoli receive air but don't have adequate blood supply for gas exchange.</td><td>PE, pulmonary infarction, cardiogenic shock</td></tr>
<tr><td><strong>Silent Unit</strong></td><td>Absence of BOTH ventilation AND perfusion.</td><td>Pneumothorax, severe ARDS</td></tr>
</table>

<div class="callout warning">
<div class="callout-title">Warning: Shunt Threshold</div>
<p><strong>Severe hypoxia occurs when shunting exceeds 20%.</strong> Shunting is the most common cause of hypoxia after thoracic or abdominal surgery and in most forms of respiratory failure. Supplemental O2 may or may not correct hypoxemia depending on the type of V/Q imbalance&mdash;true shunts are often refractory to O2 because the blood simply never encounters ventilated alveoli.</p>
</div>

<h4>Pulmonary Circulation Details <span class="tag tag-textbook">TEXTBOOK</span></h4>
<p>The pulmonary circulation is a <strong>low-pressure system</strong> (systolic 20-30 mmHg, diastolic 5-15 mmHg)&mdash;far lower than systemic circulation. About 2% of blood pumped by the right ventricle never perfuses the alveolar capillaries (physiologic shunt). In an upright person, gravity creates three zones: upper lung (poor blood supply), middle (intermediate), and lower (maximal blood supply). When lying on one side, more blood flows to the dependent (lower) lung.</p>

<h4>CO2 Transport <span class="tag tag-textbook">TEXTBOOK</span></h4>
<p>Ninety percent of CO2 is carried by red blood cells, 5% is dissolved in plasma (measured as PaCO2), and 5% is carried in other forms. Only 6% of venous CO2 is removed in the lungs with each pass. Normal arterial PaCO2 is approximately 40 mmHg.</p>

<h3 id="s1-neuro">Neurologic Control Summary</h3>
<table>
<tr><th>Structure</th><th>Location</th><th>Function</th></tr>
<tr><td>Inspiratory/expiratory centers</td><td>Medulla oblongata</td><td>Set baseline rate and depth</td></tr>
<tr><td>Apneustic center</td><td>Lower pons</td><td>Promotes deep, prolonged inspirations</td></tr>
<tr><td>Pneumotaxic center</td><td>Upper pons</td><td>Controls respiratory pattern</td></tr>
<tr><td>Central chemoreceptors</td><td>Medulla</td><td>Respond to CSF pH (reflects blood CO2)</td></tr>
<tr><td>Peripheral chemoreceptors</td><td>Aortic arch &amp; carotids</td><td>Respond first to PaO2, then PaCO2 and pH</td></tr>
<tr><td>Hering-Breuer reflex</td><td>Alveolar stretch receptors</td><td>Prevent overdistension</td></tr>
</table>

<svg viewBox="0 0 700 480" style="max-width: 700px;" role="img" aria-label="Respiratory control center diagram showing brainstem cross-section with medulla oblongata containing inspiratory and expiratory centers and central chemoreceptors responding to CO2 and pH, pons containing pneumotaxic and apneustic centers, and peripheral chemoreceptors at the aortic arch and carotid bodies responding to O2, CO2, and pH. Arrows show feedback loops to the diaphragm and respiratory muscles.">
    <defs>
        <marker id="rc-arrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#4a5568"/>
        </marker>
        <marker id="rc-arrow-red" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#dc2626"/>
        </marker>
        <linearGradient id="rc-pons" x1="0" y1="0" x2="0" y2="1">
            <stop offset="0%" stop-color="#bbf7d0"/>
            <stop offset="100%" stop-color="#86efac"/>
        </linearGradient>
        <linearGradient id="rc-medulla" x1="0" y1="0" x2="0" y2="1">
            <stop offset="0%" stop-color="#bfdbfe"/>
            <stop offset="100%" stop-color="#93c5fd"/>
        </linearGradient>
    </defs>

    <!-- Title -->
    <text x="350" y="26" text-anchor="middle" font-size="16" font-weight="bold" fill="#1a365d">Respiratory Control Centers</text>

    <!-- ===== BRAINSTEM (center) ===== -->
    <!-- Brainstem outline -->
    <path d="M 240,50 C 280,45 370,45 410,50 C 430,55 440,80 440,120 C 440,180 435,260 430,310 C 425,340 410,370 380,390 C 360,400 340,410 320,420 C 310,410 300,400 280,390 C 250,370 235,340 230,310 C 225,260 220,180 220,120 C 220,80 230,55 240,50 Z"
          fill="#f1f5f9" stroke="#4a5568" stroke-width="2"/>

    <!-- PONS (upper brainstem) -->
    <rect x="240" y="60" width="180" height="110" rx="10" fill="url(#rc-pons)" stroke="#059669" stroke-width="1.5" opacity="0.85"/>
    <text x="330" y="82" text-anchor="middle" font-size="14" font-weight="bold" fill="#047857">PONS</text>

    <!-- Pneumotaxic center (upper pons) -->
    <rect x="255" y="90" width="150" height="30" rx="6" fill="white" stroke="#059669" stroke-width="1.2"/>
    <text x="330" y="110" text-anchor="middle" font-size="11" font-weight="bold" fill="#059669">Pneumotaxic Center</text>
    <!-- Apneustic center (lower pons) -->
    <rect x="255" y="128" width="150" height="30" rx="6" fill="white" stroke="#059669" stroke-width="1.2"/>
    <text x="330" y="148" text-anchor="middle" font-size="11" font-weight="bold" fill="#059669">Apneustic Center</text>

    <!-- Divider between pons and medulla -->
    <line x1="235" y1="175" x2="425" y2="175" stroke="#4a5568" stroke-width="1" stroke-dasharray="5,3"/>

    <!-- MEDULLA (lower brainstem) -->
    <rect x="235" y="180" width="190" height="140" rx="10" fill="url(#rc-medulla)" stroke="#2563eb" stroke-width="1.5" opacity="0.85"/>
    <text x="330" y="200" text-anchor="middle" font-size="14" font-weight="bold" fill="#1d4ed8">MEDULLA</text>

    <!-- Inspiratory center -->
    <rect x="250" y="210" width="120" height="28" rx="6" fill="white" stroke="#2563eb" stroke-width="1.2"/>
    <text x="310" y="229" text-anchor="middle" font-size="10" font-weight="bold" fill="#1d4ed8">Inspiratory Center</text>
    <!-- Expiratory center -->
    <rect x="250" y="246" width="120" height="28" rx="6" fill="white" stroke="#2563eb" stroke-width="1.2"/>
    <text x="310" y="265" text-anchor="middle" font-size="10" font-weight="bold" fill="#1d4ed8">Expiratory Center</text>

    <!-- Central chemoreceptors (in medulla) -->
    <circle cx="395" cy="250" r="18" fill="#fef2f2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="395" y="246" text-anchor="middle" font-size="8" font-weight="bold" fill="#dc2626">Central</text>
    <text x="395" y="258" text-anchor="middle" font-size="8" font-weight="bold" fill="#dc2626">Chemo</text>

    <!-- Spinal cord continuation -->
    <path d="M 300,380 C 305,400 310,420 315,445 M 340,380 C 345,400 350,420 355,445"
          fill="none" stroke="#4a5568" stroke-width="2"/>

    <!-- ===== PONS FUNCTION LABELS (right side) ===== -->
    <line x1="405" y1="105" x2="470" y2="80" stroke="#059669" stroke-width="1.2"/>
    <rect x="472" y="58" rx="6" ry="6" width="210" height="40" fill="#ecfdf5" stroke="#059669" stroke-width="1"/>
    <text x="577" y="76" text-anchor="middle" font-size="10" fill="#047857" font-weight="bold">Pneumotaxic: Controls rate/pattern</text>
    <text x="577" y="90" text-anchor="middle" font-size="10" fill="#065f46">Inhibits inspiration &rarr; prevents overinflation</text>

    <line x1="405" y1="143" x2="470" y2="120" stroke="#059669" stroke-width="1.2"/>
    <rect x="472" y="105" rx="6" ry="6" width="210" height="40" fill="#ecfdf5" stroke="#059669" stroke-width="1"/>
    <text x="577" y="123" text-anchor="middle" font-size="10" fill="#047857" font-weight="bold">Apneustic: Prolongs inspiration</text>
    <text x="577" y="137" text-anchor="middle" font-size="10" fill="#065f46">Deep, prolonged breaths</text>

    <!-- ===== MEDULLA FUNCTION LABELS (right side) ===== -->
    <line x1="425" y1="225" x2="470" y2="190" stroke="#2563eb" stroke-width="1.2"/>
    <rect x="472" y="165" rx="6" ry="6" width="210" height="55" fill="#eff6ff" stroke="#2563eb" stroke-width="1"/>
    <text x="577" y="183" text-anchor="middle" font-size="10" fill="#1d4ed8" font-weight="bold">Sets baseline rate &amp; depth</text>
    <text x="577" y="198" text-anchor="middle" font-size="10" fill="#1e40af">Inspiratory: fires rhythmically</text>
    <text x="577" y="213" text-anchor="middle" font-size="10" fill="#1e40af">Expiratory: active in forced breathing</text>

    <!-- Central chemoreceptor label -->
    <line x1="413" y1="248" x2="470" y2="248" stroke="#dc2626" stroke-width="1.2"/>
    <rect x="472" y="232" rx="6" ry="6" width="210" height="38" fill="#fef2f2" stroke="#dc2626" stroke-width="1"/>
    <text x="577" y="249" text-anchor="middle" font-size="10" fill="#dc2626" font-weight="bold">Central Chemoreceptors</text>
    <text x="577" y="263" text-anchor="middle" font-size="10" fill="#991b1b">Respond to CSF pH (reflects CO&#8322;)</text>

    <!-- ===== PERIPHERAL CHEMORECEPTORS (left side) ===== -->
    <!-- Carotid body -->
    <circle cx="120" cy="120" r="16" fill="#fef2f2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="120" y="117" text-anchor="middle" font-size="8" font-weight="bold" fill="#dc2626">Carotid</text>
    <text x="120" y="128" text-anchor="middle" font-size="8" font-weight="bold" fill="#dc2626">Body</text>
    <line x1="136" y1="120" x2="220" y2="130" stroke="#dc2626" stroke-width="1.2" stroke-dasharray="4,3"/>

    <!-- Aortic arch -->
    <circle cx="120" cy="180" r="16" fill="#fef2f2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="120" y="177" text-anchor="middle" font-size="8" font-weight="bold" fill="#dc2626">Aortic</text>
    <text x="120" y="188" text-anchor="middle" font-size="8" font-weight="bold" fill="#dc2626">Arch</text>
    <line x1="136" y1="175" x2="220" y2="170" stroke="#dc2626" stroke-width="1.2" stroke-dasharray="4,3"/>

    <!-- Peripheral chemoreceptor label box -->
    <rect x="18" y="220" rx="6" ry="6" width="185" height="55" fill="#fef2f2" stroke="#dc2626" stroke-width="1"/>
    <text x="110" y="238" text-anchor="middle" font-size="10" fill="#dc2626" font-weight="bold">Peripheral Chemoreceptors</text>
    <text x="110" y="253" text-anchor="middle" font-size="10" fill="#991b1b">Respond first to &darr;PaO&#8322;</text>
    <text x="110" y="267" text-anchor="middle" font-size="10" fill="#991b1b">then &uarr;PaCO&#8322; and &darr;pH</text>
    <line x1="120" y1="196" x2="120" y2="218" stroke="#dc2626" stroke-width="1"/>

    <!-- ===== DIAPHRAGM & MUSCLES (bottom) ===== -->
    <!-- Diaphragm -->
    <path d="M 150,420 Q 250,385 335,420 Q 420,385 520,420"
          fill="none" stroke="#d97706" stroke-width="2.5"/>
    <text x="335" y="440" text-anchor="middle" font-size="13" font-weight="bold" fill="#92400e">Diaphragm</text>
    <text x="335" y="456" text-anchor="middle" font-size="10" fill="#78350f">(C3-C5 phrenic nerve)</text>

    <!-- Feedback arrows from brainstem to diaphragm -->
    <path d="M 315,390 C 310,400 320,410 325,415"
          fill="none" stroke="#d97706" stroke-width="2" marker-end="url(#rc-arrow)"/>
    <text x="290" y="405" font-size="9" fill="#92400e" font-weight="bold">Motor</text>
    <text x="290" y="415" font-size="9" fill="#92400e" font-weight="bold">output</text>

    <!-- Intercostal muscles (right side) -->
    <rect x="540" y="360" rx="6" ry="6" width="140" height="40" fill="#fef3c7" stroke="#d97706" stroke-width="1.2"/>
    <text x="610" y="378" text-anchor="middle" font-size="10" fill="#92400e" font-weight="bold">Intercostal Muscles</text>
    <text x="610" y="392" text-anchor="middle" font-size="10" fill="#78350f">(T1-T12 spinal nerves)</text>
    <line x1="430" y1="350" x2="540" y2="375" stroke="#d97706" stroke-width="1.5" marker-end="url(#rc-arrow)"/>

    <!-- Feedback arrow from chemoreceptors -->
    <path d="M 110,276 C 100,320 150,360 220,370"
          fill="none" stroke="#dc2626" stroke-width="1.5" stroke-dasharray="5,3" marker-end="url(#rc-arrow-red)"/>
    <text x="115" y="340" font-size="9" fill="#dc2626" font-style="italic">Feedback</text>

    <!-- COPD note -->
    <rect x="18" y="310" rx="6" ry="6" width="185" height="50" fill="#fef3c7" stroke="#d97706" stroke-width="1.2"/>
    <text x="110" y="328" text-anchor="middle" font-size="10" fill="#92400e" font-weight="bold">COPD Hypoxic Drive</text>
    <text x="110" y="343" text-anchor="middle" font-size="9" fill="#78350f">Chronic &uarr;CO&#8322; &rarr; central receptors</text>
    <text x="110" y="355" text-anchor="middle" font-size="9" fill="#78350f">reset &rarr; rely on &darr;O&#8322; to breathe</text>

    <!-- Legend -->
    <rect x="472" y="290" width="14" height="14" rx="3" fill="#86efac" stroke="#059669" stroke-width="1"/>
    <text x="492" y="301" font-size="10" fill="#4a5568">Pons</text>
    <rect x="540" y="290" width="14" height="14" rx="3" fill="#93c5fd" stroke="#2563eb" stroke-width="1"/>
    <text x="560" y="301" font-size="10" fill="#4a5568">Medulla</text>
    <rect x="620" y="290" width="14" height="14" rx="3" fill="#fecaca" stroke="#dc2626" stroke-width="1"/>
    <text x="640" y="301" font-size="10" fill="#4a5568">Chemoreceptors</text>
</svg>

<!-- ============================================================ -->
<!-- SECTION 2: ASSESSMENT -->
<!-- ============================================================ -->

<h2 class="section-title teal" id="s2">II. Respiratory Assessment</h2>

<h3 id="s2-symptoms">Key Symptoms</h3>

<h4>Dyspnea <span class="tag tag-slides">SLIDES</span></h4>
<p>Dyspnea is the <em>subjective</em> feeling of discomfort when breathing&mdash;it is what the patient reports, not what you measure. It is common in cardiac disorders, allergies, anemia, end-of-life states, exercise, PE, and MI. Importantly, dyspnea is a <strong>predictor of adverse outcomes</strong>. Always assess the degree (sudden vs. gradual onset), associated anxiety, and what makes it better or worse.</p>

<p><strong>Orthopnea</strong> is shortness of breath when lying flat, seen in heart disease and COPD. It is relieved by sitting or standing and is measured by the number of pillows needed (2-pillow orthopnea, 3-pillow orthopnea). <span class="tag tag-slides">SLIDES</span></p>

<h4>Cough <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<p>Cough is a protective reflex that clears the airways. It can be impaired by weakness, paralysis, immobility, NGT placement, depressed function (sedation, anesthesia, brain injury), or mechanical ventilation. Common causes include asthma, smoke exposure, GERD, ACE inhibitors, and infection.</p>

<p>The <strong>timing</strong> and <strong>character</strong> of a cough tell you different things:</p>
<table class="teal">
<tr><th>Timing</th><th>Suggests</th></tr>
<tr><td>Morning with sputum</td><td>Bronchitis</td></tr>
<tr><td>Night cough</td><td>Left-sided heart failure or bronchial asthma</td></tr>
<tr><td>After food/eating</td><td>Aspiration</td></tr>
<tr><td>New onset</td><td>Acute infection</td></tr>
<tr><td>Worse when supine</td><td>Postnasal drip (rhinosinusitis)</td></tr>
<tr><td>Dry, irritating</td><td>URI or <strong>ACE inhibitor</strong> side effect</td></tr>
<tr><td>Violent</td><td>Obstruction, bronchial spasm</td></tr>
<tr><td>Brassy</td><td>Tracheal lesion</td></tr>
<tr><td>Severe or changing</td><td>Bronchogenic carcinoma</td></tr>
</table>

<h4>Sputum <span class="tag tag-slides">SLIDES</span></h4>
<table>
<tr><th>Appearance</th><th>Suggests</th></tr>
<tr><td>Thick, purulent (yellow/green/rust)</td><td><strong>Bacterial infection</strong></td></tr>
<tr><td>Thin, mucoid</td><td>Viral bronchitis</td></tr>
<tr><td>Pink-tinged mucoid</td><td>Lung tumor</td></tr>
<tr><td>Profuse, frothy, pink</td><td><strong>Pulmonary edema</strong></td></tr>
<tr><td>Foul-smelling</td><td>Lung abscess, anaerobic infection</td></tr>
<tr><td>Gradual increase over time</td><td>Chronic bronchitis, bronchiectasis</td></tr>
</table>

<h4>Hemoptysis <span class="tag tag-slides">SLIDES</span></h4>
<p>Hemoptysis is the expectoration of blood from the respiratory tract. It can range from small streaks to massive hemorrhage and is usually sudden. Causes include infection, carcinoma, heart or blood vessel abnormalities, and PE.</p>

<table class="red">
<tr><th>Source</th><th>Characteristics</th></tr>
<tr><td><strong>Lung (hemoptysis)</strong></td><td>Bright red, frothy, mixed with sputum; tickling in throat; alkaline pH (&gt;7)</td></tr>
<tr><td><strong>Stomach (hematemesis)</strong></td><td>Vomited, mixed with food, dark/"coffee ground"; acid pH (&lt;7)</td></tr>
<tr><td>Nasopharynx</td><td>Preceded by sniffing; blood draining from nose</td></tr>
</table>

<h4>Stridor <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<p><strong>Stridor</strong> is a continuous, high-pitched sound heard over the neck, indicating narrowing of the upper respiratory tract. It demands <strong>immediate intervention</strong>&mdash;this is an airway emergency. Watch for it post-extubation.</p>

<h3 id="s2-physical">Physical Assessment Findings</h3>

<h4>Clubbing of Fingers <span class="tag tag-slides">SLIDES</span></h4>
<p>Finger clubbing is a sign of chronic hypoxic conditions. The nail bed becomes spongy and the angle between the nail and the nail bed flattens, then reverses. Associated conditions: congenital heart disease, chronic lung disease, lung malignancy, endocarditis, and inflammatory bowel disease.</p>

<h4>Cyanosis <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<p>Cyanosis (bluish skin discoloration) is a <strong>late indicator of hypoxia</strong> and is <strong>not reliable</strong>. It appears only when there is at least 5 g/dL of unoxygenated hemoglobin. <span class="tag tag-textbook">TEXTBOOK</span> Consider: a patient with Hgb 15 g/dL won't show cyanosis until a full third of their hemoglobin is deoxygenated. An <strong>anemic patient</strong> may never show cyanosis because they lack enough total hemoglobin to have 5 g/dL become unoxygenated. Conversely, a <strong>polycythemic patient</strong> may appear cyanotic even when adequately oxygenated.</p>
<ul>
<li><strong>Central cyanosis</strong>: assessed on tongue and lips&mdash;indicates decreased O2 tension in blood (more reliable)</li>
<li><strong>Peripheral cyanosis</strong>: fingers, toes, earlobes&mdash;may reflect vasoconstriction from cold, not necessarily a systemic problem</li>
</ul>

<h4>Tracheal Assessment <span class="tag tag-slides">SLIDES</span></h4>
<p>The trachea is normally midline. Place your thumb and index finger on either side to assess position. <strong>Pneumothorax or pleural effusion may displace the trachea.</strong></p>

<div class="callout memory">
<div class="callout-title">Memory: Which Way Does the Trachea Shift?</div>
<p><strong>TOWARD</strong> the problem in atelectasis/collapse (the collapsed side pulls things toward it).<br>
<strong>AWAY FROM</strong> the problem in effusion, pneumothorax, tension pneumothorax (the fluid or air pushes things to the other side).</p>
</div>

<h4>Thoracic Inspection <span class="tag tag-slides">SLIDES</span></h4>
<p>Assess color, turgor, subcutaneous tissue, and chest configuration. <strong>Barrel chest</strong> (increased anteroposterior diameter from chronic lung overinflation) is a hallmark of emphysema and COPD. <span class="tag tag-heavy">HEAVY IN SLIDES</span> Observe for use of accessory muscles: sternocleidomastoid, scalene, and trapezius during inspiration; abdominal and intercostal muscles during expiration. Also assess for nasal flaring.</p>

<h4>Chest Configuration Deformities <span class="tag tag-textbook">TEXTBOOK</span></h4>
<table>
<tr><th>Deformity</th><th>Description</th><th>Associations</th></tr>
<tr><td>Barrel chest</td><td>Increased AP diameter from lung overinflation</td><td>Aging, emphysema/COPD</td></tr>
<tr><td>Funnel chest (pectus excavatum)</td><td>Depression of lower sternum; may compress heart/great vessels &rarr; murmurs</td><td>Rickets, Marfan syndrome</td></tr>
<tr><td>Pigeon chest (pectus carinatum)</td><td>Anterior sternum displacement; increased AP diameter</td><td>Rickets, Marfan, severe kyphoscoliosis</td></tr>
<tr><td>Kyphoscoliosis</td><td>Elevated scapula, S-shaped spine; limits lung expansion</td><td>Osteoporosis, skeletal disorders</td></tr>
</table>

<h4>Tactile Fremitus <span class="tag tag-slides">SLIDES</span></h4>
<p>Tactile fremitus detects chest wall vibrations when the patient says "99" or "one, one, one." Use the palmar surface of your hands. Fremitus is more pronounced in men (deeper voice) and increased on the right side (large bronchi are closer to the chest wall). It is decreased or absent over the anterior chest (overlies the heart).</p>
<p>The key clinical principle: <strong>air does not conduct sound well.</strong></p>
<ul>
<li><strong>Emphysema</strong>: almost no tactile fremitus (hyperinflated, air-filled lungs)</li>
<li><strong>Pneumonia</strong>: increased fremitus over the affected lobe (consolidated, fluid-filled tissue conducts vibration better)</li>
</ul>

<h4>Voice Sounds (Abnormal = Consolidation) <span class="tag tag-textbook">TEXTBOOK</span></h4>
<table>
<tr><th>Test</th><th>How It Works</th><th>What It Means</th></tr>
<tr><td><strong>Bronchophony</strong></td><td>Patient says "ninety-nine"&mdash;heard louder/clearer than expected</td><td>Consolidation</td></tr>
<tr><td><strong>Egophony</strong></td><td>Patient says "E"&mdash;heard as "A" through stethoscope (E-to-A change)</td><td>Consolidation (e.g., pneumonia)</td></tr>
<tr><td><strong>Whispered pectoriloquy</strong></td><td>Patient whispers "one-two-three"&mdash;heard distinctly (should NOT be heard clearly normally)</td><td>Increased lung density</td></tr>
</table>

<h3 id="s2-patterns">Breathing Patterns <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<table>
<tr><th>Pattern</th><th>Rate/Description</th><th>Associated Conditions</th></tr>
<tr><td><strong>Normal (Eupnea)</strong></td><td>12-20 breaths/min</td><td>Normal</td></tr>
<tr><td><strong>Bradypnea</strong></td><td>&lt;10 breaths/min</td><td>Increased ICP, brain injury, drug overdose</td></tr>
<tr><td><strong>Tachypnea</strong></td><td>Rapid, shallow</td><td>Pneumonia, PE, metabolic acidosis, sepsis, pain, rib fracture</td></tr>
<tr><td><strong>Hyperpnea</strong></td><td>Increased depth, nearly equal inspiration/expiration</td><td>Exertion, anxiety, metabolic acidosis</td></tr>
<tr><td><strong>Kussmaul</strong></td><td>Increased rate AND depth; deep, labored</td><td>DKA, untreated kidney failure (metabolic acidosis)</td></tr>
<tr><td><strong>Cheyne-Stokes</strong></td><td>Crescendo-decrescendo cycle with apnea (~20 seconds)</td><td>Heart failure, respiratory center damage</td></tr>
<tr><td><strong>Biot's (Ataxic)</strong></td><td>Normal breaths (3-4) then apnea (10-60 seconds)</td><td>Drug overdose, medulla brain injury</td></tr>
<tr><td><strong>Obstructive</strong></td><td>Prolonged expiratory phase</td><td>Asthma, COPD, bronchitis</td></tr>
<tr><td><strong>Apnea</strong></td><td>Cessation of breathing</td><td>Varies</td></tr>
</table>

<h3 id="s2-sounds">Percussion Sounds &amp; Breath Sounds</h3>

<h4>Percussion <span class="tag tag-slides">SLIDES</span></h4>
<table class="purple">
<tr><th>Sound</th><th>Intensity</th><th>Normal Location</th><th>Pathology Example</th></tr>
<tr><td>Flat/Dull</td><td>Soft</td><td>Thigh</td><td>Large pleural effusion</td></tr>
<tr><td>Dull</td><td>Medium</td><td>Liver</td><td>Lobar pneumonia</td></tr>
<tr><td>Resonance</td><td>Loud</td><td>Normal lung</td><td>Simple chronic bronchitis</td></tr>
<tr><td>Hyperresonance</td><td>Very loud</td><td>(Not normal)</td><td>Emphysema, pneumothorax</td></tr>
<tr><td>Tympany</td><td>Loud</td><td>Gastric air bubble</td><td>Large pneumothorax</td></tr>
</table>

<h4>Adventitious Breath Sounds <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<table class="teal">
<tr><th>Sound</th><th>Description</th><th>Etiology</th></tr>
<tr><td><strong>Crackles (general)</strong></td><td>Nonmusical, discontinuous popping on inspiration</td><td>Fluid in airways/alveoli; delayed alveolar opening; HF, pulmonary fibrosis</td></tr>
<tr><td><strong>Coarse crackles</strong></td><td>Popping in early inspiration and throughout expiration; harsh, moist; originate in large bronchi</td><td>Obstructive pulmonary disease</td></tr>
<tr><td><strong>Fine crackles</strong></td><td>Soft, high-pitched popping in mid-to-late inspiration; sounds like hair rubbing together; originate in alveoli</td><td>Interstitial pneumonia, restrictive disease (fibrosis); in early inspiration = bronchitis/PNA</td></tr>
<tr><td><strong>Wheezes</strong></td><td>Continuous, musical, high-pitched; usually expiratory</td><td>Bronchial wall oscillation, narrowed/obstructed airway</td></tr>
<tr><td><strong>Rhonchi</strong></td><td>Deep, rumbling, snoring quality; primarily expiratory; <em>may clear with coughing</em></td><td>Secretions or tumor</td></tr>
<tr><td><strong>Pleural friction rub</strong></td><td>Low-pitched rubbing/grating; inspiration AND expiration; does NOT clear with coughing</td><td>Inflammation, loss of lubricating pleural fluid</td></tr>
<tr><td><strong>Stridor</strong></td><td>Continuous, high-pitched, over neck</td><td>Upper airway narrowing&mdash;<strong>immediate intervention</strong></td></tr>
</table>

<h4>Assessment Findings in Common Respiratory Disorders <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<table class="amber" style="font-size:.78rem;">
<tr><th>Condition</th><th>Percussion</th><th>Trachea</th><th>Breath Sounds</th><th>Adventitious Sounds</th><th>Fremitus</th></tr>
<tr><td>Normal</td><td>Resonant</td><td>Midline</td><td>Vesicular</td><td>Few transient crackles at bases</td><td>Normal</td></tr>
<tr><td>Chronic bronchitis</td><td>Resonant</td><td>Midline</td><td>Vesicular</td><td>Coarse crackles, wheezes, rhonchi</td><td>Normal</td></tr>
<tr><td>Left HF (early)</td><td>Resonant</td><td>Midline</td><td>Vesicular</td><td>Late inspiratory crackles; possible wheezes</td><td>Normal</td></tr>
<tr><td><strong>Lobar pneumonia</strong></td><td>Dull</td><td>Midline</td><td>Bronchial over involved area</td><td>Late inspiratory crackles</td><td>Increased; bronchophony, egophony, whispered pectoriloquy</td></tr>
<tr><td><strong>Atelectasis</strong></td><td>Dull</td><td>Shifted <strong>toward</strong> involved side</td><td>Usually absent</td><td>None</td><td>Usually absent</td></tr>
<tr><td><strong>Pleural effusion</strong></td><td>Dull to flat</td><td>Shifted <strong>away</strong> from affected side</td><td>Decreased to absent</td><td>Possible pleural rub</td><td>Decreased to absent</td></tr>
<tr><td><strong>Pneumothorax</strong></td><td>Hyperresonant/tympanitic</td><td>Shifted <strong>away</strong> (tension)</td><td>Decreased to absent</td><td>Possible pleural rub</td><td>Decreased to absent</td></tr>
<tr><td><strong>COPD</strong></td><td>Diffusely hyperresonant</td><td>Midline</td><td>Decreased, delayed expiration</td><td>Crackles, wheezes, rhonchi</td><td>Decreased</td></tr>
<tr><td>Asthma</td><td>Resonant to hyperresonant</td><td>Midline</td><td>Obscured by wheezes</td><td>Wheezes, possibly crackles</td><td>Decreased</td></tr>
</table>

<h4>Health Disparities in Pulmonary Health <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Rural areas: more tobacco use, younger smoking initiation, less cessation access</li>
<li>Lower income/education: more tobacco use</li>
<li>Below poverty level: more severe asthma, more hospitalizations, higher death rates</li>
<li>African American men: 37% more likely to develop lung cancer vs. Caucasian men despite similar smoking rates</li>
<li>African Americans: 55% higher asthma death rates; lower vaccination rates</li>
<li>Hispanics: higher pollution exposure, higher asthma prevalence, less likely to be diagnosed</li>
</ul>

<h4>Genetic/Familial Respiratory Disorders <span class="tag tag-slides">SLIDES</span></h4>
<p>Assess three-generation family history for: asthma, CF, COPD, alpha1-antitrypsin deficiency, primary ciliary dyskinesia, pulmonary fibrosis, pulmonary HTN, tuberous sclerosis. Risk factors include tobacco, indoor/outdoor pollutants, genetic makeup, infections, and obesity.</p>

<!-- ============================================================ -->
<!-- SECTION 3: DIAGNOSTICS & ABGs -->
<!-- ============================================================ -->

<h2 class="section-title purple" id="s3">III. Diagnostics &amp; ABG Interpretation</h2>

<h3 id="s3-etco2">ETCO2 &amp; Capnography <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>End-tidal CO2 (ETCO2) monitoring deserves special attention because the lecture emphasized it repeatedly as a <strong>more accurate predictor of respiratory status than SpO2</strong>. Here is why: SpO2 measures <em>oxygenation</em> (how much O2 hemoglobin carries), but ETCO2 measures <em>ventilation</em> (how effectively the patient is moving air and exchanging CO2). ETCO2 provides a breath-by-breath reflection of ventilation status and assesses airway, breathing, AND circulation simultaneously.</p>

<p>Normal ETCO2 range is <strong>35-45 mmHg</strong> (same as PaCO2). The colorimetric detector changes from purple to yellow when CO2 is detected. Critically, ETCO2 <strong>identifies respiratory depression and airway complications before clinical observation</strong>&mdash;before you see the patient's SpO2 drop, before you notice the change in breathing pattern.</p>

<div class="callout pearl">
<div class="callout-title">Pearl: The ETCO2 Paradox in Sedation</div>
<p>Sedation may induce respiratory depression, causing shallow breathing. Gas in the alveoli is not completely exhaled and becomes diluted by gas in the trachea and large airways (which has no CO2). So blood and alveolar CO2 actually <em>rise</em>, but expired CO2 appears to <em>decrease</em>. This is why waveform monitoring matters&mdash;look at the pattern, not just the number.</p>
</div>

<h4>Capnography Waveform Patterns <span class="tag tag-slides">SLIDES</span></h4>
<table>
<tr><th>Pattern</th><th>RR Trend</th><th>ETCO2 Trend</th><th>Interpretation</th></tr>
<tr><td>Normal</td><td>12-20</td><td>35-45 mmHg</td><td>Regular waveform with consistent height</td></tr>
<tr><td>Hyperventilation</td><td>Increases</td><td>Decreases</td><td>Blowing off CO2 too fast</td></tr>
<tr><td>Hypoventilation</td><td>Decreases</td><td>Increases</td><td>Retaining CO2; respiratory depression</td></tr>
</table>

<p>ETCO2 is affected by changes in:</p>
<ul>
<li><strong>Ventilation</strong>: asthma, COPD, airway edema, foreign body obstruction, stroke</li>
<li><strong>Diffusion</strong>: pulmonary edema, alveolar damage, CO poisoning, smoke inhalation</li>
<li><strong>Perfusion</strong>: shock, PE, cardiac arrest, severe arrhythmias</li>
</ul>

<h3>Pulse Oximetry Limitations <span class="tag tag-slides">SLIDES</span></h3>
<p>Pulse oximetry is NOT an accurate predictor in patients who are hypothermic, septic, hemodynamically unstable, wearing nail polish, or have dark skin pigment. Additional limitations from the textbook: <span class="tag tag-textbook">TEXTBOOK</span></p>
<ul>
<li>Cannot detect hyperoxemia (high PaO2)</li>
<li>Cannot measure PaO2 or ventilation directly</li>
<li>SpO2 &gt;95% = normal; &lt;90% = tissues not receiving adequate O2 &rarr; further evaluation needed</li>
</ul>

<h3 id="s3-abg">ABG Interpretation <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<h4>Normal ABG Values</h4>
<table class="purple">
<tr><th>Parameter</th><th>Normal Range</th><th>Key Threshold</th></tr>
<tr><td><strong>pH</strong></td><td>7.35 - 7.45</td><td>&lt;7.35 = acidosis; &gt;7.45 = alkalosis</td></tr>
<tr><td><strong>PaCO2</strong></td><td>35 - 45 mmHg</td><td>&gt;45 = respiratory acidosis; &lt;35 = respiratory alkalosis</td></tr>
<tr><td><strong>HCO3</strong></td><td>22 - 26 mEq/L</td><td>&lt;22 = metabolic acidosis; &gt;26 = metabolic alkalosis</td></tr>
<tr><td><strong>PaO2</strong></td><td>80 - 100 mmHg</td><td>&lt;80 = hypoxemia (lower = more severe)</td></tr>
<tr><td><strong>SaO2</strong></td><td>95 - 98%</td><td>&lt;90% = critical</td></tr>
<tr><td><strong>Base excess/deficit</strong></td><td>&plusmn;2 mEq/L</td><td>&gt;+2 = metabolic alkalosis; &lt;-2 = metabolic acidosis</td></tr>
</table>

<h4>ROME Method <span class="tag tag-slides">SLIDES</span></h4>
<div class="diagram">
<div class="diagram-title">ABG Interpretation Using ROME</div>
<p><strong>R</strong> = <strong>R</strong>espiratory: Look at pH and PCO2<br>
<strong>O</strong> = <strong>O</strong>pposite: In respiratory disorders, pH and PCO2 move in <em>opposite</em> directions<br>
&nbsp;&nbsp;&nbsp;&nbsp;pH &uarr; + PCO2 &darr; = Respiratory Alkalosis | pH &darr; + PCO2 &uarr; = Respiratory Acidosis</p>
<p><strong>M</strong> = <strong>M</strong>etabolic: Look at pH and HCO3<br>
<strong>E</strong> = <strong>E</strong>qual: In metabolic disorders, pH and HCO3 move in the <em>same</em> direction<br>
&nbsp;&nbsp;&nbsp;&nbsp;pH &uarr; + HCO3 &uarr; = Metabolic Alkalosis | pH &darr; + HCO3 &darr; = Metabolic Acidosis</p>
</div>

<h4>Compensation <span class="tag tag-slides">SLIDES</span></h4>
<table>
<tr><th>State</th><th>What You See</th><th>Interpretation</th></tr>
<tr><td><strong>Uncompensated</strong></td><td>CO2 or HCO3 is normal (only one system is abnormal)</td><td>Only one system is affected; the other hasn't kicked in yet</td></tr>
<tr><td><strong>Partially compensated</strong></td><td>NOTHING is normal (pH, CO2, and HCO3 all abnormal)</td><td>Both systems are trying to correct; the body is working on it</td></tr>
<tr><td><strong>Fully compensated</strong></td><td>pH is normal (7.35-7.45), but CO2 and HCO3 are both abnormal</td><td>Compensation successful; use 7.40 as the dividing line to determine the primary disorder</td></tr>
</table>

<h4>Acid-Base Disturbances &amp; Compensatory Responses <span class="tag tag-slides">SLIDES</span></h4>
<table class="red">
<tr><th>Disorder</th><th>pH</th><th>Primary Change</th><th>Compensation</th></tr>
<tr><td><strong>Metabolic Acidosis</strong></td><td>&darr;</td><td>HCO3 &darr;</td><td>&darr; PCO2 (hyperventilation to blow off CO2); kidneys increase H+ excretion</td></tr>
<tr><td><strong>Metabolic Alkalosis</strong></td><td>&uarr;</td><td>HCO3 &uarr;</td><td>&uarr; PCO2 (hypoventilation to retain CO2); kidneys decrease H+ excretion</td></tr>
<tr><td><strong>Respiratory Acidosis</strong></td><td>&darr;</td><td>PCO2 &uarr;</td><td>Kidneys increase HCO3 reabsorption</td></tr>
<tr><td><strong>Respiratory Alkalosis</strong></td><td>&uarr;</td><td>PCO2 &darr;</td><td>Kidneys decrease HCO3 reabsorption</td></tr>
</table>

<svg viewBox="0 0 760 620" style="max-width: 760px;" role="img" aria-label="ABG interpretation decision tree flowchart. Start by checking pH: if normal 7.35-7.45 check for compensation, if below 7.35 it is acidosis caused by either high PaCO2 (respiratory) or low HCO3 (metabolic), if above 7.45 it is alkalosis caused by either low PaCO2 (respiratory) or high HCO3 (metabolic). Each branch shows compensation check.">
    <defs>
        <marker id="abg-arrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#4a5568"/>
        </marker>
        <marker id="abg-arrow-red" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#dc2626"/>
        </marker>
        <marker id="abg-arrow-blue" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#2563eb"/>
        </marker>
        <marker id="abg-arrow-green" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#059669"/>
        </marker>
    </defs>

    <!-- Title -->
    <text x="380" y="26" text-anchor="middle" font-size="16" font-weight="bold" fill="#1a365d">ABG Interpretation Flowchart</text>

    <!-- Step 1: Check pH -->
    <rect x="290" y="45" rx="20" ry="20" width="180" height="50" fill="#e2e8f0" stroke="#4a5568" stroke-width="2"/>
    <text x="380" y="68" text-anchor="middle" font-size="13" font-weight="bold" fill="#1a365d">Step 1: Check pH</text>
    <text x="380" y="84" text-anchor="middle" font-size="10" fill="#4a5568">What is the pH?</text>

    <!-- Three branches from pH -->
    <!-- Left branch: Acidosis -->
    <line x1="310" y1="95" x2="140" y2="135" stroke="#dc2626" stroke-width="2" marker-end="url(#abg-arrow-red)"/>
    <!-- Center branch: Normal -->
    <line x1="380" y1="95" x2="380" y2="135" stroke="#059669" stroke-width="2" marker-end="url(#abg-arrow-green)"/>
    <!-- Right branch: Alkalosis -->
    <line x1="450" y1="95" x2="620" y2="135" stroke="#2563eb" stroke-width="2" marker-end="url(#abg-arrow-blue)"/>

    <!-- ===== ACIDOSIS BRANCH (LEFT) ===== -->
    <rect x="40" y="137" rx="8" ry="8" width="200" height="46" fill="#fef2f2" stroke="#dc2626" stroke-width="2"/>
    <text x="140" y="157" text-anchor="middle" font-size="13" font-weight="bold" fill="#dc2626">pH &lt; 7.35</text>
    <text x="140" y="174" text-anchor="middle" font-size="12" font-weight="bold" fill="#991b1b">ACIDOSIS</text>

    <!-- Step 2: Check CO2 and HCO3 -->
    <text x="140" y="200" text-anchor="middle" font-size="10" fill="#4a5568" font-weight="bold">Step 2: Check PaCO&#8322; &amp; HCO&#8322;&macr;</text>

    <!-- Left-left: Respiratory Acidosis -->
    <line x1="90" y1="208" x2="90" y2="230" stroke="#dc2626" stroke-width="1.5" marker-end="url(#abg-arrow-red)"/>
    <rect x="10" y="232" rx="6" ry="6" width="160" height="56" fill="#fee2e2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="90" y="250" text-anchor="middle" font-size="11" font-weight="bold" fill="#991b1b">PaCO&#8322; &gt; 45</text>
    <text x="90" y="266" text-anchor="middle" font-size="12" font-weight="bold" fill="#dc2626">Respiratory</text>
    <text x="90" y="280" text-anchor="middle" font-size="12" font-weight="bold" fill="#dc2626">Acidosis</text>

    <!-- Compensation check -->
    <line x1="90" y1="288" x2="90" y2="310" stroke="#4a5568" stroke-width="1" marker-end="url(#abg-arrow)"/>
    <rect x="15" y="312" rx="4" ry="4" width="150" height="40" fill="#f0fdf4" stroke="#059669" stroke-width="1"/>
    <text x="90" y="330" text-anchor="middle" font-size="10" fill="#059669" font-weight="bold">Compensation?</text>
    <text x="90" y="344" text-anchor="middle" font-size="10" fill="#065f46">HCO&#8322;&macr; &gt; 26 = Yes</text>

    <!-- Left-right: Metabolic Acidosis -->
    <line x1="190" y1="208" x2="190" y2="230" stroke="#dc2626" stroke-width="1.5" marker-end="url(#abg-arrow-red)"/>
    <rect x="110" y="232" rx="6" ry="6" width="160" height="56" fill="#fee2e2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="190" y="250" text-anchor="middle" font-size="11" font-weight="bold" fill="#991b1b">HCO&#8322;&macr; &lt; 22</text>
    <text x="190" y="266" text-anchor="middle" font-size="12" font-weight="bold" fill="#dc2626">Metabolic</text>
    <text x="190" y="280" text-anchor="middle" font-size="12" font-weight="bold" fill="#dc2626">Acidosis</text>

    <line x1="190" y1="288" x2="190" y2="310" stroke="#4a5568" stroke-width="1" marker-end="url(#abg-arrow)"/>
    <rect x="115" y="312" rx="4" ry="4" width="150" height="40" fill="#f0fdf4" stroke="#059669" stroke-width="1"/>
    <text x="190" y="330" text-anchor="middle" font-size="10" fill="#059669" font-weight="bold">Compensation?</text>
    <text x="190" y="344" text-anchor="middle" font-size="10" fill="#065f46">PaCO&#8322; &lt; 35 = Yes</text>

    <!-- ===== NORMAL BRANCH (CENTER) ===== -->
    <rect x="300" y="137" rx="8" ry="8" width="160" height="46" fill="#f0fdf4" stroke="#059669" stroke-width="2"/>
    <text x="380" y="157" text-anchor="middle" font-size="13" font-weight="bold" fill="#059669">pH 7.35 - 7.45</text>
    <text x="380" y="174" text-anchor="middle" font-size="12" font-weight="bold" fill="#047857">NORMAL</text>

    <line x1="380" y1="183" x2="380" y2="205" stroke="#4a5568" stroke-width="1.5" marker-end="url(#abg-arrow)"/>
    <rect x="300" y="207" rx="6" ry="6" width="160" height="86" fill="#ecfdf5" stroke="#059669" stroke-width="1.5"/>
    <text x="380" y="225" text-anchor="middle" font-size="10" fill="#047857" font-weight="bold">Check for compensation:</text>
    <text x="380" y="243" text-anchor="middle" font-size="10" fill="#065f46">Both CO&#8322; &amp; HCO&#8322;&macr; normal?</text>
    <text x="380" y="258" text-anchor="middle" font-size="10" fill="#059669" font-weight="bold">&rarr; True normal</text>
    <text x="380" y="276" text-anchor="middle" font-size="10" fill="#065f46">Both CO&#8322; &amp; HCO&#8322;&macr; abnormal?</text>
    <text x="380" y="291" text-anchor="middle" font-size="10" fill="#d97706" font-weight="bold">&rarr; Fully compensated</text>

    <!-- Fully compensated tip -->
    <line x1="380" y1="293" x2="380" y2="315" stroke="#4a5568" stroke-width="1" marker-end="url(#abg-arrow)"/>
    <rect x="300" y="317" rx="4" ry="4" width="160" height="35" fill="#fef3c7" stroke="#d97706" stroke-width="1"/>
    <text x="380" y="333" text-anchor="middle" font-size="10" fill="#92400e" font-weight="bold">Use 7.40 as divider:</text>
    <text x="380" y="346" text-anchor="middle" font-size="10" fill="#78350f">&lt;7.40 = acidotic | &gt;7.40 = alkalotic</text>

    <!-- ===== ALKALOSIS BRANCH (RIGHT) ===== -->
    <rect x="520" y="137" rx="8" ry="8" width="200" height="46" fill="#eff6ff" stroke="#2563eb" stroke-width="2"/>
    <text x="620" y="157" text-anchor="middle" font-size="13" font-weight="bold" fill="#2563eb">pH &gt; 7.45</text>
    <text x="620" y="174" text-anchor="middle" font-size="12" font-weight="bold" fill="#1d4ed8">ALKALOSIS</text>

    <text x="620" y="200" text-anchor="middle" font-size="10" fill="#4a5568" font-weight="bold">Step 2: Check PaCO&#8322; &amp; HCO&#8322;&macr;</text>

    <!-- Right-left: Respiratory Alkalosis -->
    <line x1="570" y1="208" x2="570" y2="230" stroke="#2563eb" stroke-width="1.5" marker-end="url(#abg-arrow-blue)"/>
    <rect x="490" y="232" rx="6" ry="6" width="160" height="56" fill="#dbeafe" stroke="#2563eb" stroke-width="1.5"/>
    <text x="570" y="250" text-anchor="middle" font-size="11" font-weight="bold" fill="#1d4ed8">PaCO&#8322; &lt; 35</text>
    <text x="570" y="266" text-anchor="middle" font-size="12" font-weight="bold" fill="#2563eb">Respiratory</text>
    <text x="570" y="280" text-anchor="middle" font-size="12" font-weight="bold" fill="#2563eb">Alkalosis</text>

    <line x1="570" y1="288" x2="570" y2="310" stroke="#4a5568" stroke-width="1" marker-end="url(#abg-arrow)"/>
    <rect x="495" y="312" rx="4" ry="4" width="150" height="40" fill="#f0fdf4" stroke="#059669" stroke-width="1"/>
    <text x="570" y="330" text-anchor="middle" font-size="10" fill="#059669" font-weight="bold">Compensation?</text>
    <text x="570" y="344" text-anchor="middle" font-size="10" fill="#065f46">HCO&#8322;&macr; &lt; 22 = Yes</text>

    <!-- Right-right: Metabolic Alkalosis -->
    <line x1="670" y1="208" x2="670" y2="230" stroke="#2563eb" stroke-width="1.5" marker-end="url(#abg-arrow-blue)"/>
    <rect x="590" y="232" rx="6" ry="6" width="160" height="56" fill="#dbeafe" stroke="#2563eb" stroke-width="1.5"/>
    <text x="670" y="250" text-anchor="middle" font-size="11" font-weight="bold" fill="#1d4ed8">HCO&#8322;&macr; &gt; 26</text>
    <text x="670" y="266" text-anchor="middle" font-size="12" font-weight="bold" fill="#2563eb">Metabolic</text>
    <text x="670" y="280" text-anchor="middle" font-size="12" font-weight="bold" fill="#2563eb">Alkalosis</text>

    <line x1="670" y1="288" x2="670" y2="310" stroke="#4a5568" stroke-width="1" marker-end="url(#abg-arrow)"/>
    <rect x="595" y="312" rx="4" ry="4" width="150" height="40" fill="#f0fdf4" stroke="#059669" stroke-width="1"/>
    <text x="670" y="330" text-anchor="middle" font-size="10" fill="#059669" font-weight="bold">Compensation?</text>
    <text x="670" y="344" text-anchor="middle" font-size="10" fill="#065f46">PaCO&#8322; &gt; 45 = Yes</text>

    <!-- ===== ROME MEMORY AID ===== -->
    <rect x="170" y="385" rx="8" ry="8" width="420" height="90" fill="#f8fafc" stroke="#4a5568" stroke-width="1.5"/>
    <text x="380" y="408" text-anchor="middle" font-size="13" font-weight="bold" fill="#1a365d">ROME Memory Aid</text>
    <text x="380" y="428" text-anchor="middle" font-size="11" fill="#dc2626"><tspan font-weight="bold">R</tspan>espiratory = <tspan font-weight="bold">O</tspan>pposite &mdash; pH and CO&#8322; move in opposite directions</text>
    <text x="380" y="448" text-anchor="middle" font-size="11" fill="#2563eb"><tspan font-weight="bold">M</tspan>etabolic = <tspan font-weight="bold">E</tspan>qual &mdash; pH and HCO&#8322;&macr; move in same direction</text>
    <text x="380" y="468" text-anchor="middle" font-size="10" fill="#4a5568" font-style="italic">Tip: The body NEVER overcompensates &mdash; if pH is normal with abnormal values, identify the primary disorder using 7.40</text>

    <!-- Compensation states summary -->
    <rect x="60" y="490" rx="6" ry="6" width="200" height="55" fill="#fef3c7" stroke="#d97706" stroke-width="1"/>
    <text x="160" y="510" text-anchor="middle" font-size="10" font-weight="bold" fill="#92400e">Uncompensated</text>
    <text x="160" y="524" text-anchor="middle" font-size="10" fill="#78350f">Only ONE system abnormal</text>
    <text x="160" y="538" text-anchor="middle" font-size="10" fill="#78350f">(pH abnormal + 1 value off)</text>

    <rect x="280" y="490" rx="6" ry="6" width="200" height="55" fill="#fed7aa" stroke="#ea580c" stroke-width="1"/>
    <text x="380" y="510" text-anchor="middle" font-size="10" font-weight="bold" fill="#9a3412">Partially Compensated</text>
    <text x="380" y="524" text-anchor="middle" font-size="10" fill="#7c2d12">NOTHING is normal</text>
    <text x="380" y="538" text-anchor="middle" font-size="10" fill="#7c2d12">(pH + CO&#8322; + HCO&#8322;&macr; all off)</text>

    <rect x="500" y="490" rx="6" ry="6" width="200" height="55" fill="#d1fae5" stroke="#059669" stroke-width="1"/>
    <text x="600" y="510" text-anchor="middle" font-size="10" font-weight="bold" fill="#047857">Fully Compensated</text>
    <text x="600" y="524" text-anchor="middle" font-size="10" fill="#065f46">pH is NORMAL</text>
    <text x="600" y="538" text-anchor="middle" font-size="10" fill="#065f46">(but CO&#8322; &amp; HCO&#8322;&macr; both off)</text>

    <!-- Key bottom note -->
    <text x="380" y="575" text-anchor="middle" font-size="11" fill="#4a5568" font-weight="bold">3-Step Process: (1) pH &rarr; acid or base? (2) CO&#8322; or HCO&#8322;&macr; &rarr; respiratory or metabolic? (3) Other value &rarr; compensating?</text>

    <!-- Legend -->
    <rect x="210" y="592" width="14" height="14" rx="3" fill="#fee2e2" stroke="#dc2626" stroke-width="1"/>
    <text x="230" y="603" font-size="10" fill="#4a5568">Acidosis</text>
    <rect x="300" y="592" width="14" height="14" rx="3" fill="#f0fdf4" stroke="#059669" stroke-width="1"/>
    <text x="320" y="603" font-size="10" fill="#4a5568">Normal</text>
    <rect x="380" y="592" width="14" height="14" rx="3" fill="#dbeafe" stroke="#2563eb" stroke-width="1"/>
    <text x="400" y="603" font-size="10" fill="#4a5568">Alkalosis</text>
    <rect x="465" y="592" width="14" height="14" rx="3" fill="#d1fae5" stroke="#059669" stroke-width="1"/>
    <text x="485" y="603" font-size="10" fill="#4a5568">Compensated</text>
</svg>

<h3 id="s3-imaging">Imaging &amp; Diagnostic Procedures <span class="tag tag-slides">SLIDES</span></h3>

<table>
<tr><th>Test</th><th>Purpose</th><th>Key Notes</th></tr>
<tr><td><strong>PFTs (Spirometry)</strong></td><td>Diagnose chronic respiratory disorders; assess dysfunction extent</td><td>FEV1/FVC &lt;85% = airway obstruction; FEF 25-75% detects early small airway disease</td></tr>
<tr><td><strong>CXR</strong></td><td>Verify tube/line placement; visualize fluid densities</td><td>First-line imaging for most respiratory complaints</td></tr>
<tr><td><strong>CT</strong></td><td>Contrast between bone, soft tissue, air</td><td>More detailed than CXR</td></tr>
<tr><td><strong>MRI</strong></td><td>Stage cancer, diagnose PE</td><td>Contraindicated: morbid obesity, claustrophobia, agitation, implanted metal</td></tr>
<tr><td><strong>Fluoroscopy</strong></td><td>Live x-ray to assist in lung mass/nodule removal</td><td>Real-time imaging</td></tr>
<tr><td><strong>Pulmonary Angiography</strong></td><td>Visualize pulmonary vessels with contrast</td><td>Invasive; used for PE diagnosis</td></tr>
<tr><td><strong>V/Q Scan</strong></td><td>Radioactive tracer to detect PE</td><td>Ventilation WITHOUT perfusion = PE</td></tr>
<tr><td><strong>PET Scan</strong></td><td>Evaluate lung nodules for malignancy</td><td>More accurate than CT for malignancies; distinguishes viable from dead tissue</td></tr>
<tr><td><strong>Bronchoscopy</strong></td><td>Direct inspection of larynx, trachea, bronchi; remove foreign bodies/mucus</td><td>Requires informed consent. Post-procedure: NPO until cough reflex returns</td></tr>
<tr><td><strong>Thoracentesis</strong></td><td>Remove pleural fluid; pleural biopsy; instill medication</td><td>RN: ensure consent, verify understanding, positioning, monitor vitals/sedation, send specimens to lab</td></tr>
</table>

<h4>Sedation Reversal Agents <span class="tag tag-slides">SLIDES</span></h4>
<table class="red">
<tr><th>Agent</th><th>Reverses</th></tr>
<tr><td><strong>Naloxone (Narcan)</strong></td><td>Opioids</td></tr>
<tr><td><strong>Flumazenil (Romazicon)</strong></td><td>Benzodiazepines</td></tr>
</table>

<!-- ============================================================ -->
<!-- SECTION 4: OXYGEN THERAPY -->
<!-- ============================================================ -->

<h2 class="section-title green" id="s4">IV. Oxygen Therapy &amp; Delivery</h2>

<p><strong>Oxygen is a medication</strong>&mdash;use the lowest amount necessary. <span class="tag tag-heavy">HEAVY IN SLIDES</span></p>

<h3>Hypoxemia &amp; Hypoxia</h3>
<p><strong>Hypoxemia</strong> is decreased arterial O2 (PaO2 &lt;60 mmHg). It manifests as agitation, confusion, lethargy, increased BP, diaphoresis, heart rate changes, and central cyanosis (a LATE sign). Hypoxemia leads to <strong>hypoxia</strong>&mdash;decreased O2 delivery to tissues. Rapid O2 deterioration causes CNS changes early. In chronic O2 deprivation (COPD with hypercarbia), patients present with delayed reactions, lethargy, and drowsiness. <span class="tag tag-slides">SLIDES</span></p>

<div class="callout warning">
<div class="callout-title">Warning: O2 Toxicity &amp; COPD</div>
<p><strong>O2 toxicity</strong> leads to lung damage similar to ARDS&mdash;avoid prolonged high FiO2 when possible.</p>
<p><strong>In COPD patients</strong>: high-flow O2 depresses respiratory drive. Alveolar hypoventilation cannot accommodate increased O2. Maintain SpO2 &gt;90% at the lowest effective flow rate.</p>
</div>

<h3 id="s4-devices">Oxygen Delivery Devices <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<h4>Low-Flow Devices</h4>
<table>
<tr><th>Device</th><th>Flow Rate</th><th>FiO2</th><th>Advantages</th><th>Disadvantages</th></tr>
<tr><td><strong>Nasal Cannula</strong></td><td>1-6 L/min</td><td>24-44%</td><td>Lightweight, comfortable, inexpensive, can eat/talk</td><td>Easily dislodged, skin breakdown, nasal drying, variable FiO2</td></tr>
<tr><td>Oropharyngeal catheter</td><td>Varies</td><td>Varies</td><td>&mdash;</td><td>Nasal mucosa irritation, frequent nostril alternation</td></tr>
<tr><td><strong>Simple Face Mask</strong></td><td>6-10 L/min</td><td>40-60%</td><td>Higher FiO2 than cannula</td><td>Poor fit, must remove to eat</td></tr>
<tr><td><strong>Partial Rebreather</strong></td><td>6-10 L/min</td><td>50-75%</td><td>Reservoir bag collects exhaled O2 for rebreathing; higher FiO2 than simple mask</td><td>Bag must NOT fully deflate; must remove to eat</td></tr>
<tr><td><strong>Non-Rebreather (NRB)</strong></td><td>10-15 L/min</td><td>60-100%</td><td>One-way valve prevents rebreathing exhaled air; highest FiO2 of mask devices</td><td><strong>Keep reservoir bag inflated at all times</strong>; flow must be &ge;10 L/min to prevent CO2 accumulation</td></tr>
</table>

<h4>High-Flow Devices</h4>
<table class="teal">
<tr><th>Device</th><th>FiO2</th><th>Advantages</th><th>Disadvantages</th></tr>
<tr><td><strong>Venturi Mask</strong></td><td>24-40% (precise)</td><td>Precise FiO2, additional humidity available</td><td>Must remove to eat</td></tr>
<tr><td>Transtracheal catheter</td><td>Low levels</td><td>Concealed by clothing, less L/min needed</td><td>Requires surgical placement, regular cleaning</td></tr>
<tr><td>Tracheostomy collar</td><td>Accurate FiO2</td><td>Good humidity</td><td>Requires surgery, suctioning for patency</td></tr>
<tr><td>Face tent</td><td>Fairly accurate FiO2</td><td>Good humidity, comfortable</td><td>Heavy with tubing</td></tr>
<tr><td><strong>HFNC</strong></td><td>Up to 100%</td><td>Up to 60 L/min; used extensively in COVID</td><td><strong>Aerosolizing&mdash;airborne precautions needed</strong></td></tr>
</table>

<svg viewBox="0 0 740 520" style="max-width: 740px;" role="img" aria-label="Oxygen delivery devices visual comparison showing five devices from lowest to highest FiO2: Nasal Cannula at 1-6 L/min delivering 24-44% FiO2, Simple Face Mask at 6-10 L/min delivering 40-60%, Non-Rebreather Mask at 10-15 L/min delivering 60-95%, Venturi Mask with precise FiO2 from 24-50%, and High-Flow Nasal Cannula up to 60 L/min delivering 21-100% FiO2.">
    <defs>
        <linearGradient id="o2-low" x1="0" y1="1" x2="0" y2="0">
            <stop offset="0%" stop-color="#dbeafe"/>
            <stop offset="100%" stop-color="#93c5fd"/>
        </linearGradient>
        <linearGradient id="o2-med" x1="0" y1="1" x2="0" y2="0">
            <stop offset="0%" stop-color="#d1fae5"/>
            <stop offset="100%" stop-color="#6ee7b7"/>
        </linearGradient>
        <linearGradient id="o2-high" x1="0" y1="1" x2="0" y2="0">
            <stop offset="0%" stop-color="#fef3c7"/>
            <stop offset="100%" stop-color="#fcd34d"/>
        </linearGradient>
        <linearGradient id="o2-vhigh" x1="0" y1="1" x2="0" y2="0">
            <stop offset="0%" stop-color="#fed7aa"/>
            <stop offset="100%" stop-color="#fb923c"/>
        </linearGradient>
        <linearGradient id="o2-max" x1="0" y1="1" x2="0" y2="0">
            <stop offset="0%" stop-color="#fecaca"/>
            <stop offset="100%" stop-color="#f87171"/>
        </linearGradient>
    </defs>

    <!-- Title -->
    <text x="370" y="26" text-anchor="middle" font-size="16" font-weight="bold" fill="#1a365d">Oxygen Delivery Devices &mdash; Visual Comparison</text>
    <text x="370" y="44" text-anchor="middle" font-size="11" fill="#4a5568">Low &rarr; High FiO&#8322; Delivery</text>

    <!-- FiO2 scale bar at top -->
    <rect x="60" y="55" width="620" height="14" rx="7" fill="#e2e8f0"/>
    <rect x="60" y="55" width="120" height="14" rx="7" fill="#93c5fd"/>
    <rect x="180" y="55" width="130" height="14" fill="#6ee7b7"/>
    <rect x="310" y="55" width="140" height="14" fill="#fcd34d"/>
    <rect x="450" y="55" width="100" height="14" fill="#fb923c"/>
    <rect x="550" y="55" width="130" height="14" rx="7" fill="#f87171"/>
    <text x="60" y="82" font-size="9" fill="#64748b">21%</text>
    <text x="370" y="82" text-anchor="middle" font-size="9" fill="#64748b">50%</text>
    <text x="670" y="82" text-anchor="end" font-size="9" fill="#64748b">100%</text>

    <!-- ===== DEVICE 1: NASAL CANNULA ===== -->
    <rect x="20" y="100" width="130" height="340" rx="8" fill="url(#o2-low)" stroke="#2563eb" stroke-width="1.5"/>
    <!-- Icon: nasal prongs -->
    <circle cx="85" cy="140" r="22" fill="white" stroke="#2563eb" stroke-width="1.5"/>
    <ellipse cx="77" cy="138" rx="4" ry="6" fill="none" stroke="#2563eb" stroke-width="1.5"/>
    <ellipse cx="93" cy="138" rx="4" ry="6" fill="none" stroke="#2563eb" stroke-width="1.5"/>
    <path d="M 73,142 Q 85,155 97,142" fill="none" stroke="#2563eb" stroke-width="1.2"/>
    <!-- Text -->
    <text x="85" y="180" text-anchor="middle" font-size="12" font-weight="bold" fill="#1e40af">Nasal</text>
    <text x="85" y="195" text-anchor="middle" font-size="12" font-weight="bold" fill="#1e40af">Cannula</text>
    <line x1="40" y1="210" x2="130" y2="210" stroke="#2563eb" stroke-width="0.5" opacity="0.5"/>
    <text x="85" y="232" text-anchor="middle" font-size="11" fill="#1e40af" font-weight="bold">1-6 L/min</text>
    <text x="85" y="255" text-anchor="middle" font-size="13" fill="#1e40af" font-weight="bold">24-44%</text>
    <text x="85" y="272" text-anchor="middle" font-size="10" fill="#1e40af">FiO&#8322;</text>
    <line x1="40" y1="285" x2="130" y2="285" stroke="#2563eb" stroke-width="0.5" opacity="0.5"/>
    <text x="85" y="305" text-anchor="middle" font-size="10" fill="#1e3a8a">Comfortable</text>
    <text x="85" y="320" text-anchor="middle" font-size="10" fill="#1e3a8a">Can eat/talk</text>
    <text x="85" y="340" text-anchor="middle" font-size="9" fill="#64748b">~4% per L/min</text>
    <text x="85" y="355" text-anchor="middle" font-size="9" fill="#64748b">above 21%</text>

    <!-- LOW-FLOW label -->
    <rect x="20" y="415" width="130" height="22" rx="4" fill="#2563eb"/>
    <text x="85" y="430" text-anchor="middle" font-size="10" font-weight="bold" fill="white">LOW-FLOW</text>

    <!-- ===== DEVICE 2: SIMPLE FACE MASK ===== -->
    <rect x="162" y="100" width="130" height="340" rx="8" fill="url(#o2-med)" stroke="#059669" stroke-width="1.5"/>
    <!-- Icon: face mask -->
    <circle cx="227" cy="140" r="22" fill="white" stroke="#059669" stroke-width="1.5"/>
    <path d="M 210,130 Q 227,155 244,130" fill="none" stroke="#059669" stroke-width="2"/>
    <line x1="210" y1="130" x2="204" y2="135" stroke="#059669" stroke-width="1.5"/>
    <line x1="244" y1="130" x2="250" y2="135" stroke="#059669" stroke-width="1.5"/>
    <text x="227" y="180" text-anchor="middle" font-size="12" font-weight="bold" fill="#047857">Simple</text>
    <text x="227" y="195" text-anchor="middle" font-size="12" font-weight="bold" fill="#047857">Face Mask</text>
    <line x1="182" y1="210" x2="272" y2="210" stroke="#059669" stroke-width="0.5" opacity="0.5"/>
    <text x="227" y="232" text-anchor="middle" font-size="11" fill="#047857" font-weight="bold">6-10 L/min</text>
    <text x="227" y="255" text-anchor="middle" font-size="13" fill="#047857" font-weight="bold">40-60%</text>
    <text x="227" y="272" text-anchor="middle" font-size="10" fill="#047857">FiO&#8322;</text>
    <line x1="182" y1="285" x2="272" y2="285" stroke="#059669" stroke-width="0.5" opacity="0.5"/>
    <text x="227" y="305" text-anchor="middle" font-size="10" fill="#065f46">Must remove</text>
    <text x="227" y="320" text-anchor="middle" font-size="10" fill="#065f46">to eat</text>
    <text x="227" y="340" text-anchor="middle" font-size="9" fill="#dc2626" font-weight="bold">Min 6 L/min</text>
    <text x="227" y="355" text-anchor="middle" font-size="9" fill="#64748b">(prevent CO&#8322;</text>
    <text x="227" y="368" text-anchor="middle" font-size="9" fill="#64748b">rebreathing)</text>

    <rect x="162" y="415" width="130" height="22" rx="4" fill="#059669"/>
    <text x="227" y="430" text-anchor="middle" font-size="10" font-weight="bold" fill="white">LOW-FLOW</text>

    <!-- ===== DEVICE 3: NON-REBREATHER ===== -->
    <rect x="304" y="100" width="130" height="340" rx="8" fill="url(#o2-high)" stroke="#d97706" stroke-width="1.5"/>
    <!-- Icon: mask + bag -->
    <circle cx="369" cy="135" r="22" fill="white" stroke="#d97706" stroke-width="1.5"/>
    <path d="M 352,125 Q 369,150 386,125" fill="none" stroke="#d97706" stroke-width="2"/>
    <ellipse cx="369" cy="162" rx="12" ry="8" fill="none" stroke="#d97706" stroke-width="1.5"/>
    <text x="369" y="164" text-anchor="middle" font-size="7" fill="#d97706">bag</text>
    <text x="369" y="186" text-anchor="middle" font-size="12" font-weight="bold" fill="#92400e">Non-</text>
    <text x="369" y="200" text-anchor="middle" font-size="12" font-weight="bold" fill="#92400e">Rebreather</text>
    <line x1="324" y1="215" x2="414" y2="215" stroke="#d97706" stroke-width="0.5" opacity="0.5"/>
    <text x="369" y="237" text-anchor="middle" font-size="11" fill="#92400e" font-weight="bold">10-15 L/min</text>
    <text x="369" y="260" text-anchor="middle" font-size="13" fill="#92400e" font-weight="bold">60-95%</text>
    <text x="369" y="277" text-anchor="middle" font-size="10" fill="#92400e">FiO&#8322;</text>
    <line x1="324" y1="290" x2="414" y2="290" stroke="#d97706" stroke-width="0.5" opacity="0.5"/>
    <text x="369" y="310" text-anchor="middle" font-size="10" fill="#78350f">One-way valve</text>
    <text x="369" y="325" text-anchor="middle" font-size="10" fill="#78350f">Bag must stay</text>
    <text x="369" y="340" text-anchor="middle" font-size="10" fill="#dc2626" font-weight="bold">INFLATED</text>
    <text x="369" y="358" text-anchor="middle" font-size="9" fill="#64748b">Highest FiO&#8322;</text>
    <text x="369" y="371" text-anchor="middle" font-size="9" fill="#64748b">of mask devices</text>

    <rect x="304" y="415" width="130" height="22" rx="4" fill="#d97706"/>
    <text x="369" y="430" text-anchor="middle" font-size="10" font-weight="bold" fill="white">LOW-FLOW</text>

    <!-- ===== DEVICE 4: VENTURI MASK ===== -->
    <rect x="446" y="100" width="130" height="340" rx="8" fill="url(#o2-vhigh)" stroke="#ea580c" stroke-width="1.5"/>
    <!-- Icon: mask + adapters -->
    <circle cx="511" cy="135" r="22" fill="white" stroke="#ea580c" stroke-width="1.5"/>
    <path d="M 494,125 Q 511,150 528,125" fill="none" stroke="#ea580c" stroke-width="2"/>
    <rect x="501" y="153" width="6" height="8" rx="1" fill="#2563eb"/>
    <rect x="509" y="153" width="6" height="8" rx="1" fill="#059669"/>
    <rect x="517" y="153" width="6" height="8" rx="1" fill="#d97706"/>
    <text x="511" y="186" text-anchor="middle" font-size="12" font-weight="bold" fill="#9a3412">Venturi</text>
    <text x="511" y="200" text-anchor="middle" font-size="12" font-weight="bold" fill="#9a3412">Mask</text>
    <line x1="466" y1="215" x2="556" y2="215" stroke="#ea580c" stroke-width="0.5" opacity="0.5"/>
    <text x="511" y="237" text-anchor="middle" font-size="11" fill="#9a3412" font-weight="bold">Varies by</text>
    <text x="511" y="251" text-anchor="middle" font-size="11" fill="#9a3412" font-weight="bold">adapter</text>
    <text x="511" y="274" text-anchor="middle" font-size="12" fill="#9a3412" font-weight="bold">PRECISE</text>
    <text x="511" y="290" text-anchor="middle" font-size="10" fill="#9a3412">24-50% FiO&#8322;</text>
    <line x1="466" y1="300" x2="556" y2="300" stroke="#ea580c" stroke-width="0.5" opacity="0.5"/>
    <text x="511" y="318" text-anchor="middle" font-size="10" fill="#7c2d12">Color-coded</text>
    <text x="511" y="333" text-anchor="middle" font-size="10" fill="#7c2d12">adapters</text>
    <text x="511" y="353" text-anchor="middle" font-size="9" fill="#dc2626" font-weight="bold">Best for COPD</text>
    <text x="511" y="368" text-anchor="middle" font-size="9" fill="#64748b">(precise control</text>
    <text x="511" y="381" text-anchor="middle" font-size="9" fill="#64748b">prevents &darr;drive)</text>

    <rect x="446" y="415" width="130" height="22" rx="4" fill="#ea580c"/>
    <text x="511" y="430" text-anchor="middle" font-size="10" font-weight="bold" fill="white">HIGH-FLOW</text>

    <!-- ===== DEVICE 5: HFNC ===== -->
    <rect x="588" y="100" width="130" height="340" rx="8" fill="url(#o2-max)" stroke="#dc2626" stroke-width="1.5"/>
    <!-- Icon: wide bore cannula -->
    <circle cx="653" cy="140" r="22" fill="white" stroke="#dc2626" stroke-width="1.5"/>
    <ellipse cx="643" cy="138" rx="6" ry="7" fill="none" stroke="#dc2626" stroke-width="2"/>
    <ellipse cx="663" cy="138" rx="6" ry="7" fill="none" stroke="#dc2626" stroke-width="2"/>
    <path d="M 637,142 Q 653,158 669,142" fill="none" stroke="#dc2626" stroke-width="1.5"/>
    <text x="653" y="180" text-anchor="middle" font-size="12" font-weight="bold" fill="#991b1b">High-Flow</text>
    <text x="653" y="195" text-anchor="middle" font-size="12" font-weight="bold" fill="#991b1b">Nasal Cannula</text>
    <line x1="608" y1="210" x2="698" y2="210" stroke="#dc2626" stroke-width="0.5" opacity="0.5"/>
    <text x="653" y="232" text-anchor="middle" font-size="11" fill="#991b1b" font-weight="bold">Up to 60 L/min</text>
    <text x="653" y="255" text-anchor="middle" font-size="13" fill="#991b1b" font-weight="bold">21-100%</text>
    <text x="653" y="272" text-anchor="middle" font-size="10" fill="#991b1b">FiO&#8322;</text>
    <line x1="608" y1="285" x2="698" y2="285" stroke="#dc2626" stroke-width="0.5" opacity="0.5"/>
    <text x="653" y="305" text-anchor="middle" font-size="10" fill="#7f1d1d">Heated, humidified</text>
    <text x="653" y="320" text-anchor="middle" font-size="10" fill="#7f1d1d">Some PEEP effect</text>
    <text x="653" y="340" text-anchor="middle" font-size="9" fill="#dc2626" font-weight="bold">Aerosolizing!</text>
    <text x="653" y="355" text-anchor="middle" font-size="9" fill="#64748b">Airborne precautions</text>
    <text x="653" y="370" text-anchor="middle" font-size="9" fill="#64748b">required</text>

    <rect x="588" y="415" width="130" height="22" rx="4" fill="#dc2626"/>
    <text x="653" y="430" text-anchor="middle" font-size="10" font-weight="bold" fill="white">HIGH-FLOW</text>

    <!-- Bottom legend -->
    <text x="370" y="470" text-anchor="middle" font-size="11" fill="#4a5568">FiO&#8322; increases left &rarr; right | Each L/min on nasal cannula &asymp; +4% FiO&#8322; above room air (21%)</text>
    <rect x="100" y="485" width="540" height="28" rx="6" fill="#fef2f2" stroke="#dc2626" stroke-width="1"/>
    <text x="370" y="504" text-anchor="middle" font-size="11" fill="#991b1b" font-weight="bold">Key Rule: Always use LOWEST effective FiO&#8322; &mdash; prolonged high O&#8322; causes toxicity and absorption atelectasis</text>
</svg>

<!-- ============================================================ -->
<!-- SECTION 5: UPPER RESPIRATORY DISORDERS -->
<!-- ============================================================ -->

<h2 class="section-title teal" id="s5">V. Upper Respiratory Tract Disorders</h2>

<h3>Viral Rhinitis (Common Cold) <span class="tag tag-slides">SLIDES</span></h3>
<p>Up to 200 different viruses cause the common cold. Presentation: low-grade temperature, nasal congestion, rhinorrhea, sneezing, sore throat, muscle aches. Treatment is supportive: fluids, rest, NSAIDs, antihistamines, expectorants. The virus is shed for <strong>2 days before symptoms appear</strong>, making it highly contagious.</p>

<h3>Rhinitis <span class="tag tag-slides">SLIDES</span></h3>
<p>Inflammation and irritation of the nasal mucous membranes. <strong>Allergic rhinitis</strong> is triggered by dust, dander, pollen, and mold. <strong>Drug-induced rhinitis</strong> can be caused by ACE inhibitors, beta-blockers, statins, antidepressants, antianxiety medications, and aspirin. Treatment: antihistamines and corticosteroid nasal sprays.</p>

<p><strong>Rhinitis medicamentosa</strong> is rebound nasal congestion from overuse of OTC topical decongestants (phenylephrine, oxymetazoline). <span class="tag tag-textbook">TEXTBOOK</span> Key teaching: topical decongestants should NOT be used for more than 3-4 days.</p>

<h3>Rhinosinusitis <span class="tag tag-slides">SLIDES</span></h3>
<p>Inflammation of the paranasal sinuses and nasal cavity, typically following a cold. Bacterial or viral. Presents with facial pressure, pain, colored nasal discharge, and high fever.</p>

<table>
<tr><th>Classification</th><th>Duration</th></tr>
<tr><td>Acute</td><td>&lt;4 weeks</td></tr>
<tr><td>Subacute</td><td>4-12 weeks</td></tr>
<tr><td>Chronic (CRS)</td><td>&gt;12 weeks</td></tr>
<tr><td>Recurrent acute</td><td>&ge;4 episodes ABRS/year</td></tr>
</table>

<h4>ABRS vs. AVRS <span class="tag tag-textbook">TEXTBOOK</span></h4>
<table>
<tr><th>Feature</th><th>ABRS (Bacterial)</th><th>AVRS (Viral)</th></tr>
<tr><td>Fever</td><td>High (&ge;39&deg;C / 102&deg;F)</td><td>Lower</td></tr>
<tr><td>Duration</td><td>Symptoms persist &ge;10 days or worsen</td><td>&lt;10 days, don't worsen</td></tr>
<tr><td>Facial pain</td><td>Present</td><td>Usually absent</td></tr>
<tr><td>Treatment</td><td>Antibiotics (amoxicillin or amoxicillin-clavulanate first-line)</td><td>Supportive only</td></tr>
</table>

<div class="callout warning">
<div class="callout-title">Warning: Rhinosinusitis Complications</div>
<p>Rare but serious: osteomyelitis, orbital cellulitis (&rarr; ptosis, proptosis, chemosis &rarr; <strong>loss of vision if pressure on optic nerve</strong>), cavernous sinus thrombosis, meningitis, brain abscess.</p>
</div>

<h3>Pharyngitis <span class="tag tag-slides">SLIDES</span></h3>
<p>Inflammation of the pharynx. Most cases are viral; <strong>15% are Group A Streptococcus (GAS)</strong>&mdash;these need antibiotics. Presentation: pain, fever, vasodilation, edema, redness, possible creamy exudate on tonsils, malaise, bad breath.</p>

<p>GAS pharyngitis: fiery-red pharyngeal membrane, swollen tonsils with white-purple exudate, enlarged tender cervical lymph nodes, NO cough, fever &gt;38.3&deg;C. Treatment: <strong>Penicillin V potassium &times; 10 days</strong> (first-line). <span class="tag tag-textbook">TEXTBOOK</span></p>

<div class="callout warning">
<div class="callout-title">Warning: Untreated Strep Pharyngitis</div>
<p>Complications include <strong>rheumatic fever</strong> (onset 2-3 weeks post-pharyngitis) and <strong>glomerulonephritis</strong>. Full course of antibiotics is critical&mdash;not just symptom resolution.</p>
</div>

<h3>Tonsillitis &amp; Peritonsillar Abscess <span class="tag tag-slides">SLIDES</span></h3>
<p><strong>Tonsillitis</strong>: less common than pharyngitis; most common pathogen is Epstein-Barr virus. If bacterial, penicillin is first-line. Chronic cases may require tonsillectomy.</p>

<p><strong>Peritonsillar abscess (Quinsy)</strong>: most common major suppurative complication of sore throat. Adults 20-40. Purulent exudate after tonsillar infection that can spread to neck and chest. Key findings: severe sore throat, fever, <strong>trismus</strong> (inability to open mouth), drooling, intense pain, rancid breath, raspy voice. Treatment: antimicrobials + steroids; may need needle aspiration/I&amp;D. Can be <strong>life-threatening</strong> if it spreads (mediastinitis, airway obstruction).</p>

<h3>Laryngitis <span class="tag tag-slides">SLIDES</span></h3>
<p>Inflammation of the larynx. Hoarseness, aphonia (loss of voice), severe cough. Treatment: voice rest, avoid irritants, inhalation of cool steam.</p>

<h3>Epistaxis <span class="tag tag-textbook">TEXTBOOK</span></h3>
<p>Most common site: <strong>anterior septum</strong> (Kiesselbach plexus). Initial management: sit upright, tilt head FORWARD (not back), pinch soft nose against septum for 5-10 minutes. If persistent: silver nitrate cautery, nasal packing, or balloon catheter. Risk factors: local infection, HTN, anticoagulants/aspirin, thrombocytopenia, nasal trauma, liver disease.</p>

<h3 id="s5-osa">Obstructive Sleep Apnea (OSA) <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>Recurrent upper airway obstruction during sleep with reduced ventilation. Risk factors: obesity (major&mdash;increased neck circumference, peripharyngeal fat), large neck, male sex, post-menopause, older age. Prevalence is ~26% of adults aged 30-70, and up to 90% are undiagnosed. <span class="tag tag-slides">SLIDES</span></p>

<div class="callout warning">
<div class="callout-title">Warning: OSA Cardiovascular Risk</div>
<p><strong>High prevalence of HTN; high risk for MI and stroke.</strong> All hypertensive adults should be screened for OSA. Episodes of hypoxia and hypercapnia trigger sympathetic activation, driving up blood pressure.</p>
</div>

<p><strong>Diagnostic criteria</strong>: episodes of apnea during sleep for &ge;10 seconds, &ge;5 episodes/hour, awakening with a snort, loud snoring. Diagnosed with <strong>polysomnography</strong> (overnight sleep study monitoring EEG, ECG, EMG, airflow, pulse oximetry, leg movements).</p>

<p><strong>Assessment findings</strong>: excessive daytime sleepiness, frequent nocturnal awakening, insomnia, morning headaches, personality changes, impotence, HTN, arrhythmias, pulmonary HTN, cor pulmonale, polycythemia, enuresis.</p>

<p><strong>Treatment ladder</strong>:</p>
<ol>
<li>Weight loss, avoid alcohol, positional therapy (avoid sleeping on back)</li>
<li>MAD (mandibular advancement device)&mdash;effective for mild-moderate</li>
<li><strong>CPAP</strong> (continuous positive airway pressure)&mdash;prevents airway collapse</li>
<li><strong>BiPAP</strong>&mdash;for severe cases with hypoxemia/hypercapnia</li>
<li>Surgery: tonsillectomy, UPPP (50% effective), septoplasty</li>
</ol>

<h3 id="s5-laryngeal">Laryngeal Cancer <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>One-quarter of all head and neck cancers; most common in patients &gt;65 years. Almost all are <strong>squamous cell carcinoma</strong>. 55% present with lymph node involvement at diagnosis. Recurrence usually within the first 2-3 years. <span class="tag tag-slides">SLIDES</span></p>

<p><strong>Risk factors</strong>: tobacco, asbestos, paint fumes, wood dust, chemicals, nutritional deficiencies, alcohol abuse, male gender, African Americans.</p>

<p><strong>Manifestations by location</strong> <span class="tag tag-textbook">TEXTBOOK</span>:</p>
<ul>
<li><strong>Glottic</strong>: hoarseness &gt;2 weeks (early sign&mdash;tumor impedes vocal cords)</li>
<li><strong>Supraglottic/subglottic</strong>: voice changes NOT always early; may present with persistent cough, sore throat, dysphagia, lump in neck</li>
<li>Late: dysphagia, dyspnea, weight loss, ear pain (referred)</li>
</ul>

<p><strong>Treatment goals</strong>: preserve swallowing, speech, and breathing without tracheostomy when possible. Options: surgery (vocal cord stripping, cordectomy, laser excision, partial or total laryngectomy), radiation, chemotherapy.</p>

<h4>Laryngectomy <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<div class="compare-row">
<div class="compare-card left">
<h4>Partial Laryngectomy</h4>
<p>Used for early-stage glottic tumors with one cord involvement. High cure rate. Airway remains intact. No expected swallowing difficulty. Voice may be hoarse but preserved.</p>
</div>
<div class="compare-card right">
<h4>Total Laryngectomy</h4>
<p>Complete removal of larynx (hyoid, epiglottis, cricoid cartilage, 2-3 tracheal rings). Curative in most laryngeal cancers. Results in: <strong>permanent vocal loss</strong> and <strong>permanent tracheostomy</strong>.</p>
<p>Communication alternatives: writing, lip reading, esophageal speech, artificial (electric) larynx, tracheoesophageal puncture (TEP) with Blom-Singer valve (most resembles normal speech).</p>
</div>
</div>

<h4>Laryngectomy Nursing Care <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Semi-Fowler/Fowler position &rarr; decrease edema, promote lung expansion</li>
<li>Assess lung sounds; opioids reduce respiratory drive</li>
<li>Turn, cough, deep breathe</li>
<li>Change disposable laryngeal tube q8h</li>
<li><strong>NPO for 7 days post-op</strong>; NGT, PEG, IVF until swallow study clears oral feedings</li>
<li>Alternative communication: call light, notepad, tablet, smartphone</li>
<li>Wound drains: observe/measure; remove when drainage &lt;30 mL/day &times; 2 consecutive days</li>
</ul>

<h4>Laryngectomy Complications <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<table class="red">
<tr><th>Complication</th><th>Key Points</th></tr>
<tr><td><strong>Respiratory distress</strong></td><td>Restlessness (early), hypoxia, agitation, confusion, increased RR, accessory muscles, nasal flaring, decreased SpO2, cyanosis (LATE)</td></tr>
<tr><td><strong>Hemorrhage</strong></td><td>Monitor drainage; <strong>frequent swallowing = sign of bleeding!</strong> Carotid artery rupture possible&mdash;apply pressure, call for help</td></tr>
<tr><td><strong>Infection</strong></td><td>In older adults, temp and WBC may be blunted&mdash;monitor LOC</td></tr>
<tr><td>Skin breakdown</td><td>Poor wound healing, fistula, observe for hematoma</td></tr>
<tr><td><strong>Aspiration</strong></td><td>HOB &gt;30&deg;, check residuals, give antiemetics for N/V</td></tr>
<tr><td>Tracheoesophageal stenosis</td><td>Abnormal narrowing of trachea or stoma</td></tr>
</table>

<!-- ============================================================ -->
<!-- SECTION 6: LOWER RESPIRATORY INFECTIONS -->
<!-- ============================================================ -->

<h2 class="section-title red" id="s6">VI. Lower Respiratory Tract Infections</h2>

<h3>Pneumonia Classifications <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>Pneumonia is classified by where and how the patient acquired it, which determines the likely organism and treatment approach:</p>

<table>
<tr><th>Type</th><th>Definition</th><th>Key Detail</th></tr>
<tr><td><strong>CAP</strong> (Community-Acquired)</td><td>Occurs in the community or within 48 hours of hospitalization</td><td>Incidence increases with age</td></tr>
<tr><td><strong>HCAP</strong> (Healthcare-Associated)</td><td>Non-hospitalized patient with recent healthcare contact</td><td>Hospitalized &ge;2 days, resides in SNF, received abx/chemo/wound care within 30 days, HD at hospital/clinic, home infusion/wound care, family member with MDRO</td></tr>
<tr><td><strong>HAP</strong> (Hospital-Acquired)</td><td>PNA occurring &ge;48 hours after admission</td><td>Hospital-acquired organisms</td></tr>
<tr><td><strong>VAP</strong> (Ventilator-Associated)</td><td>PNA &ge;48 hours after ETT placement</td><td>Highest mortality; prevented by VAP bundle</td></tr>
</table>

<h4>Clinical Manifestations <span class="tag tag-slides">SLIDES</span></h4>
<p>Sudden onset of chills, fever, pleuritic pain aggravated by deep breathing and coughing, tachypnea, SOB, accessory muscle use. Possible sore throat, nasal congestion, orthopnea.</p>

<h4>Risk Factors &amp; Special Populations <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>DM, HF, alcoholism, COPD (<em>H. influenzae</em>), CF (pseudomonal and staph), influenza (staph PNA), smoking, immobility, depressed cough reflex</li>
<li><strong>AIDS &rarr; Pneumocystis jirovecii (PCP)</strong>&mdash;opportunistic infection</li>
<li><strong>Aspiration pneumonia</strong>: infection with bacteria from the upper airway OR non-bacterial substances entering the lungs</li>
</ul>

<h4>Treatment &amp; Prevention <span class="tag tag-slides">SLIDES</span></h4>
<p>Antibiotics if bacterial; supportive if viral. Add O2 for desaturation&mdash;may progress to mechanical ventilation. <strong>Prevention</strong>: pneumonia vaccine for adults &gt;65 (both PCV13 and PPSV23, one year apart) and &gt;19 years if immunocompromised.</p>

<h4>Nursing Interventions <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Administer antibiotics, antipyretics, antitussives, decongestants</li>
<li>Fluids (caution in older adults and/or CHF&mdash;fluid overload risk)</li>
<li>Respiratory treatments, bed rest, position changes, early ambulation</li>
<li>O2, deep breathing/coughing, proper nutrition</li>
</ul>
<p><strong>Complications</strong>: shock, respiratory failure, pleural effusion.</p>

<h3>Sarcoidosis <span class="tag tag-slides">SLIDES</span></h3>
<p>An interstitial lung disease presenting in ages 20-40, thought to be a hypersensitivity reaction to an exogenous agent with inherited predisposition. The inflammatory process produces <strong>noninfectious granulomas</strong> that reduce lung compliance, cause fibrosis, and reduce lung volumes.</p>
<p><strong>Manifestations</strong>: dyspnea, cough, hemoptysis, congestion, anorexia, fatigue, weight loss, joint pain, fever, granulomatous lesions (skin, liver, kidney, spleen, CNS). Confirmed by biopsy. PFTs may show reduced TLC; ABGs may show hypoxemia and hypercapnia.</p>
<p><strong>Treatment</strong>: corticosteroids (taper after 12 months). If unable to reduce steroid dose, add immune modulator (methotrexate).</p>

<!-- ============================================================ -->
<!-- SECTION 7: OBSTRUCTIVE PULMONARY DISEASE -->
<!-- ============================================================ -->

<h2 class="section-title amber" id="s7">VII. Obstructive Pulmonary Disease</h2>

<h3 id="s7-atelectasis">Atelectasis <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>Atelectasis is the collapse of alveoli&mdash;either acute or chronic. <strong>Acute atelectasis is most common in the post-operative setting.</strong> It can be obstructive (blockage prevents air from entering alveoli) or nonobstructive (reduced ventilation). Can also occur from increased external pressure: pleural effusion, pneumothorax, hemothorax. <span class="tag tag-slides">SLIDES</span></p>

<p><strong>Manifestations</strong>: SOB, cough, sputum production, tachycardia, tachypnea, pleural pain, central cyanosis, increased WOB, decreased arterial O2, diminished breath sounds, crackles.</p>

<h4>Prevention &amp; Nursing Interventions <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Position changes, ambulation, OOB to chair</li>
<li>Deep breathing and coughing, incentive spirometry</li>
<li>Suction as needed; postural drainage</li>
<li>Pain control (multimodal&mdash;opioids depress respiratory drive)</li>
</ul>

<div class="callout pearl">
<div class="callout-title">Pearl: ICOUGH Protocol</div>
<p><strong>I</strong> = Incentive Spirometry | <strong>C</strong> = Coughing &amp; Deep Breathing | <strong>O</strong> = Oral Care | <strong>U</strong> = Understanding (patient education) | <strong>G</strong> = Get OOB to chair &times;3 daily | <strong>H</strong> = HOB &gt;30&deg;</p>
</div>

<h4>Incentive Spirometry <span class="tag tag-slides">SLIDES</span></h4>
<p>Expands alveoli, reduces or treats atelectasis. Patient should be in semi-Fowler or upright position. Use diaphragmatic breathing. Cough during and after each session. Splint the incision when coughing postoperatively. Perform approximately <strong>10 breaths per session, repeat each waking hour</strong>.</p>

<h4>Chest Physiotherapy / Postural Drainage <span class="tag tag-slides">SLIDES</span></h4>
<p>Secretions drain from bronchioles into bronchi/trachea, then are coughed or suctioned out. Secretions pool in the lung bases. Bronchodilators or mucolytics improve drainage. Chest percussion (machine or manual) can help loosen secretions. Performed <strong>2-3 times daily PRIOR to meals</strong> (reduce N/V and aspiration risk). <span class="tag tag-slides">SLIDES</span></p>

<h3 id="s7-copd">COPD <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>COPD is a slowly progressive obstructive disease with reduced airflow and impaired O2/CO2 exchange. <strong>Tobacco smoke accounts for 80-90% of cases.</strong> Additional risk factors: secondhand smoke, increased age, occupational exposure (dust, chemicals), indoor/outdoor air pollution, and alpha1-antitrypsin deficiency (genetic enzyme inhibitor that normally protects lung tissue from destruction). <span class="tag tag-slides">SLIDES</span></p>

<div class="compare-row">
<div class="compare-card left">
<h4>Emphysema</h4>
<p>Destruction of overdistended alveoli from chronic inflammation. Alveolar walls are destroyed &rarr; increased dead space &rarr; no gas exchange can occur. Chronic cough, sputum production, SOB.</p>
<p>Leads to hypoxemia, hypercapnia, respiratory acidosis, and <strong>cor pulmonale</strong> (right-sided heart failure from long-term high BP in pulmonary arteries &rarr; backup in venous system, dependent edema, JVD).</p>
<p><strong>Hallmarks</strong>: barrel chest, weight loss, SOB on exertion. Increased in fall/winter when infections rise.</p>
</div>
<div class="compare-card right">
<h4>Chronic Bronchitis</h4>
<p><strong>Definition</strong>: cough and sputum production for <strong>3 months in 2 consecutive years</strong>.</p>
<p>Smoke and irritants inflame the airways causing increased mucous hypersecretion, mucous plugging, reduced ciliary function. Bronchial walls thicken, the lumen narrows. Alveoli and bronchioles become fibrosed &rarr; increased respiratory infections.</p>
</div>
</div>

<h4>COPD Management <span class="tag tag-slides">SLIDES</span></h4>

<p><strong>Smoking cessation</strong> (gum, inhaler, patch, sublingual tablet, lozenge; medications: bupropion SR, nortriptyline, clonidine, Chantix). Not candidates for cessation meds: pregnant patients, adolescents, light smokers (&le;10/day). Safety: <strong>no smoking with home O2</strong>.</p>

<p><strong>Bronchodilators</strong>: relieve bronchospasm, improve expiratory flow (for stable COPD). <strong>Corticosteroids</strong>: improve symptoms but <strong>do NOT slow disease progression</strong>; inhaled preferred (long-term oral &rarr; muscle weakness, respiratory failure). <span class="tag tag-slides">SLIDES</span></p>

<p><strong>Annual flu vaccine</strong> <span class="tag tag-heavy">HEAVY IN SLIDES</span> &mdash; heavily emphasized in lecture.</p>

<p>O2 therapy: maintain SpO2 &gt;90%. Remember: high O2 depresses respiratory drive in COPD patients.</p>

<h4>COPD Bronchodilator Medications <span class="tag tag-slides">SLIDES</span></h4>
<table>
<tr><th>Class</th><th>Examples</th></tr>
<tr><td><strong>SABA</strong> (Short-Acting Beta-2 Agonist)</td><td>Albuterol, levalbuterol, terbutaline</td></tr>
<tr><td><strong>LABA</strong> (Long-Acting Beta-2 Agonist)</td><td>Arformoterol, formoterol, salmeterol, indacaterol, olodaterol</td></tr>
<tr><td><strong>Anticholinergics</strong></td><td>Ipratropium bromide, tiotropium bromide, umeclidinium</td></tr>
<tr><td>Combination SABA + Anticholinergic</td><td>Salbutamol/ipratropium (DuoNeb)</td></tr>
<tr><td><strong>ICS</strong> (Inhaled Corticosteroids)</td><td>Beclomethasone, budesonide, fluticasone</td></tr>
<tr><td>Combination ICS + LABA</td><td>Budesonide/formoterol, fluticasone/salmeterol, fluticasone furoate/vilanterol</td></tr>
</table>

<h3 id="s7-asthma">Asthma <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>Chronic airway inflammation leading to recurrent episodes of cough, chest tightness, wheezing, and SOB&mdash;often early morning or late at night. <strong>Allergies are the strongest predisposing factor</strong>: seasonal, dust, dander, mold, pollens, roach droppings, air pollution, smoke. <span class="tag tag-slides">SLIDES</span></p>

<p>During exacerbations, bronchoconstriction occurs, causing increased respiratory effort, diaphoresis, tachycardia, widened pulse pressure, hypoxemia, and central cyanosis.</p>

<p><strong>Medications</strong>: SABA (rescue)&mdash;albuterol/Ventolin, relax smooth muscle for quick relief. LABA (controller)&mdash;salmeterol, used WITH anti-inflammatory to control symptoms. Daily Peak Flow monitoring recommended for moderate-to-severe persistent asthma.</p>

<h4>Status Asthmaticus <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>

<p>A severe, rapid, persistent asthma attack that <strong>does NOT respond to regular therapy</strong>. Labored breathing, wheezing, engorged neck veins, prolonged exhalation.</p>

<div class="callout warning">
<div class="callout-title">Warning: Silent Chest in Status Asthmaticus</div>
<p><strong>If wheezing disappears, this may signal impending respiratory failure</strong>&mdash;it means air movement has decreased so severely there is not enough flow to produce a wheeze. <strong>Increasing PaCO2 is a warning sign.</strong></p>
</div>

<p><strong>Medical treatment</strong>: SABA, systemic corticosteroids, supplemental O2, IVF, <strong>Mg Sulfate 2g over 20 minutes</strong> (smooth muscle relaxation), ABGs. If respiratory acidosis increasing and patient fatigued &rarr; possible mechanical ventilation.</p>

<p><strong>Nursing</strong>: actively assess airway and response to treatment; be prepared for next intervention; assess skin turgor for dehydration; cardiac monitoring for arrhythmias; no flowers/smoke/perfumes/chemicals; educate on asthma action plan.</p>

<h3 id="s7-cf">Cystic Fibrosis (CF) <span class="tag tag-slides">SLIDES</span></h3>

<p><strong>Autosomal recessive</strong> disease, most common in Caucasians. Most diagnosed at age 2; median survival late 30s. Presents with productive cough, wheezing, hyperinflation of lung fields. Chronic inflammation and infection with impaired mucous clearance. <span class="tag tag-slides">SLIDES</span></p>

<p><strong>Airway clearance is the KEY to management</strong>: chest PT, anti-inflammatory agents. Long-term high-dose NSAIDs (ages 6-17) slow loss of lung function. Nursing: symptom management, secretion removal, chest PT, education on fluid intake and nutrition, end-of-life care planning. Chest PT best performed <strong>before meals</strong> (avoid vomiting), before bed and in the morning.</p>

<!-- ============================================================ -->
<!-- SECTION 8: LUNG CANCER & THORACIC SURGERY -->
<!-- ============================================================ -->

<h2 class="section-title red" id="s8">VIII. Lung Cancer &amp; Thoracic Surgery</h2>

<h3>Lung Cancer <span class="tag tag-slides">SLIDES</span></h3>

<p>Lung cancer is the <strong>leading cause of cancer death</strong> in the United States. The most common cause is inhaled carcinogens, with cigarette smoke responsible for &gt;85% of cases. Cancer arises from a single epithelial cell that undergoes abnormal growth leading to malignancy. <span class="tag tag-slides">SLIDES</span></p>

<h4>Two Major Categories</h4>
<table>
<tr><th>Type</th><th>Percentage</th><th>Key Features</th></tr>
<tr><td><strong>NSCLC</strong> (Non-Small Cell)</td><td>84%</td><td>Squamous cell (20%), adenocarcinoma (41%), large cell (5%), others (18%). Staged I (early) through IV (metastatic spread). Primary surgical candidate.</td></tr>
<tr><td><strong>SCLC</strong> (Small Cell)</td><td>13%</td><td>Small cells that grow <strong>rapidly</strong> and metastasize extensively. Treatment: surgery, radiation, laser therapy, stent placement to open airways.</td></tr>
</table>

<p><strong>Risk factors</strong>: tobacco smoke (active and passive), environmental exposure, genetics, dietary deficits, COPD, TB.</p>

<p><strong>Most common sign</strong>: cough or change in chronic cough (dry and persistent without sputum). Dyspnea is common in early stages. <strong>Pain is a late sign</strong> and may indicate bone metastasis.</p>

<p><strong>Pack-year calculation</strong>: (packs per day) &times; (years smoked). Example: 1 pack/day for 20 years = 20 pack-years.</p>

<p><strong>Diagnostics</strong>: CXR, CT, fiberoptic bronchoscopy, fine-needle aspiration, bone scans, PET scans, abdominal scans, MRI.</p>

<p><strong>Treatment</strong> depends on cell type and stage: surgery (mainly NSCLC), radiation, chemotherapy, gene therapy. Radiation can cure but is mainly used for symptom relief. Chemo alters tumor growth as an adjunct to surgery/radiation. Palliative care should be considered early for symptom control and life care planning.</p>

<h3>Thoracic Surgeries <span class="tag tag-slides">SLIDES</span></h3>

<table>
<tr><th>Surgery</th><th>Description</th><th>Key Points</th></tr>
<tr><td><strong>Lobectomy</strong></td><td>Removal of one lobe</td><td>Common for NSCLC. Right lung removal is more dangerous due to larger vascular bed.</td></tr>
<tr><td><strong>Pneumonectomy</strong></td><td>Removal of entire lung</td><td>When lobectomy is insufficient. Used for cancer, TB, abscesses.</td></tr>
<tr><td><strong>Thoracotomy</strong></td><td>Surgical incision between ribs to access lungs or chest organs</td><td>More common than total lung removal. Used for cancer, emphysema, tumors, infections.</td></tr>
</table>

<p><strong>Preoperative</strong>: assess age, obesity, smoking history, lung disease, comorbidities. Educate on expectations, pursed-lip breathing, how to splint incision.</p>
<p><strong>Postoperative</strong>: monitor chest tube drainage, watch for arrhythmias and respiratory distress. Immobility, pressure injuries, pain, confusion, and malnutrition are ongoing concerns.</p>

<!-- ============================================================ -->
<!-- SECTION 9: PLEURAL & CHEST TRAUMA -->
<!-- ============================================================ -->

<h2 class="section-title amber" id="s9">IX. Pleural Disorders &amp; Chest Trauma</h2>

<h3>Pleurisy <span class="tag tag-slides">SLIDES</span></h3>
<p>The parietal pleura has many sensory nerves stimulated by inflammation and stretching. The visceral pleura lacks sensory nerves. <strong>Pleuritic pain</strong> is sharp, "catches" on inspiration, described as being "stabbed by a knife." It is typically one-sided and worsened by deep breathing, coughing, and sneezing. Management: lay on the affected side to splint the chest wall; splint with a pillow when coughing. May develop with pneumonia, URI, TB, or PE.</p>

<h3>Pleural Effusion <span class="tag tag-slides">SLIDES</span></h3>
<p>Fluid collection in the pleural space (between parietal and visceral pleurae). Normal pleural fluid: 5-15 mL. Accumulates as a complication of HF, TB, pneumonia, PE, viral infections. Can be clear, bloody, or purulent. <span class="tag tag-slides">SLIDES</span></p>
<ul>
<li><strong>Pneumonia-related effusion</strong>: fever, chills, pleuritic pain</li>
<li><strong>Malignancy-related effusion</strong>: dyspnea when flat, coughing; fluid reaccumulates within days/weeks</li>
</ul>
<p><strong>Assessment</strong>: diminished/absent breath sounds, decreased fremitus, dull/flat percussion. Diagnosed by CXR, CT, thoracentesis. Treat the cause, prevent reaccumulation, relieve pain and respiratory compromise.</p>

<h3>Empyema <span class="tag tag-slides">SLIDES</span></h3>
<p>Thick, purulent fluid collection in the pleural space. Fibrin walls off the infection. Signs similar to pneumonia plus fever, night sweats, pleural pain, cough, dyspnea, weight loss. Treatment: thoracentesis (if fluid not too thick), chest tube or wedge resection, <strong>4-6 weeks of antibiotics</strong>.</p>

<h3>Blunt Chest Trauma <span class="tag tag-slides">SLIDES</span></h3>
<p>Most common cause: <strong>MVA</strong> (steering wheel, seat belts, falls, bicycle handlebars). Can cause chest wall fractures, dislocations, injuries to pleura, lungs, heart, and great vessels. Results in hypoxemia, hypovolemia, cardiac failure (tamponade). Assess and treat aggressively: establish advanced airway, restore fluid volume.</p>

<h4>Flail Chest <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<p><strong>Three or more ribs fractured at two or more sites</strong>&mdash;this creates a free-floating segment of chest wall that has lost stability and impairs respirations. The hallmark finding is <strong>paradoxical movement</strong>: the flail segment moves inward on inhalation and outward on exhalation (opposite of normal chest wall movement). This decreases ventilation and gas exchange. Fix with hooks/wires for stabilization. Lung contusion is common; patient may be sensitive to fluid overload. Can be fatal if untreated.</p>

<h3>Penetrating Chest Trauma <span class="tag tag-slides">SLIDES</span></h3>
<p>Restore and maintain cardiopulmonary function. Establish airway, assess for shock and additional injuries. High risk of intra-abdominal injuries. Diagnostics: CXR, ABG, continuous pulse oximetry, continuous cardiac monitoring. Treatment: large-bore IV, fluid/blood replacement, type and crossmatch, initiate massive hemorrhage protocol, NGT (decompress), Foley (urine output), chest tube (re-inflate lung).</p>

<h3>Pneumothorax &amp; Hemothorax <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>
<p><strong>Pneumothorax</strong>: air in the pleural space. <strong>Hemothorax</strong>: blood in the pleural space.</p>

<div class="callout warning">
<div class="callout-title">Warning: Tension Pneumothorax</div>
<p>Air enters the pleural space and is <strong>trapped</strong>&mdash;it creates positive pressure. The affected lung collapses. The heart, great vessels, and trachea <strong>deviate to the UNAFFECTED side</strong>. Both respiratory and circulatory function are compromised: increased intrathoracic pressure &rarr; decreased venous return &rarr; decreased cardiac output &rarr; impaired circulation. Pulse may become undetectable (<strong>PEA</strong>&mdash;think H's and T's). Treatment: re-expand the lung, get air out of the pleural space.</p>
</div>

<h3 id="s9-chest-tubes">Chest Drainage Systems <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<table>
<tr><th>System</th><th>Description</th><th>Key Features</th></tr>
<tr><td><strong>Traditional Water Seal (Wet)</strong></td><td>3 chambers: collection, water-seal, wet suction control</td><td>Requires sterile fluid in both water-seal and suction chambers. <strong>Intermittent bubbling = functioning properly.</strong></td></tr>
<tr><td><strong>Dry Suction Water Seal</strong></td><td>3 chambers: collection, water-seal, suction regulator dial</td><td>Sterile fluid in water-seal chamber at 2 cm only. Quieter. Has positive/negative pressure release valves.</td></tr>
<tr><td><strong>Dry Suction (One-Way Valve)</strong></td><td>Mechanical valve: air leaves chest but can't return</td><td>No fluid needed. Works if knocked over. Ideal for ambulatory patients. Quick setup for emergencies.</td></tr>
</table>

<svg viewBox="0 0 720 520" style="max-width: 720px;" role="img" aria-label="Three-chamber chest drainage system diagram showing collection chamber with graduated markings on the left, water seal chamber with 2 cm water level in the middle, and suction control chamber with 20 cm water level on the right. Includes troubleshooting annotations for no tidaling, continuous bubbling, and sudden drainage increase.">
    <defs>
        <linearGradient id="ct-water" x1="0" y1="0" x2="0" y2="1">
            <stop offset="0%" stop-color="#bfdbfe" stop-opacity="0.6"/>
            <stop offset="100%" stop-color="#2563eb" stop-opacity="0.3"/>
        </linearGradient>
        <linearGradient id="ct-drainage" x1="0" y1="0" x2="0" y2="1">
            <stop offset="0%" stop-color="#fca5a5" stop-opacity="0.5"/>
            <stop offset="100%" stop-color="#dc2626" stop-opacity="0.3"/>
        </linearGradient>
    </defs>

    <!-- Title -->
    <text x="360" y="26" text-anchor="middle" font-size="16" font-weight="bold" fill="#1a365d">Three-Chamber Chest Drainage System</text>
    <text x="360" y="44" text-anchor="middle" font-size="11" fill="#4a5568">From patient &rarr; Collection &rarr; Water Seal &rarr; Suction</text>

    <!-- Patient tube arrow -->
    <text x="30" y="140" font-size="10" fill="#4a5568" font-weight="bold">From</text>
    <text x="30" y="152" font-size="10" fill="#4a5568" font-weight="bold">Patient</text>
    <line x1="65" y1="145" x2="88" y2="145" stroke="#4a5568" stroke-width="2" marker-end="url(#ct-arrow)"/>
    <defs>
        <marker id="ct-arrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#4a5568"/>
        </marker>
    </defs>

    <!-- ===== CHAMBER 1: COLLECTION ===== -->
    <rect x="90" y="60" width="180" height="280" rx="6" fill="white" stroke="#4a5568" stroke-width="2"/>
    <rect x="90" y="60" width="180" height="30" rx="6" fill="#2563eb" stroke="#2563eb" stroke-width="2"/>
    <rect x="90" y="85" width="180" height="5" fill="#2563eb"/>
    <text x="180" y="80" text-anchor="middle" font-size="12" font-weight="bold" fill="white">1. COLLECTION</text>

    <!-- Graduated markings -->
    <line x1="95" y1="120" x2="110" y2="120" stroke="#94a3b8" stroke-width="0.8"/>
    <text x="115" y="124" font-size="9" fill="#64748b">2500 mL</text>
    <line x1="95" y1="150" x2="110" y2="150" stroke="#94a3b8" stroke-width="0.8"/>
    <text x="115" y="154" font-size="9" fill="#64748b">2000 mL</text>
    <line x1="95" y1="180" x2="110" y2="180" stroke="#94a3b8" stroke-width="0.8"/>
    <text x="115" y="184" font-size="9" fill="#64748b">1500 mL</text>
    <line x1="95" y1="210" x2="110" y2="210" stroke="#94a3b8" stroke-width="0.8"/>
    <text x="115" y="214" font-size="9" fill="#64748b">1000 mL</text>
    <line x1="95" y1="240" x2="110" y2="240" stroke="#94a3b8" stroke-width="0.8"/>
    <text x="115" y="244" font-size="9" fill="#64748b">500 mL</text>

    <!-- Drainage fluid -->
    <rect x="92" y="225" width="176" height="113" fill="url(#ct-drainage)" rx="0"/>

    <!-- Label below -->
    <text x="180" y="360" text-anchor="middle" font-size="10" fill="#4a5568" font-weight="bold">Monitor: amount,</text>
    <text x="180" y="374" text-anchor="middle" font-size="10" fill="#4a5568" font-weight="bold">color, consistency</text>

    <!-- Connection line 1â†’2 -->
    <line x1="270" y1="145" x2="290" y2="145" stroke="#4a5568" stroke-width="2" marker-end="url(#ct-arrow)"/>

    <!-- ===== CHAMBER 2: WATER SEAL ===== -->
    <rect x="292" y="60" width="180" height="280" rx="6" fill="white" stroke="#4a5568" stroke-width="2"/>
    <rect x="292" y="60" width="180" height="30" rx="6" fill="#059669" stroke="#059669" stroke-width="2"/>
    <rect x="292" y="85" width="180" height="5" fill="#059669"/>
    <text x="382" y="80" text-anchor="middle" font-size="12" font-weight="bold" fill="white">2. WATER SEAL</text>

    <!-- Water level at 2 cm -->
    <rect x="294" y="290" width="176" height="48" fill="url(#ct-water)" rx="0"/>
    <line x1="294" y1="290" x2="470" y2="290" stroke="#2563eb" stroke-width="1.5" stroke-dasharray="4,3"/>
    <text x="382" y="308" text-anchor="middle" font-size="11" font-weight="bold" fill="#1d4ed8">2 cm H&#8322;O</text>

    <!-- Tidaling waves -->
    <path d="M 310,285 Q 320,278 330,285 Q 340,292 350,285 Q 360,278 370,285 Q 380,292 390,285 Q 400,278 410,285 Q 420,292 430,285 Q 440,278 450,285"
          fill="none" stroke="#2563eb" stroke-width="1.2" opacity="0.6"/>
    <text x="382" y="275" text-anchor="middle" font-size="9" fill="#1d4ed8" font-style="italic">~ tidaling ~</text>

    <!-- Tube going into water -->
    <line x1="382" y1="100" x2="382" y2="300" stroke="#4a5568" stroke-width="3"/>

    <!-- Label below -->
    <text x="382" y="360" text-anchor="middle" font-size="10" fill="#059669" font-weight="bold">Tidaling = normal</text>
    <text x="382" y="374" text-anchor="middle" font-size="10" fill="#dc2626" font-weight="bold">Bubbling = air leak</text>

    <!-- Connection line 2â†’3 -->
    <line x1="472" y1="145" x2="492" y2="145" stroke="#4a5568" stroke-width="2" marker-end="url(#ct-arrow)"/>

    <!-- ===== CHAMBER 3: SUCTION CONTROL ===== -->
    <rect x="494" y="60" width="180" height="280" rx="6" fill="white" stroke="#4a5568" stroke-width="2"/>
    <rect x="494" y="60" width="180" height="30" rx="6" fill="#d97706" stroke="#d97706" stroke-width="2"/>
    <rect x="494" y="85" width="180" height="5" fill="#d97706"/>
    <text x="584" y="80" text-anchor="middle" font-size="12" font-weight="bold" fill="white">3. SUCTION CONTROL</text>

    <!-- Water level at 20 cm -->
    <rect x="496" y="150" width="176" height="188" fill="url(#ct-water)" rx="0"/>
    <line x1="496" y1="150" x2="672" y2="150" stroke="#2563eb" stroke-width="1.5" stroke-dasharray="4,3"/>
    <text x="584" y="170" text-anchor="middle" font-size="11" font-weight="bold" fill="#1d4ed8">20 cm H&#8322;O</text>

    <!-- Bubbles -->
    <circle cx="560" cy="200" r="4" fill="none" stroke="#60a5fa" stroke-width="1" opacity="0.7"/>
    <circle cx="575" cy="190" r="3" fill="none" stroke="#60a5fa" stroke-width="1" opacity="0.7"/>
    <circle cx="590" cy="210" r="5" fill="none" stroke="#60a5fa" stroke-width="1" opacity="0.7"/>
    <circle cx="605" cy="195" r="3.5" fill="none" stroke="#60a5fa" stroke-width="1" opacity="0.7"/>
    <circle cx="570" cy="220" r="4" fill="none" stroke="#60a5fa" stroke-width="1" opacity="0.5"/>

    <!-- Suction line out -->
    <text x="584" y="108" text-anchor="middle" font-size="10" fill="#4a5568">To wall suction &rarr;</text>

    <!-- Label below -->
    <text x="584" y="360" text-anchor="middle" font-size="10" fill="#d97706" font-weight="bold">Gentle continuous</text>
    <text x="584" y="374" text-anchor="middle" font-size="10" fill="#d97706" font-weight="bold">bubbling expected</text>

    <!-- ===== TROUBLESHOOTING BOX ===== -->
    <rect x="90" y="395" width="584" height="115" rx="8" fill="#fef2f2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="382" y="418" text-anchor="middle" font-size="13" font-weight="bold" fill="#991b1b">Troubleshooting</text>

    <circle cx="115" cy="440" r="8" fill="#dc2626"/>
    <text x="115" y="444" text-anchor="middle" font-size="11" fill="white" font-weight="bold">!</text>
    <text x="130" y="436" font-size="10" fill="#7f1d1d" font-weight="bold">No tidaling in water seal</text>
    <text x="130" y="450" font-size="10" fill="#4a5568">= Obstruction (milk tubing) OR full lung re-expansion</text>

    <circle cx="115" cy="470" r="8" fill="#dc2626"/>
    <text x="115" y="474" text-anchor="middle" font-size="11" fill="white" font-weight="bold">!</text>
    <text x="130" y="466" font-size="10" fill="#7f1d1d" font-weight="bold">Continuous bubbling in water seal</text>
    <text x="130" y="480" font-size="10" fill="#4a5568">= Air leak in system &mdash; check all connections and dressing</text>

    <circle cx="115" cy="498" r="8" fill="#dc2626"/>
    <text x="115" y="502" text-anchor="middle" font-size="11" fill="white" font-weight="bold">!</text>
    <text x="130" y="494" font-size="10" fill="#7f1d1d" font-weight="bold">Sudden increase in drainage (&gt;200 mL/hr)</text>
    <text x="130" y="508" font-size="10" fill="#4a5568">= Hemorrhage &mdash; notify provider STAT</text>
</svg>

<h4>Chest Tube Nursing Care <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Frequent breath sound assessment (rate, depth, pattern)</li>
<li>Encourage deep breathing (IS)</li>
<li>Check for leaks and monitor drainage</li>
<li>Assess site; manage pain (multimodal: patches, NSAIDs, IV Tylenol)</li>
<li>Mobilize patient; shoulder exercises 8-12 hours post-surgery</li>
<li>Monitor cardiac status (dysrhythmias are common)</li>
<li><strong>Check for air leak</strong>: bubbling in chamber, subcutaneous emphysema/crepitus</li>
<li>Splint abdomen for pain, coughing, deep breathing</li>
<li>Ensure chamber is in safe position (won't fall over)</li>
<li>Maintain on suction per MD orders</li>
</ul>

<div class="callout pearl">
<div class="callout-title">Pearl: Chest Tube Bedside Safety Equipment</div>
<p>Always at bedside: <strong>Vaseline gauze, Kelly clamps, sterile water, dressing and tape.</strong></p>
</div>

<h4>Subcutaneous Emphysema <span class="tag tag-slides">SLIDES</span></h4>
<p>Air trapped in tissue under the skin (neck, chest, arms, face). Identified by a <strong>crackling sensation when palpated (crepitus)</strong>. Air is spontaneously absorbed in most cases. In severe cases, tracheostomy may be needed if the airway is threatened.</p>

<!-- ============================================================ -->
<!-- SECTION 10: ARF & ARDS -->
<!-- ============================================================ -->

<h2 class="section-title red" id="s10">X. Acute Respiratory Failure &amp; ARDS</h2>

<h3>Acute Respiratory Failure <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>Acute respiratory failure is defined by three criteria occurring together: <strong>PaO2 &lt;60 mmHg</strong> AND <strong>PaCO2 &gt;50 mmHg</strong> (hypercapnia) AND <strong>pH &lt;7.35</strong> (acidosis). Differentiate acute from chronic: chronic respiratory failure progresses over time or persists after an acute event (e.g., COPD). Chronic patients can develop acute exacerbations (aCOPD). <span class="tag tag-slides">SLIDES</span></p>

<h4>Causes</h4>
<ul>
<li>Drug overdose, head trauma, infection, hemorrhage, OSA</li>
<li><strong>Neuromuscular</strong>: Guillain-Barr&eacute;, ALS, spinal cord trauma</li>
<li><strong>Musculoskeletal</strong>: chest trauma</li>
<li><strong>Oxygenation failures</strong>: ARDS, HF, COPD, PE</li>
<li><strong>Ventilation failures post-surgery</strong>: anesthesia, sedation, decreased respiratory drive</li>
</ul>

<div class="compare-row">
<div class="compare-card left" style="border-color:var(--amber);background:var(--amber-bg);">
<h4>Early Signs</h4>
<ul>
<li>Restlessness</li>
<li>Fatigue, headache</li>
<li>Dyspnea, air hunger</li>
<li>Tachycardia</li>
<li>Accessory muscle use</li>
<li>Elevated blood pressure</li>
</ul>
</div>
<div class="compare-card right" style="border-color:var(--red);background:var(--red-bg);">
<h4>Late Signs</h4>
<ul>
<li>Confusion, lethargy</li>
<li>Tachycardia, tachypnea</li>
<li>Central cyanosis</li>
<li>Diaphoresis</li>
</ul>
</div>
</div>

<h4>Nursing Care for ARF <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Assist with intubation, administer sedation</li>
<li>Insert orogastric tube, assist central line insertion, Foley catheter</li>
<li>Apply restraints as needed, continuous cardiac/respiratory monitoring</li>
<li>Turning q2, oral care q2 (prevent VAP), SCDs</li>
<li>All components of VAP bundle</li>
</ul>

<h3>ARDS (Acute Respiratory Distress Syndrome) <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>ARDS is a <strong>severe inflammatory process</strong> causing diffuse alveolar damage and progressive pulmonary edema. The defining feature: <strong>hypoxemia that is unresponsive to O2 therapy regardless of increased PEEP</strong>. Reduced lung compliance. CXR shows bilateral infiltrates resembling cardiogenic pulmonary edema. Mortality: 27-50%, with MODS and septic shock as the major cause of death. <span class="tag tag-slides">SLIDES</span></p>

<div class="patho-chain">Trigger event &rarr; Release of cellular/chemical mediators &rarr; Capillary membrane injury &rarr; Structural lung damage
&darr;
Severe V/Q mismatch &rarr; Alveolar collapse (loss of surfactant) &rarr; Decreased compliance &rarr; Severe hypoxemia
&darr;
Increased dead space &rarr; Stiff, non-compliant lungs &rarr; Refractory to supplemental O2</div>

<svg viewBox="0 0 660 780" style="max-width: 660px;" role="img" aria-label="ARDS pathophysiology cascade flowchart showing progression from initial insult through inflammatory response, alveolar-capillary membrane damage, pulmonary edema, surfactant dysfunction, V/Q mismatch, severe refractory hypoxemia, decreased compliance, to mechanical ventilation requirement. Color gradient from yellow early stages to dark red severe stages. Side annotations show PaO2/FiO2 ratio less than 300 and bilateral infiltrates on chest X-ray.">
    <defs>
        <linearGradient id="ards-early" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#fef3c7"/>
            <stop offset="100%" stop-color="#fde68a"/>
        </linearGradient>
        <linearGradient id="ards-mid" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#fed7aa"/>
            <stop offset="100%" stop-color="#fdba74"/>
        </linearGradient>
        <linearGradient id="ards-late" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#fca5a5"/>
            <stop offset="100%" stop-color="#f87171"/>
        </linearGradient>
        <linearGradient id="ards-critical" x1="0" y1="0" x2="1" y2="0">
            <stop offset="0%" stop-color="#ef4444"/>
            <stop offset="100%" stop-color="#b91c1c"/>
        </linearGradient>
        <linearGradient id="ards-severity" x1="0" y1="0" x2="0" y2="1">
            <stop offset="0%" stop-color="#fde68a"/>
            <stop offset="35%" stop-color="#fdba74"/>
            <stop offset="65%" stop-color="#f87171"/>
            <stop offset="100%" stop-color="#991b1b"/>
        </linearGradient>
        <marker id="ards-arrow" viewBox="0 0 10 10" refX="9" refY="5" markerWidth="7" markerHeight="7" orient="auto-start-reverse">
            <path d="M 0 0 L 10 5 L 0 10 Z" fill="#4a5568"/>
        </marker>
    </defs>

    <!-- Title -->
    <text x="330" y="28" text-anchor="middle" font-size="16" font-weight="bold" fill="#1a365d">ARDS Pathophysiology Cascade</text>

    <!-- Severity gradient bar (left) -->
    <rect x="15" y="50" width="16" height="680" rx="8" fill="url(#ards-severity)"/>
    <text x="23" y="44" text-anchor="middle" font-size="9" fill="#92400e" font-weight="bold">EARLY</text>
    <text x="23" y="745" text-anchor="middle" font-size="9" fill="#991b1b" font-weight="bold">CRITICAL</text>

    <!-- Box 1: Initial Insult -->
    <rect x="130" y="50" rx="8" ry="8" width="340" height="52" fill="url(#ards-early)" stroke="#d97706" stroke-width="1.5"/>
    <text x="300" y="72" text-anchor="middle" font-size="13" font-weight="bold" fill="#92400e">Initial Insult</text>
    <text x="300" y="90" text-anchor="middle" font-size="10" fill="#78350f">Sepsis | Trauma | Aspiration | Pneumonia</text>
    <!-- Arrow -->
    <line x1="300" y1="102" x2="300" y2="120" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 2: Inflammatory Response -->
    <rect x="130" y="122" rx="8" ry="8" width="340" height="52" fill="url(#ards-early)" stroke="#d97706" stroke-width="1.5"/>
    <text x="300" y="144" text-anchor="middle" font-size="13" font-weight="bold" fill="#92400e">Widespread Inflammatory Response</text>
    <text x="300" y="162" text-anchor="middle" font-size="10" fill="#78350f">Neutrophil activation, cytokine release</text>
    <line x1="300" y1="174" x2="300" y2="192" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 3: Membrane Damage -->
    <rect x="130" y="194" rx="8" ry="8" width="340" height="52" fill="url(#ards-mid)" stroke="#ea580c" stroke-width="1.5"/>
    <text x="300" y="216" text-anchor="middle" font-size="13" font-weight="bold" fill="#9a3412">Alveolar-Capillary Membrane Damage</text>
    <text x="300" y="234" text-anchor="middle" font-size="10" fill="#7c2d12">Endothelial and epithelial injury</text>
    <line x1="300" y1="246" x2="300" y2="264" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 4: Permeability -->
    <rect x="130" y="266" rx="8" ry="8" width="340" height="52" fill="url(#ards-mid)" stroke="#ea580c" stroke-width="1.5"/>
    <text x="300" y="286" text-anchor="middle" font-size="13" font-weight="bold" fill="#9a3412">&uarr; Permeability &rarr; Protein-Rich Fluid Leaks</text>
    <text x="300" y="304" text-anchor="middle" font-size="10" fill="#7c2d12">Fluid floods alveoli (non-cardiogenic edema)</text>
    <line x1="300" y1="318" x2="300" y2="336" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 5: Pulmonary Edema -->
    <rect x="130" y="338" rx="8" ry="8" width="340" height="52" fill="url(#ards-late)" stroke="#dc2626" stroke-width="1.5"/>
    <text x="300" y="358" text-anchor="middle" font-size="13" font-weight="bold" fill="#991b1b">Pulmonary Edema (Non-Cardiogenic)</text>
    <text x="300" y="376" text-anchor="middle" font-size="10" fill="#7f1d1d">Alveoli fill with fluid, not air</text>
    <line x1="300" y1="390" x2="300" y2="408" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 6: Surfactant Dysfunction -->
    <rect x="130" y="410" rx="8" ry="8" width="340" height="52" fill="url(#ards-late)" stroke="#dc2626" stroke-width="1.5"/>
    <text x="300" y="430" text-anchor="middle" font-size="13" font-weight="bold" fill="#991b1b">Surfactant Dysfunction &rarr; Alveolar Collapse</text>
    <text x="300" y="448" text-anchor="middle" font-size="10" fill="#7f1d1d">Loss of surface tension reduction</text>
    <line x1="300" y1="462" x2="300" y2="480" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 7: V/Q Mismatch -->
    <rect x="130" y="482" rx="8" ry="8" width="340" height="52" fill="url(#ards-late)" stroke="#dc2626" stroke-width="1.5"/>
    <text x="300" y="502" text-anchor="middle" font-size="13" font-weight="bold" fill="#991b1b">Atelectasis + V/Q Mismatch + Shunting</text>
    <text x="300" y="520" text-anchor="middle" font-size="10" fill="#7f1d1d">Blood passes unventilated alveoli</text>
    <line x1="300" y1="534" x2="300" y2="552" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 8: Severe Hypoxemia -->
    <rect x="130" y="554" rx="8" ry="8" width="340" height="52" fill="url(#ards-critical)" stroke="#991b1b" stroke-width="2"/>
    <text x="300" y="574" text-anchor="middle" font-size="13" font-weight="bold" fill="white">Severe Hypoxemia (Refractory to O&#8322;)</text>
    <text x="300" y="592" text-anchor="middle" font-size="10" fill="#fef2f2">PaO&#8322; does NOT improve with supplemental O&#8322;</text>
    <line x1="300" y1="606" x2="300" y2="624" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 9: Decreased Compliance -->
    <rect x="130" y="626" rx="8" ry="8" width="340" height="52" fill="url(#ards-critical)" stroke="#991b1b" stroke-width="2"/>
    <text x="300" y="646" text-anchor="middle" font-size="13" font-weight="bold" fill="white">&darr; Lung Compliance (Stiff Lungs)</text>
    <text x="300" y="664" text-anchor="middle" font-size="10" fill="#fef2f2">Increased work of breathing, fatigue</text>
    <line x1="300" y1="678" x2="300" y2="696" stroke="#4a5568" stroke-width="1.5" marker-end="url(#ards-arrow)"/>

    <!-- Box 10: Mechanical Ventilation -->
    <rect x="105" y="698" rx="8" ry="8" width="390" height="52" fill="#991b1b" stroke="#7f1d1d" stroke-width="2"/>
    <text x="300" y="720" text-anchor="middle" font-size="14" font-weight="bold" fill="white">Requires Mechanical Ventilation</text>
    <text x="300" y="738" text-anchor="middle" font-size="10" fill="#fecaca">Low TV (6 mL/kg), High PEEP, Prone Positioning</text>

    <!-- Side annotation: PaO2/FiO2 -->
    <rect x="490" y="280" rx="6" ry="6" width="155" height="70" fill="#fef2f2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="567" y="300" text-anchor="middle" font-size="11" font-weight="bold" fill="#991b1b">Diagnostic Criteria</text>
    <text x="567" y="316" text-anchor="middle" font-size="10" fill="#7f1d1d">PaO&#8322;/FiO&#8322; &lt; 300</text>
    <text x="567" y="332" text-anchor="middle" font-size="10" fill="#7f1d1d">Bilateral infiltrates (CXR)</text>
    <text x="567" y="346" text-anchor="middle" font-size="10" fill="#7f1d1d">NOT cardiogenic</text>
    <line x1="490" y1="310" x2="470" y2="300" stroke="#dc2626" stroke-width="1" stroke-dasharray="4,3"/>

    <!-- Side annotation: Severity -->
    <rect x="490" y="520" rx="6" ry="6" width="155" height="70" fill="#fef2f2" stroke="#dc2626" stroke-width="1.5"/>
    <text x="567" y="540" text-anchor="middle" font-size="11" font-weight="bold" fill="#991b1b">ARDS Severity</text>
    <text x="567" y="556" text-anchor="middle" font-size="10" fill="#7f1d1d">Mild: P/F 200-300</text>
    <text x="567" y="570" text-anchor="middle" font-size="10" fill="#7f1d1d">Moderate: P/F 100-200</text>
    <text x="567" y="584" text-anchor="middle" font-size="10" fill="#991b1b" font-weight="bold">Severe: P/F &lt; 100</text>
    <line x1="490" y1="555" x2="470" y2="530" stroke="#dc2626" stroke-width="1" stroke-dasharray="4,3"/>
</svg>

<h4>Risk Factors <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Aspiration (gastric secretions, drowning), COVID-19 PNA, drug ingestion/overdose</li>
<li>Fat or air embolism</li>
<li>Hematologic disorders (DIC, massive transfusions, cardiopulmonary bypass)</li>
<li>Localized infection (bacterial, fungal, viral PNA)</li>
<li>Major surgery, metabolic disorders (pancreatitis, uremia)</li>
<li>Prolonged high O2 concentration inhalation, smoke, corrosive substances</li>
<li>Sepsis, shock (any cause), trauma (pulmonary contusion, multiple fractures, head injury)</li>
</ul>

<h4>ARDS Phases &amp; Management <span class="tag tag-slides">SLIDES</span></h4>

<p><strong>Acute Phase</strong> (severe, rapid onset &lt;72 hours after event): CXR looks like pulmonary edema with bilateral infiltrates. Increased alveolar dead space, stiff non-compliant lungs. Arterial hypoxemia unresponsive to supplemental O2.</p>

<p><strong>Management</strong>:</p>
<ul>
<li>Intubate; baseline temperature prior to paralytic</li>
<li><strong>Sedate AND paralyze</strong> (DO NOT remove sedation if chemically paralyzed)</li>
<li>Add nitric oxide to reduce V/Q mismatch</li>
<li>Fluid and nutrition support</li>
<li>Maintain SpO2 &gt;90%</li>
<li>Suction as needed; frequent ABG monitoring</li>
<li>Skin care, frequent oral care, eye care (corneal abrasions from chemical paralysis)</li>
<li>Aggressive support: high PEEP, fluid support, vasopressors, <strong>prone positioning</strong></li>
</ul>

<p><strong>Recovery Phase</strong>: hypoxemia lessens, CXR improves, lungs become more compliant.</p>

<div class="callout warning">
<div class="callout-title">Warning: Complications of Chemical Paralysis</div>
<p>VTE, muscle atrophy, skin breakdown, foot drop, hemorrhage. Higher PEEP may help lower FiO2 but can cause hypotension from capillary leakage and decreased cardiac output.</p>
</div>

<!-- ============================================================ -->
<!-- SECTION 11: MECHANICAL VENTILATION -->
<!-- ============================================================ -->

<h2 class="section-title blue" id="s11">XI. Airway Management &amp; Mechanical Ventilation</h2>

<h3>Endotracheal Intubation <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>Oral or nasal tube placed into the trachea (oral is more common and less traumatic). Maintains the airway during respiratory distress. A laryngoscope is used for placement; the tube is positioned <strong>2 cm above the carina</strong>. The cuff is inflated to prevent air leak and secure the tube. Placement is confirmed with <strong>CXR</strong>. <span class="tag tag-slides">SLIDES</span></p>

<p>ETT should be converted to a <strong>tracheostomy at 14-21 days</strong> to reduce trauma to the tracheal lining, prevent vocal cord paralysis, and prevent fistula formation.</p>

<p><strong>Extubation</strong>: check for cuff leak, stridor, and work of breathing post-removal.</p>

<h4>ETT Bedside Safety &amp; Assessment <span class="tag tag-slides">SLIDES</span></h4>
<ul>
<li>Measure ETT markings at the start of every shift</li>
<li>Ambu-bag with facemask, suction (Yankauer), O2 flow meter at bedside</li>
<li>Vent settings as ordered</li>
<li>Assess for vent synchrony (agitation, restlessness, nasal flaring, accessory muscle use)</li>
<li>HOB &gt;30 degrees</li>
</ul>

<h3>Tracheostomy <span class="tag tag-slides">SLIDES</span></h3>
<p><strong>Tracheotomy</strong> = the procedure (opening into the trachea). <strong>Tracheostomy tube</strong> = the device placed. Opening between the <strong>2nd and 3rd tracheal rings</strong>. Usually done in OR, bronchoscopy suite, or bedside in ICU for emergencies.</p>
<p>Indications: bypass upper airway obstruction, long-term mechanical ventilation, prevent aspiration in paralyzed/unconscious patient, replace ETT, emergent situations.</p>

<div class="callout warning">
<div class="callout-title">Warning: Cuff Pressure</div>
<p><strong>High cuff pressure</strong> &rarr; tracheal bleeding, ischemia, pressure necrosis.<br>
<strong>Low cuff pressure</strong> &rarr; aspiration risk.</p>
</div>

<p><strong>Trach bedside safety</strong>: extra trach set at bedside, obturator at bedside, Ambu-bag with facemask, suction, Yankauer, O2 flow meter.</p>

<h3>Mechanical Ventilation <span class="tag tag-slides">SLIDES</span></h3>
<p>The most invasive form of oxygen treatment. ICU nurse and respiratory therapist assess for vent synchrony. <strong>Vent alarms must always be ON.</strong> Tidal Volume = volume of each breath.</p>

<h4>Ventilator Modes <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<table>
<tr><th>Mode</th><th>How It Works</th></tr>
<tr><td><strong>CMV / Assist-Control (A/C)</strong></td><td>Delivers preset TV and RR. If patient initiates a breath, the vent assists to ensure full set volume is delivered.</td></tr>
<tr><td><strong>IMV</strong></td><td>Combination of set and spontaneous breaths. Patient may "buck the vent" (try to exhale when vent initiates breath).</td></tr>
<tr><td><strong>SIMV</strong></td><td>Between set breaths, patient can breathe with no assist. Vent senses exhale and won't force a breath. Fighting the vent is reduced.</td></tr>
<tr><td><strong>Pressure Support</strong></td><td>Pressure applied to help patient breathe on own. As strength increases, support is reduced.</td></tr>
<tr><td><strong>PEEP</strong></td><td>Applied at end of expiration. Reverses/prevents microatelectasis. Allows lower FiO2. "Best PEEP" = oxygenation without hemodynamic compromise.</td></tr>
<tr><td><strong>CPAP</strong></td><td>Continuous positive airway pressure during spontaneous breathing.</td></tr>
</table>

<h4>Troubleshooting Ventilator Problems <span class="tag tag-slides">SLIDES</span></h4>
<table class="amber">
<tr><th>Problem</th><th>Cause</th><th>Solution</th></tr>
<tr><td>Increased peak airway pressure</td><td>Coughing, plugged tube, decreased compliance, kinked tubing, pneumothorax, bronchospasm</td><td>Suction; adjust sensitivity; sedate if needed; manually ventilate</td></tr>
<tr><td>Decreased pressure / volume loss</td><td>Increased compliance, leak in circuit, loose cuff</td><td>Check circuit, correct leak</td></tr>
<tr><td>Patient-vent dyssynchrony</td><td>Various</td><td>Assess for hypoxia/bronchospasm, check ABGs, sedate if necessary</td></tr>
</table>

<h4>Complications of Mechanical Ventilation <span class="tag tag-slides">SLIDES</span></h4>
<table class="red">
<tr><th>Complication</th><th>Mechanism</th><th>Nursing Response</th></tr>
<tr><td><strong>Cardiac compromise</strong></td><td>PEEP compresses heart/vessels during inspiration &rarr; decreased venous return &rarr; decreased CO</td><td>Monitor for hypoxia: restlessness, tachycardia, tachypnea, pallor, diaphoresis, decreased urine output</td></tr>
<tr><td><strong>Barotrauma / Pneumothorax</strong></td><td>Excessive pressure &rarr; alveolar rupture</td><td>Monitor for decreased SpO2 and respiratory distress</td></tr>
<tr><td><strong>VAP</strong></td><td>Bypass of normal defense mechanisms, breaks in circuit, decreased mobility, impaired cough</td><td>Follow VAP bundle; assess sputum changes; monitor infection signs (elevated WBC, temp, HR, RR; decreased BP)</td></tr>
<tr><td><strong>Delirium</strong></td><td>Sedation, immobility, sensory deprivation</td><td>Use ABCDEF Bundle</td></tr>
</table>

<h3 id="s11-vap">VAP Prevention Bundle (5 Elements) <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>
<ol>
<li><strong>HOB elevation 30&deg;-45&deg;</strong></li>
<li><strong>Daily sedation vacations</strong> and assessment of readiness to extubate</li>
<li><strong>Peptic ulcer disease prophylaxis</strong></li>
<li><strong>DVT prophylaxis</strong></li>
<li><strong>Daily oral care with chlorhexidine (0.12%)</strong></li>
</ol>

<h4>ABCDEF Bundle (ICU Liberation) <span class="tag tag-heavy">HEAVY IN SLIDES</span></h4>
<table class="teal">
<tr><th>Letter</th><th>Component</th><th>Details</th></tr>
<tr><td><strong>A</strong></td><td>Awakening &amp; spontaneous breathing trials</td><td>Nurse determines if safe to stop sedation; RT determines if patient is a candidate for breathing trial</td></tr>
<tr><td><strong>B</strong></td><td>Breathing coordination</td><td>Coordinated sedation interruption with spontaneous breathing trials</td></tr>
<tr><td><strong>C</strong></td><td>Choice of sedation/analgesia</td><td>Minimize sedation depth; choose appropriate agents</td></tr>
<tr><td><strong>D</strong></td><td>Delirium monitoring</td><td>CAM-ICU assessment q2-4 hours</td></tr>
<tr><td><strong>E</strong></td><td>Early mobility</td><td>Criteria: responds to verbal stimuli, &lt;60% FiO2, &lt;10 cm PEEP, no contraindications</td></tr>
<tr><td><strong>F</strong></td><td>Family engagement &amp; empowerment</td><td>Encourage unrestricted access for designated support person</td></tr>
</table>

<h3>Suctioning <span class="tag tag-slides">SLIDES</span></h3>
<p>Use inline suction to maintain sterility. <strong>Increase O2 to 100% before suctioning.</strong> Suction for <strong>no longer than 10 seconds</strong>.</p>

<h3 id="s11-weaning">Ventilator Weaning &amp; Extubation <span class="tag tag-slides">SLIDES</span></h3>

<p>Daily weaning trial when physiologically and hemodynamically stable. Patient must be able to spontaneously breathe and be recovering from the underlying condition. Stable vitals and ABGs are necessary.</p>

<p>Monitor SpO2, CO2, HR, RR, BP during weaning. CPAP mode enables spontaneous breathing with some pressure support. Monitor for reduced TV.</p>

<div class="callout warning">
<div class="callout-title">Warning: Signs of Weaning Failure</div>
<p>Rising CO2, increasing HR and RR, diaphoresis, nasal flaring, accessory muscle use. If CO2 rises from 36 to 65, HR increases from 102 to 126, and RR increases from 20 to 35 with diaphoresis&mdash;the patient is not tolerating the wean.</p>
</div>

<h4>Extubation Process <span class="tag tag-slides">SLIDES</span></h4>
<ol>
<li>Obtain order; notify respiratory therapist</li>
<li>RT checks for cuff leak (ensures minimal stridor risk)</li>
<li>Explain procedure to patient</li>
<li>Raise HOB</li>
<li>Set up suction at bedside</li>
<li>O2 flow meter for aerosolized mask</li>
<li>Suction through ETT and oral cavity</li>
<li>Remove OGT at time of extubation</li>
<li>Monitor for respiratory distress and stridor</li>
<li>Keep NPO until safe for swallow evaluation</li>
</ol>

<h3>Geriatric Considerations with Mechanical Ventilation <span class="tag tag-slides">SLIDES</span></h3>
<p>Older patients are often sedated with benzos and opioids (potentially inappropriate per Beers Criteria), often restrained, immobilized from length of time on vent, and sensory deprived&mdash;<strong>all leading to delirium</strong>. Use minimal sedation, reduce restraints, mobilize daily. Every day in bed leads to significant deconditioning. Use patient's glasses and hearing aids. Once extubated, allow dentures.</p>

<h3>Airway Management <span class="tag tag-slides">SLIDES</span></h3>
<p>Airways can become obstructed by food, vomit, blood, or mucous. Airway enlargement concerns: swelling, laryngeal edema, carcinoma, abscess. Patients needing airway protection: ALOC (loss of protective reflexes), seizures, neck/head trauma, anaphylaxis, neuromuscular weakness.</p>

<!-- ============================================================ -->
<!-- SECTION 12: PE & PULMONARY HTN -->
<!-- ============================================================ -->

<h2 class="section-title purple" id="s12">XII. Pulmonary Embolism &amp; Pulmonary Hypertension</h2>

<h3>Pulmonary Embolism (PE) <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<p>Obstruction of the pulmonary artery originating from the venous system or right side of the heart. Can be a blood clot, fat embolus, amniotic fluid, or air embolus. Gas exchange is impaired or absent. <strong>DVT is the most common cause</strong> (VTE = term encompassing both PE and DVT). <span class="tag tag-slides">SLIDES</span></p>

<div class="callout warning">
<div class="callout-title">Warning: Time-Critical Emergency</div>
<p><strong>Death often occurs within 1 hour of symptom onset.</strong> Assess frequently. Do not dismiss sudden-onset chest pain or SOB.</p>
</div>

<p><strong>Manifestations</strong>: SOB, chest pain (sudden, pleuritic), substernal pain (mimics angina), anxiety, tachycardia, cough, syncope.</p>

<h4>PE Diagnosis <span class="tag tag-slides">SLIDES</span></h4>
<table>
<tr><th>Test</th><th>Role</th></tr>
<tr><td><strong>MDCTA</strong> (Multidetector CT Pulmonary Angiography)</td><td><strong>Gold standard</strong> for diagnosis</td></tr>
<tr><td>Pulmonary Angiography</td><td>Good diagnostic alternative</td></tr>
<tr><td><strong>D-Dimer</strong></td><td>Highly sensitive (96.2% sensitive, 87.5% accuracy). Best for <strong>ruling OUT</strong> PE.</td></tr>
<tr><td>ABG, ECG, V/Q Scan</td><td>Supporting diagnostics</td></tr>
</table>

<h4>PE Treatment <span class="tag tag-slides">SLIDES</span></h4>
<p><strong>PREVENTION is key</strong>: SCDs, subQ heparin, Lovenox, ambulation. For active PE: start heparin GTT, discharge home with long-term anticoagulation. Assess vitals q2; monitor INR, aPTT, PTT, anti-Xa. Thrombolytics if no contraindications. Surgical removal if large PE and unstable. <strong>IVC filter</strong> for patients with recurrent PEs.</p>

<h3>Pulmonary Hypertension <span class="tag tag-slides">SLIDES</span></h3>
<p>High pressure in the pulmonary artery causes the heart to work harder and weakens over time. Not evident until late progression. Risk factors: congenital heart disease, appetite suppressants, stimulant medications, portal HTN, HIV.</p>

<p><strong>Dyspnea is the main symptom</strong>&mdash;first with exertion, then at rest. Other findings: substernal chest pain, weakness, fatigue, syncope, right-sided HF, distended neck veins, anorexia, RUQ pain.</p>

<p><strong>Diagnosed</strong>: history, CXR, PFT, ECG, echocardiogram. <strong>Management</strong>: calcium channel blockers, prostanoids, phosphodiesterase inhibitors, diuretics, O2, anticoagulation, digoxin, exercise.</p>

<p><strong>Nursing</strong>: identify high-risk patients (COPD, PE, congenital heart disease), administer medications, provide emotional support, refer to support groups.</p>

<!-- ============================================================ -->
<!-- SECTION 13: COVID-19 -->
<!-- ============================================================ -->

<h2 class="section-title red" id="s13">XIII. COVID-19</h2>

<h3>Pathophysiology &amp; Transmission <span class="tag tag-slides">SLIDES</span></h3>
<p>COVID-19 is caused by SARS-CoV-2, a novel beta coronavirus (like MERS and SARS) that originated in bats. Primary transmission is via <strong>respiratory droplets</strong> (coughing, sneezing, singing, talking, breathing within 6 feet). <strong>Airborne transmission</strong> occurs during aerosol-generating procedures (intubation, extubation, suctioning, resuscitation). Individuals may be most infectious early in the disease, often <strong>before symptom onset</strong>.</p>

<p><strong>Incubation</strong>: 2-14 days (average 4-5 days). <strong>Classifications</strong>:</p>
<ul>
<li><strong>Mild</strong>: no or mild pneumonia</li>
<li><strong>Severe</strong>: dyspnea, hypoxia, respiratory distress</li>
<li><strong>Critical</strong>: respiratory failure, shock, multisystem organ failure</li>
</ul>

<h4>Risk Factors <span class="tag tag-slides">SLIDES</span></h4>
<p>Advanced age (&gt;80 years = highest mortality), cancer, chronic conditions, obesity, smoking, male sex. African American, Hispanic, and South Asian individuals account for higher hospitalizations and deaths due to socioeconomic disparities. Minorities have lower vaccination rates.</p>

<h3>Treatment <span class="tag tag-slides">SLIDES</span></h3>
<ul>
<li><strong>Remdesivir</strong>: only FDA-approved drug for hospitalized COVID-19 patients</li>
<li><strong>Corticosteroids</strong>: limited to patients requiring supplemental O2</li>
<li><strong>Prone positioning</strong>: improves oxygenation (12-16 hours/day when mechanically ventilated)</li>
<li><strong>HFNC</strong>: up to 60 L/min in adults (often 100% FiO2 with non-rebreather on top); airborne precautions due to aerosolizing nature</li>
<li><strong>ECMO</strong>: for refractory respiratory failure (outcomes still evolving)</li>
</ul>

<h3>COVID-19 Nursing Interventions <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>
<ul>
<li>Administer prescribed medications</li>
<li>Assess respiratory effort, WOB, accessory muscle use</li>
<li>Sedate for vent synchrony; collaborate with RT for FiO2 titration</li>
<li>Consider chemical paralytic (monitor TOF)</li>
<li><strong>Prone positioning</strong>: pad bony prominences, change electrode placement to back</li>
<li><strong>Common for pneumothorax</strong> due to high PEEP&mdash;keep chest tray at bedside (atrium, Vaseline gauze, sterile water, Kelly clamps)</li>
<li>OGT, Foley, central line</li>
<li>Oral care q2, SCDs or anticoagulation (increased clotting risk)</li>
<li><strong>Check blood sugars q6</strong> (tube feedings + steroids increase blood glucose)</li>
<li>ECMO may be used for refractory cases; dialysis often needed (kidney failure)</li>
<li>Administer vasopressors to support BP</li>
</ul>

<h4>PPE Protocol <span class="tag tag-slides">SLIDES</span></h4>
<p><strong>Standard contact/droplet</strong>: gowns, gloves, surgical mask, face shield or goggles. <strong>Aerosol-generating procedures</strong>: N95 or PAPR. Proper donning and doffing sequence is critical&mdash;observed by trained colleague to decrease contamination risk. Donning occurs outside patient area; doffing begins inside patient area.</p>

<h4>Effects on Healthcare Workers <span class="tag tag-slides">SLIDES</span></h4>
<p>Burnout, compassion fatigue, depression, PTSD. Early signs: difficulty concentrating, anger, withdrawal, nightmares. Interventions: talk to trusted colleagues, limit news/social media, exercise, meditation, notify supervisor, engage employer mental health services.</p>

<!-- ============================================================ -->
<!-- SECTION 14: GERONTOLOGIC -->
<!-- ============================================================ -->

<h2 class="section-title teal" id="s14">XIV. Gerontologic Considerations</h2>

<h3>Structural Changes with Aging <span class="tag tag-heavy">HEAVY IN SLIDES</span></h3>

<table>
<tr><th>Change</th><th>Consequence</th></tr>
<tr><td>Decreased cilia and mucus production</td><td>Increased infection rate</td></tr>
<tr><td>Decreased cough and gag reflex</td><td>Higher aspiration risk</td></tr>
<tr><td>Vital capacity peaks in mid-20s, gradual decline in middle adulthood</td><td>Reduced respiratory reserve</td></tr>
<tr><td>After age 40: alveolar surface area reduced</td><td>Less gas exchange area</td></tr>
<tr><td>Around age 50: alveoli lose elasticity, chest wall mobility declines</td><td>Decreased vital capacity</td></tr>
<tr><td>Calcification of intercostal cartilages</td><td>Rigidity/stiffness of thoracic cage</td></tr>
<tr><td>Kyphosis, skeletal changes</td><td>Barrel chest, increased AP diameter</td></tr>
<tr><td>Decreased respiratory muscle strength</td><td>Increased WOB, increased risk for inspiratory muscle fatigue</td></tr>
<tr><td>Decreased peripheral chemosensitivity</td><td>Blunted response to hypoxia</td></tr>
</table>

<h4>Functional Changes</h4>
<ul>
<li>Increased residual volume (RV)</li>
<li>Decreased IRV, ERV, FVC</li>
<li>Premature closure of airways</li>
<li>Increased respiratory dead space</li>
<li>Reduced ability to rapidly move air in and out</li>
</ul>

<h4>Nursing Considerations</h4>
<p>Home health nurses and respiratory therapists may visit. The RN educates on home safety, flow rate orders, when to use O2 (at night, PRN for SOB, or continuous), and fire safety with home O2.</p>

<h4>Upper Respiratory Changes <span class="tag tag-textbook">TEXTBOOK</span></h4>
<ul>
<li>Nose lengthens, tip droops &rarr; airflow restriction &rarr; geriatric rhinitis (thin watery drainage)</li>
<li>Decreased sense of smell</li>
<li>Laryngitis more common, often secondary to GERD</li>
<li>Voice changes: higher pitch in men, lower in women; thinner, tremulous quality</li>
<li>Antihistamines/decongestants used cautiously (side effects + drug interactions)</li>
<li>Rhinosinusitis is the 6th most common chronic disease in older adults</li>
</ul>

<!-- ============================================================ -->
<!-- SECTION 15: PHARMACOLOGY -->
<!-- ============================================================ -->

<h2 class="section-title green" id="s15">XV. Pharmacology Summary</h2>

<h3>Bronchodilators</h3>
<table>
<tr><th>Class</th><th>Examples</th><th>Key Notes</th></tr>
<tr><td><strong>SABA</strong></td><td>Albuterol, levalbuterol, terbutaline</td><td>Quick relief / rescue; relax smooth muscle</td></tr>
<tr><td><strong>LABA</strong></td><td>Salmeterol, formoterol, indacaterol, olodaterol, arformoterol</td><td>Controller; use WITH anti-inflammatory agent</td></tr>
<tr><td><strong>Anticholinergics</strong></td><td>Ipratropium, tiotropium, umeclidinium</td><td>Bronchodilation via different mechanism</td></tr>
<tr><td>Combo SABA + Anticholinergic</td><td>Salbutamol/ipratropium (DuoNeb)</td><td>Dual-action</td></tr>
</table>

<h3>Corticosteroids</h3>
<table class="teal">
<tr><th>Route</th><th>Examples</th><th>Notes</th></tr>
<tr><td><strong>Inhaled (ICS)</strong></td><td>Beclomethasone, budesonide, fluticasone</td><td>Preferred for long-term; fewer systemic effects</td></tr>
<tr><td>Systemic</td><td>Dexamethasone, methylprednisolone, prednisone</td><td>Short-term for exacerbations; long-term oral &rarr; muscle weakness</td></tr>
<tr><td>Combo ICS + LABA</td><td>Budesonide/formoterol, fluticasone/salmeterol, fluticasone furoate/vilanterol</td><td>Convenient combination inhalers</td></tr>
</table>

<h3>Other Key Medications</h3>
<table class="purple">
<tr><th>Drug</th><th>Class</th><th>Use</th><th>Key Notes</th></tr>
<tr><td><strong>Naloxone (Narcan)</strong></td><td>Opioid antagonist</td><td>Reverse opioid respiratory depression</td><td>Rapid onset</td></tr>
<tr><td><strong>Flumazenil (Romazicon)</strong></td><td>Benzo antagonist</td><td>Reverse benzo sedation</td><td></td></tr>
<tr><td><strong>Mg Sulfate</strong></td><td>Electrolyte</td><td>Status asthmaticus</td><td>2g over 20 min; smooth muscle relaxation</td></tr>
<tr><td><strong>Heparin GTT</strong></td><td>Anticoagulant</td><td>PE treatment</td><td>Monitor aPTT, anti-Xa</td></tr>
<tr><td><strong>Enoxaparin (Lovenox)</strong></td><td>LMWH</td><td>PE prevention/treatment</td><td>SubQ injection</td></tr>
<tr><td><strong>Chlorhexidine 0.12%</strong></td><td>Antiseptic</td><td>Oral care for VAP prevention</td><td>Part of VAP bundle</td></tr>
<tr><td><strong>Remdesivir</strong></td><td>Antiviral</td><td>Hospitalized COVID-19</td><td>Only FDA-approved COVID treatment</td></tr>
</table>

<h3>Smoking Cessation Aids</h3>
<ul>
<li><strong>NRT</strong>: gum, inhaler, patch, sublingual tablet, lozenge</li>
<li><strong>Medications</strong>: bupropion SR, nortriptyline, clonidine, Chantix (varenicline)</li>
<li>Not candidates: pregnant patients, adolescents, light smokers (&le;10/day)</li>
</ul>

<!-- ============================================================ -->
<!-- SECTION 16: NCLEX HIGH-YIELD -->
<!-- ============================================================ -->

<h2 class="section-title red" id="s16">XVI. NCLEX High-Yield Review</h2>

<p>These are the concepts most likely to appear in exam questions, distilled from lecture emphasis and clinical significance:</p>

<table>
<tr><th>#</th><th>Concept</th></tr>
<tr><td>1</td><td><strong>ETCO2 &gt; SpO2</strong> for detecting respiratory compromise early. SpO2 = oxygenation; ETCO2 = ventilation.</td></tr>
<tr><td>2</td><td><strong>Stridor = emergency.</strong> Immediate intervention (upper airway obstruction).</td></tr>
<tr><td>3</td><td><strong>Barrel chest = emphysema/COPD</strong> (chronic lung overinflation).</td></tr>
<tr><td>4</td><td><strong>Cyanosis is a LATE sign</strong> of hypoxia. Not reliable in anemia or dark skin.</td></tr>
<tr><td>5</td><td><strong>Central cyanosis</strong> assessed on tongue and lips (more reliable than peripheral).</td></tr>
<tr><td>6</td><td><strong>Pneumonia prevention</strong>: vaccine &gt;65 (PCV13 + PPSV23); annual flu vaccine for COPD.</td></tr>
<tr><td>7</td><td><strong>ARDS</strong>: hypoxemia UNRESPONSIVE to O2 regardless of PEEP; bilateral CXR infiltrates.</td></tr>
<tr><td>8</td><td><strong>Status asthmaticus</strong>: if wheezing disappears &rarr; impending respiratory failure.</td></tr>
<tr><td>9</td><td><strong>COPD + O2</strong>: high-flow O2 depresses respiratory drive; maintain SpO2 &gt;90%.</td></tr>
<tr><td>10</td><td><strong>Chronic bronchitis definition</strong>: cough + sputum for 3 months in 2 consecutive years.</td></tr>
<tr><td>11</td><td><strong>Flail chest</strong>: &ge;3 ribs fractured at &ge;2 sites &rarr; paradoxical movement.</td></tr>
<tr><td>12</td><td><strong>Tension pneumothorax</strong>: structures deviate to UNAFFECTED side; PEA possible.</td></tr>
<tr><td>13</td><td><strong>PE</strong>: death within 1 hour of onset; D-dimer to rule out; MDCTA = gold standard.</td></tr>
<tr><td>14</td><td><strong>VAP bundle</strong>: HOB 30-45&deg;, sedation vacations, PUD prophylaxis, DVT prophylaxis, oral care with chlorhexidine.</td></tr>
<tr><td>15</td><td><strong>Suctioning</strong>: no longer than 10 seconds; increase O2 to 100% before.</td></tr>
<tr><td>16</td><td><strong>ETT &rarr; trach</strong>: convert at 14-21 days.</td></tr>
<tr><td>17</td><td><strong>Hemoptysis vs. hematemesis</strong>: lung = bright red, frothy; stomach = dark, coffee grounds.</td></tr>
<tr><td>18</td><td><strong>ABGs (ROME)</strong>: pH 7.35-7.45, PaCO2 35-45, HCO3 22-26, PaO2 &gt;80.</td></tr>
<tr><td>19</td><td><strong>ICOUGH</strong>: IS, Cough/deep breathe, Oral care, Understanding, OOB &times;3/day, HOB &gt;30&deg;.</td></tr>
<tr><td>20</td><td><strong>Chest tube safety</strong>: Vaseline gauze, Kelly clamps, sterile water at bedside.</td></tr>
<tr><td>21</td><td><strong>Postural drainage</strong>: performed 2-3&times;/day BEFORE meals.</td></tr>
<tr><td>22</td><td><strong>Subcutaneous emphysema</strong>: crackling on palpation (crepitus); air self-absorbs.</td></tr>
<tr><td>23</td><td><strong>Laryngectomy</strong>: frequent swallowing = sign of bleeding.</td></tr>
<tr><td>24</td><td><strong>CF</strong>: autosomal recessive, most common in Caucasians; airway clearance is key.</td></tr>
<tr><td>25</td><td><strong>Naloxone</strong> reverses opioids; <strong>Flumazenil</strong> reverses benzodiazepines.</td></tr>
<tr><td>26</td><td><strong>Tracheal shift</strong>: TOWARD atelectasis/collapse; AWAY FROM effusion/pneumothorax.</td></tr>
<tr><td>27</td><td><strong>Lung cancer</strong>: leading cause of cancer death; &gt;85% from cigarette smoke; most common sign is cough/change in cough.</td></tr>
<tr><td>28</td><td><strong>Oxyhemoglobin curve</strong>: PaO2 &lt;60 mmHg = steep slope; right shift = release more O2 to tissues.</td></tr>
<tr><td>29</td><td><strong>ABCDEF bundle</strong>: Awakening, Breathing, Choice of sedation, Delirium monitoring, Early mobility, Family engagement.</td></tr>
<tr><td>30</td><td><strong>VC &lt;10 mL/kg</strong> = unable to sustain spontaneous ventilation.</td></tr>
</table>

<div class="callout clinical">
<div class="callout-title">Final Clinical Pearl</div>
<p>"The most important skill in respiratory nursing isn't knowing every breath sound&mdash;it's noticing when something has changed. Restlessness before desaturation. Subtle tachycardia before respiratory distress. The patient who 'just doesn't look right.' Trust your assessment, verify with data, and never hesitate to escalate."</p>
</div>

</main>
</div>
</body>
</html>
